activity_id,assay_chembl_id,assay_description,assay_type,molecule_chembl_id,relation,standard_units,standard_value,target_chembl_id,target_organism,type,units,value,canonical smiles,pIC50
32260,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL68920,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,uM,0.041,Cc1cc(C)c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)[nH]1,7.3872161432802645
32680,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL137635,=,nM,9300.0,CHEMBL203,Homo sapiens,IC50,uM,9.3,CN(c1ccccc1)c1ncnc2ccc(N/N=N/Cc3ccccn3)cc12,5.031517051446065
32770,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL306988,=,nM,500000.0,CHEMBL203,Homo sapiens,IC50,uM,500.0,CC(=C(C#N)C#N)c1ccc(NC(=O)CCC(=O)O)cc1,3.3010299956639813
62149,CHEMBL679674,Inhibition of Epidermal growth factor receptor,B,CHEMBL47940,=,nM,3200.0,CHEMBL203,Homo sapiens,IC50,uM,3.2,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1,5.494850021680094
78012,CHEMBL679949,Evaluated for inhibitory activity towards tyrosine kinase Epidermal growth factor receptor,B,CHEMBL432941,=,nM,8880.0,CHEMBL203,Homo sapiens,IC50,uM,8.88,COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c3c(c2CCC(=O)O)CCCC3)c1,5.051587034221399
81208,CHEMBL674698,Inhibition of Epidermal growth factor receptor,B,CHEMBL322395,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,nM,3000.0,COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCOCC5)cc4)ccc23)c(Cl)cc1Cl,5.522878745280337
105739,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL138691,=,nM,2282.0,CHEMBL203,Homo sapiens,IC50,nM,2282.0,C=CC(=O)N(CCN(C)C)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,5.641684359917805
107298,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL322298,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2,CCn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccccc3)nc21,6.698970004336019
107993,CHEMBL677213,Inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells,B,CHEMBL136058,=,nM,8.8,CHEMBL203,Homo sapiens,IC50,nM,8.8,O=C(/C=C/C(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1)NCCCN1CCOCC1,8.05551732784983
108863,CHEMBL683041,Inhibition of Epidermal Growth Factor Receptor (EGFR) autophosphorylation,B,CHEMBL939,=,nM,515.0,CHEMBL203,Homo sapiens,IC50,uM,0.515,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,6.288192770958809
110218,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL292323,=,nM,6500.0,CHEMBL203,Homo sapiens,IC50,uM,6.5,COc1cccc2c(C(=O)Nc3ccccc3)c(SSc3c(C(=O)Nc4ccccc4)c4cccc(OC)c4n3C)n(C)c12,5.187086643357144
114538,CHEMBL677390,Inhibition of human epidermal growth factor receptor (EGFR),B,CHEMBL293261,=,nM,850.0,CHEMBL203,Homo sapiens,IC50,uM,0.85,O=C(CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)NCc2ccccc2)[nH]c2ccccc12)NCc1ccccc1,6.070581074285707
115581,CHEMBL679549,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),B,CHEMBL267019,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5,O=C1NC(=O)c2cc(Nc3ccc(O)cc3)c(Nc3ccc(O)cc3)cc21,5.6020599913279625
117231,CHEMBL679948,Inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells,B,CHEMBL434827,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0,CCN(CC)CCCNC(=O)/C=C/C(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,7.6777807052660805
182065,CHEMBL677888,Inhibition of Epidermal growth factor receptor (Her1/ErbB1),B,CHEMBL428690,=,nM,7600.0,CHEMBL203,Homo sapiens,IC50,nM,7600.0,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,5.119186407719209
183887,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL14932,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,nM,98.0,Oc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1,7.008773924307505
185100,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL38199,=,nM,3.7,CHEMBL203,Homo sapiens,IC50,nM,3.7,Brc1cccc(Nc2ncnc3cc4c(cnn4CCN4CCOCC4)cc23)c1,8.431798275933005
208009,CHEMBL676158,Inhibition of Epidermal growth factor receptor from human A431 carcinoma cell membranes,B,CHEMBL39337,=,nM,0.44,CHEMBL203,Homo sapiens,IC50,nM,0.44,Brc1cccc(Nc2ncnc3cc4[nH]ncc4cc23)c1,9.356547323513812
265169,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL338448,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9,CO[C@H]1[C@@H](N(C)C(=O)c2ccccc2)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.721246399047171
271226,CHEMBL675521,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL57323,=,nM,610.0,CHEMBL203,Homo sapiens,IC50,uM,0.61,Cc1cccc(C)c1-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C,6.214670164989233
272862,CHEMBL680015,Inhibition of EGFR,B,CHEMBL160846,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008,CS(=O)(=O)CCNc1nc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)cs1,8.096910013008056
273532,CHEMBL675520,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 cell membranes,B,CHEMBL26001,=,nM,250000.0,CHEMBL203,Homo sapiens,IC50,uM,250.0,O=P(O)(O)C(O)c1ccc2ccccc2c1,3.6020599913279625
278588,CHEMBL675380,Inhibition of epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL76599,=,nM,5530.0,CHEMBL203,Homo sapiens,IC50,uM,5.53,CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1ccccc1,5.257274868695301
307859,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL2448064,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3,COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CCNCC1.Cl,6.522878745280337
313559,CHEMBL677206,Inhibition of epidermal growth factor receptor (EGFr),B,CHEMBL135861,=,nM,13000.0,CHEMBL203,Homo sapiens,IC50,uM,13.0,CNC(=O)c1c([Se][Se]c2[nH]c3ccccc3c2C(=O)NC)[nH]c2ccccc12,4.886056647693163
322969,CHEMBL679946,Concentration required to inhibit phosphorylation of isolated human epidermal growth factor tyrosine kinase receptor by 50%,B,CHEMBL63356,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5,Oc1cc2cc(-c3cccnc3)cnc2cc1O,6.301029995663981
346388,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL113996,=,nM,13570.0,CHEMBL203,Homo sapiens,IC50,uM,13.57,COc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCOCC1,4.867420152340263
348082,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL126384,=,nM,5.4,CHEMBL203,Homo sapiens,IC50,nM,5.4,Brc1cccc(Nc2ncnc3cc(NCCCCN4CCOCC4)ncc23)c1,8.267606240177031
352156,CHEMBL673451,Inhibition of epidermal growth factor receptor (EGFR) autophosphorylation in A431 cells,B,CHEMBL128987,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0,Brc1cccc(Nc2ncnc3cc(NCCN4CCOCC4)ncc23)c1,7.443697499232713
352158,CHEMBL677386,Inhibition of epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL340898,=,nM,3.5,CHEMBL203,Homo sapiens,IC50,nM,3.5,Cc1cccc(Nc2ncnc3cc(NCCCn4ccnc4)ncc23)c1,8.455931955649724
391087,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL355330,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3,Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCC1,6.522878745280337
393852,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL153525,=,nM,1.24,CHEMBL203,Homo sapiens,IC50,nM,1.24,Brc1cccc(Nc2ncnc3ccc4cc[nH]c4c23)c1,8.906578314837764
393860,CHEMBL677214,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 cells,B,CHEMBL152905,=,nM,86.0,CHEMBL203,Homo sapiens,IC50,nM,86.0,Nc1ccc2sc3c(Nc4cccc(Br)c4)ncnc3c2c1,7.0655015487564325
418892,CHEMBL674026,Inhibition of EGFR kinase,B,CHEMBL97162,=,nM,83.0,CHEMBL203,Homo sapiens,IC50,nM,83.0,COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1,7.080921907623926
431817,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL169780,=,nM,2540.0,CHEMBL203,Homo sapiens,IC50,uM,2.54,Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCN(CCO)CC1,5.595166283380062
454181,CHEMBL677879,Inhibition of epidermal growth factor receptor (EGF-R),B,CHEMBL172514,=,nM,310.0,CHEMBL203,Homo sapiens,IC50,uM,0.31,COCCNCCN1CCC(n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)CC1,6.508638306165727
468916,CHEMBL672267,Inhibition of EGF receptor kinase,B,CHEMBL10,=,nM,96000.0,CHEMBL203,Homo sapiens,IC50,nM,96000.0,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,4.017728766960431
476108,CHEMBL674700,Inhibition of Epidermal growth factor receptor (EGFr),B,CHEMBL113185,=,nM,5100.0,CHEMBL203,Homo sapiens,IC50,nM,5100.0,COc1cc(Nc2nccc(-c3ccc(NCCN)nc3)n2)cc(OC)c1OC,5.292429823902063
479781,CHEMBL676160,Inhibition of Epidermal growth factor receptor autophosphorylation.,B,CHEMBL543661,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0,COc1cc(Nc2ncnc3cc(OC)c(OC)cc23)cc(OC)c1.Cl,5.522878745280337
481537,CHEMBL677382,Inhibition of epidermal growth factor receptor,B,CHEMBL301483,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3,CCNC(=O)Nc1nc2nc(NCCCCN(CC)CC)ncc2cc1-c1c(Cl)cccc1Cl,5.886056647693163
509788,CHEMBL676161,"Inhibition of Epidermal growth factor receptor autophosphorylation, 0.05-0.10",B,CHEMBL555321,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05,Cl.Clc1cccc(Nc2ncnc3ccccc23)c1,7.301029995663981
512206,CHEMBL674105,Inhibitory activity against HER1 kinase,B,CHEMBL131577,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0,Cc1cccc(Cl)c1NC(=O)c1cnc(NC(=O)C2CC2)s1,5.0
515465,CHEMBL674692,Inhibition of Epidermal growth factor receptor,B,CHEMBL48614,=,nM,1680.0,CHEMBL203,Homo sapiens,IC50,uM,1.68,CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccccc2Cl)C3=O)CC1,5.774690718274137
548235,CHEMBL677830,Inhibitory activity against Epidermal growth factor receptor,B,CHEMBL150177,=,nM,84800.0,CHEMBL203,Homo sapiens,IC50,uM,84.8,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c(C)c1CCC(=O)O,4.071604147743286
553697,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL56505,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,uM,0.035,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN(CCO)CCO,7.455931955649724
561023,CHEMBL677887,Inhibition of Epidermal growth factor receptor,B,CHEMBL7699,=,nM,58800.0,CHEMBL203,Homo sapiens,IC50,uM,58.8,O=c1c(-c2cccc(Cl)c2)coc2cc(O)ccc12,4.230622673923862
564386,CHEMBL674638,Inhibition of in vitro activity of EGFr enzyme from A431 cells in presence of 5 uM ATP,B,CHEMBL112925,=,nM,8700.0,CHEMBL203,Homo sapiens,IC50,uM,8.7,Nc1ccc(-c2cc(=O)c3cc(N)ccc3o2)cc1,5.060480747381382
564605,CHEMBL677889,Inhibition of Epidermal growth factor receptor-dependent phosphorylation,B,CHEMBL7917,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12,COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC,6.920818753952375
565025,CHEMBL677385,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,B,CHEMBL281467,=,nM,374.8,CHEMBL203,Homo sapiens,IC50,nM,374.8,C=CC(=O)Nc1cnc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1,6.426200417784259
592926,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL347668,=,nM,8500.0,CHEMBL203,Homo sapiens,IC50,uM,8.5,O=C(CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)NCc2ccc(C(=O)O)c(O)c2)[nH]c2ccccc12)NCc1ccc(C(=O)O)c(O)c1,5.070581074285707
593023,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL541307,=,nM,3900.0,CHEMBL203,Homo sapiens,IC50,uM,3.9,CN(C)CC(CNNC(N)=O)C(=O)c1ccc(OCc2ccccc2)cc1.Cl,5.4089353929735005
600251,CHEMBL843057,Inhibition of epidermal growth factor receptor (EGFR),B,CHEMBL414013,=,nM,75000.0,CHEMBL203,Homo sapiens,IC50,uM,75.0,COc1cc2c(cc1OC)Nc1ncnc(O)c1C2,4.1249387366083
634376,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL144791,=,nM,850.0,CHEMBL203,Homo sapiens,IC50,uM,0.85,N#C/C(=C\c1cc(O)c(O)c(Br)c1)S(=O)(=O)/C(C#N)=C/c1cc(O)c(O)c(Br)c1,6.070581074285707
641520,CHEMBL675238,Inhibition of EGF receptor,B,CHEMBL30432,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001,CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1,9.0
641694,CHEMBL676154,Inhibition of Epidermal growth factor receptor tyrosine kinase,B,CHEMBL87084,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0,Oc1cc2cc(-c3ccncc3)cnc2cc1O,5.301029995663981
672816,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL76432,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,uM,0.068,c1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1,7.167491087293763
675130,CHEMBL674104,Inhibition of Epidermal growth factor receptor autophosphorylation,B,CHEMBL53898,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCc1ccccc1,6.154901959985743
685998,CHEMBL674103,Inhibition of Epidermal growth factor receptor,B,CHEMBL327725,=,nM,44000.0,CHEMBL203,Homo sapiens,IC50,uM,44.0,CC(O)C(/N=C1/C=C(O)/C(=N\C(C(=O)O)C(C)O)C=C1O)C(=O)O,4.356547323513813
694287,CHEMBL674699,Inhibition of Epidermal growth factor receptor,B,CHEMBL47660,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0,N#C/C(=C\c1cc(O)ccc1O)C(N)=O,5.0
715862,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL174634,=,nM,2650.0,CHEMBL203,Homo sapiens,IC50,uM,2.65,Cc1ccccc1-c1cn(-c2ccccc2)c2ncnc(N)c12,5.576754126063192
717675,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL161956,=,nM,0.22,CHEMBL203,Homo sapiens,IC50,nM,0.22,CN(CCO)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.657577319177793
725650,CHEMBL676074,Inhibition of tyrosine/glutamic acid copolymer phosphorylation by epidermal growth factor receptor prepared of human A431,B,CHEMBL53753,=,nM,0.008,CHEMBL203,Homo sapiens,IC50,nM,0.008,CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,11.096910013008056
726661,CHEMBL677212,Inhibition of epidermal growth factor receptor (EGF-R),B,CHEMBL13629,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Br)cc32)c1C,5.0
729369,CHEMBL676233,Inhibition of tyrosine/glutamic acid copolymer phosphorylation by epidermal growth factor receptor prepared of human A431,B,CHEMBL162821,=,nM,0.45,CHEMBL203,Homo sapiens,IC50,nM,0.45,CNc1cc2c(Nc3cccc(C)c3)ncnc2cn1,9.346787486224656
729944,CHEMBL674012,Tested for inhibition of EGF-receptor tyrosine kinase in intact cells,B,CHEMBL105436,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0,COc1cccc(-c2cn(-c3ccc(CCN(C)CCO)cc3)c3ncnc(N)c23)c1,5.0
736015,CHEMBL674025,Inhibition of EGFR kinase,B,CHEMBL22978,=,nM,797.0,CHEMBL203,Homo sapiens,IC50,uM,0.797,CN1CCC(O)(c2nc(-c3ccc(F)cc3)c(-c3ccncc3)o2)CC1,6.098541678603888
740505,CHEMBL673924,Inhibition of tyrosine/glutamic acid copolymer phosphorylation by epidermal growth factor receptor prepared of human A431,B,CHEMBL433520,=,nM,4.6,CHEMBL203,Homo sapiens,IC50,uM,0.0046,CCN(CC)CC(O)CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.337242168318426
755917,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL333454,=,nM,8700.0,CHEMBL203,Homo sapiens,IC50,uM,8.7,COc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccc(C)cc2)c1O,5.060480747381382
756378,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL76958,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0,O=C(O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1,6.0
758241,CHEMBL689289,Inhibition of polyGAT phosphorylation by EGF receptor,B,CHEMBL424625,=,nM,125000.0,CHEMBL203,Homo sapiens,IC50,uM,125.0,COc1cc(/C=C(\C#N)C(N)=O)cc(CSCCC(=O)O)c1O,3.9030899869919438
761546,CHEMBL673783,Inhibition of erbB-1 receptor tyrosine kinase from A431 human epidermoid carcinoma cells,B,CHEMBL477,=,nM,195000.0,CHEMBL203,Homo sapiens,IC50,uM,195.0,Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,3.709965388637482
765669,CHEMBL677530,Inhibition of Epidermal growth factor receptor,B,CHEMBL388978,=,nM,49.0,CHEMBL203,Homo sapiens,IC50,uM,0.049,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,7.309803919971486
789300,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL286343,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0,C=CC(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCCCn1ccnc1,8.522878745280337
838576,CHEMBL677885,Inhibition of Epidermal growth factor receptor,B,CHEMBL57366,=,nM,450.0,CHEMBL203,Homo sapiens,IC50,uM,0.45,CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl,6.346787486224656
848306,CHEMBL674011,Inhibition of EGF-receptor,B,CHEMBL56236,=,nM,6680.0,CHEMBL203,Homo sapiens,IC50,uM,6.68,Cc1cc(C)c(C)c(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1C,5.175223537524454
865808,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL293889,=,nM,4300.0,CHEMBL203,Homo sapiens,IC50,uM,4.3,Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cc(Cl)ccc3n2C)c(C(=O)Nc2ccccc2)c2cc(Cl)ccc21,5.366531544420414
865829,CHEMBL677205,Inhibition of Epidermal growth factor receptor from A431 cells,B,CHEMBL420624,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1,Nc1ccc2c(Nc3cccc(Br)c3)ncnc2c1,10.0
866294,CHEMBL676159,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK).,B,CHEMBL85021,=,nM,15300.0,CHEMBL203,Homo sapiens,IC50,uM,15.3,CC(C)c1cc(/C=C2\C(=O)Nc3ccccc32)cc(C(C)C)c1O,4.815308569182402
867224,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL329161,=,nM,897.0,CHEMBL203,Homo sapiens,IC50,nM,897.0,O=[N+]([O-])c1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.047207556955908
867376,CHEMBL856168,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL53690,=,nM,0.91,CHEMBL203,Homo sapiens,IC50,nM,0.91,C=CC(=O)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1,9.040958607678906
868682,CHEMBL678292,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,B,CHEMBL126192,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002,CCOc1cc2ncnc(Nc3cccc(-c4nccs4)c3)c2cc1OCC,8.698970004336019
873549,CHEMBL674018,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL280757,=,nM,0.69,CHEMBL203,Homo sapiens,IC50,nM,0.69,C=CC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Br)c3)c2c1,9.161150909262744
879690,CHEMBL678293,Inhibition of Epidermal growth factor receptor,B,CHEMBL126456,=,nM,4800.0,CHEMBL203,Homo sapiens,IC50,uM,4.8,CCOc1cc2ncnc(Nc3cccc(-c4csc(C)n4)c3)c2cc1OCC,5.318758762624412
882799,CHEMBL676151,Inhibition of tyrosine kinase Epidermal growth factor receptor,B,CHEMBL278287,=,nM,49000.0,CHEMBL203,Homo sapiens,IC50,uM,49.0,Cc1ccc(N(C)C(=O)c2ccccc2)cc1Nc1nccc(-c2cccnc2)n1,4.309803919971486
902741,CHEMBL679676,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL53203,=,nM,5.8,CHEMBL203,Homo sapiens,IC50,nM,5.8,C=CC(=O)Nc1ccc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2c1,8.236572006437063
905960,CHEMBL675381,In vitro activity against Epidermal growth factor receptor (using poly(Glu4Tyr1) as a substrate),B,CHEMBL266182,=,nM,180000.0,CHEMBL203,Homo sapiens,IC50,uM,180.0,O=C1c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C(=O)N1NCC(O)CO,3.744727494896694
921287,CHEMBL675386,Inhibition of the epidermal growth factor receptor.,B,CHEMBL59099,=,nM,45000.0,CHEMBL203,Homo sapiens,IC50,uM,45.0,NCCCNC(=O)c1cccc(Nc2nccc(-c3cccnc3)n2)c1,4.346787486224656
946785,CHEMBL873595,Inhibition of epidermal growth factor receptor (EGFR),B,CHEMBL49350,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4,O=C(NCCc1ccccc1)c1cc2ccc(O)c(O)c2cn1,5.853871964321762
949286,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL93173,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,uM,0.17,COc1cc2ncnc(NCc3cccc(C)c3)c2cc1OC,6.769551078621726
987820,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL328106,=,nM,0.96,CHEMBL203,Homo sapiens,IC50,nM,0.96,COc1cc2ncnc(Nc3ccc(Br)cc3)c2cc1OC,9.017728766960431
1003161,CHEMBL675242,Inhibit of epidermal growth factor receptor (EGFR),B,CHEMBL367625,=,nM,5100.0,CHEMBL203,Homo sapiens,IC50,uM,5.1,CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21,5.292429823902063
1027809,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL93783,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,uM,0.014,CN(C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)CCO,7.853871964321762
1030178,CHEMBL683040,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,B,CHEMBL93032,=,nM,0.17,CHEMBL203,Homo sapiens,IC50,nM,0.17,Oc1cc2ncnc(Nc3cccc(Br)c3)c2cc1O,9.769551078621726
1036198,CHEMBL677211,Displacement of [gamma-32P]-ATP from Epidermal growth factor receptor in A431 cell-free extracts,B,CHEMBL319620,=,nM,4000.0,CHEMBL203,Homo sapiens,IC50,uM,4.0,O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O,5.3979400086720375
1036448,CHEMBL679548,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 cells,B,CHEMBL172652,=,nM,4.1,CHEMBL203,Homo sapiens,IC50,nM,4.1,Brc1cccc(Nc2ncnc3cc4[nH]nnc4cc23)c1,8.387216143280265
1068012,CHEMBL674695,Inhibition of Epidermal growth factor receptor,B,CHEMBL101683,=,nM,7300.0,CHEMBL203,Homo sapiens,IC50,uM,7.3,O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1,5.136677139879544
1068226,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL301359,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0,c1ccc2ncncc2c1,7.568636235841013
1075322,CHEMBL677215,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,B,CHEMBL53796,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0,CN(C)c1ccc2ncnc(Nc3cccc(Br)c3)c2n1,7.494850021680094
1102403,CHEMBL676150,Inhibition of Epidermal growth factor receptor from human A431 cell membranes,B,CHEMBL29197,=,nM,0.029,CHEMBL203,Homo sapiens,IC50,pM,29.0,COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC,10.537602002101044
1111718,CHEMBL675388,Inhibition of epidermal growth factor receptor (EGFR),B,CHEMBL132466,=,nM,18000.0,CHEMBL203,Homo sapiens,IC50,uM,18.0,COc1cc2cc3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3cc2cc1OC,4.7447274948966935
1133410,CHEMBL677207,In vitro inhibition of intrinsic tyrosine protein kinase activity of the Epidermal growth factor receptor using tripeptide RR-Src,B,CHEMBL358092,=,nM,14000.0,CHEMBL203,Homo sapiens,IC50,uM,14.0,COC(=O)c1ccc(-c2ccc(-c3ccccc3)cc2O)cc1,4.853871964321762
1142979,CHEMBL683042,Inhibition of human epidermal growth factor receptor,B,CHEMBL49596,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,uM,5.6,Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(N)nc21,5.251811972993799
1144128,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL54471,=,nM,880.0,CHEMBL203,Homo sapiens,IC50,uM,0.88,Cc1ccc(C(=O)/C(C#N)=C/c2ccc(O)c(O)c2)cc1,6.055517327849832
1144368,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL332612,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005,Nc1ccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1,8.301029995663981
1152815,CHEMBL677883,"In vitro inhibition of Epidermal growth factor receptor (HER-1,ErbB) expressed in baculovirus",B,CHEMBL153843,=,nM,10400.0,CHEMBL203,Homo sapiens,IC50,nM,10400.0,O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1,4.982966660701219
1165161,CHEMBL676153,Inhibition of epidermal growth factor receptor autophosphorylation,B,CHEMBL55204,=,nM,5100.0,CHEMBL203,Homo sapiens,IC50,uM,5.1,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccc(F)cc1,5.292429823902063
1175338,CHEMBL677882,In vitro inhibition of Epidermal growth factor receptor expressed in baculovirus,B,CHEMBL24828,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,nM,500.0,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,6.301029995663981
1191697,CHEMBL683037,"Inhibition of human Epidermal growth factor receptor, HER-1",B,CHEMBL2111784,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1,C[C@H](Nc1cc(-c2sc(C3CCN(C)CC3)nc2-c2ccc(F)cc2)ccn1)c1ccccc1,5.958607314841775
1196231,CHEMBL821544,Inhibition of c-erbB2 receptor,B,CHEMBL290389,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,uM,0.35,COc1cc(/C=C(\C#N)C(N)=O)cc(Sc2nc3ccccc3s2)c1O,6.455931955649724
1197965,CHEMBL689294,Inhibition of human Epidermal growth factor receptor,B,CHEMBL419409,=,nM,8800.0,CHEMBL203,Homo sapiens,IC50,uM,8.8,COc1ccc(C#CC(C)(C)N)cc1C(=O)c1ccc(Nc2ccc(F)cc2F)cc1,5.055517327849831
1200013,CHEMBL674642,Inhibition of EGF-R Tyrosine kinase (TK),B,CHEMBL103552,=,nM,4100.0,CHEMBL203,Homo sapiens,IC50,uM,4.1,O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O,5.3872161432802645
1227781,CHEMBL677529,Inhibition of Epidermal growth factor receptor,B,CHEMBL27085,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0,Cc1nc(O)c2c(ccc3[nH]c(Nc4c(Cl)cccc4Cl)nc32)c1C,4.0
1257897,CHEMBL674697,Inhibition of Epidermal growth factor receptor,B,CHEMBL104466,=,nM,3700.0,CHEMBL203,Homo sapiens,IC50,uM,3.7,COc1cc2ncc(N[C@H]3CC[C@H](O)CC3)nc2cc1OC,5.431798275933005
1266764,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL75208,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2,Cc1[nH]c2ncnc(Nc3cccc(C#N)c3)c2c1C,6.698970004336019
1400129,CHEMBL832814,Inhibition of epidermal growth factor receptor,B,CHEMBL177688,=,nM,1360.0,CHEMBL203,Homo sapiens,IC50,uM,1.36,OCCCNc1cncc(-c2cncc(Nc3cccc(Cl)c3)n2)c1,5.866461091629782
1418537,CHEMBL832627,Inhibitory concentration against EGFR by using [gamma-33P]-ATP as radioligand in pH 7.5,B,CHEMBL181275,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2,Fc1ccc(Nc2ncnc3nn4ccccc4c23)cc1Cl,6.698970004336019
1423098,CHEMBL828723,Inhibition of poly(L-glutamic acid-L-tyrosine) phosphorylation by EGFR tyrosine kinase of A431 carcinoma cells,B,CHEMBL52765,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,uM,0.044,Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.356547323513813
1429096,CHEMBL830975,Inhibition of Epidermal growth factor receptor,B,CHEMBL49120,=,nM,44000.0,CHEMBL203,Homo sapiens,IC50,uM,44.0,CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1,4.356547323513813
1453093,CHEMBL832673,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,B,CHEMBL186802,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,uM,5.6,COc1cc2ncnc(Nc3cccc(NC(=O)c4ccccc4)c3)c2cc1OC,5.251811972993799
1462325,CHEMBL832893,In vitro inhibition of Epidermal growth factor receptor,B,CHEMBL185637,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11,Fc1ccc(Nc2ncnn3cccc23)cc1Cl,6.958607314841775
1487653,CHEMBL829442,Inhibition of Epidermal growth factor receptor,B,CHEMBL363130,=,nM,8400.0,CHEMBL203,Homo sapiens,IC50,uM,8.4,Cc1ccsc1C(=O)n1nc(Nc2ccc(S(N)(=O)=O)cc2)nc1N,5.075720713938118
1495537,CHEMBL832761,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL190651,=,nM,252.0,CHEMBL203,Homo sapiens,IC50,nM,252.0,COCC(=O)Nc1ccc2ncnc(Nc3cc(Cl)c(Cl)cc3F)c2c1,6.598599459218456
1495548,CHEMBL829928,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 1000-5000 nM,B,CHEMBL190567,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,nM,5000.0,COCC(=O)Nc1ccc2ncnc(Nc3cccc(I)c3)c2c1,5.301029995663981
1495551,CHEMBL828302,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 5-25 nM,B,CHEMBL275762,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0,O=C(CCl)Nc1ccc2ncnc(Nc3cc(Cl)c(Cl)cc3F)c2c1,7.6020599913279625
1495655,CHEMBL828301,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 4-10 nM,B,CHEMBL193160,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0,O=C(CCl)Nc1ccc2ncnc(Nc3cccc(I)c3)c2c1,8.0
1495659,CHEMBL829088,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 10-50 nM,B,CHEMBL190094,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0,CN(C)C/C=C/C(=O)Nc1ccc2ncnc(Nc3cc(Cl)c(Cl)cc3F)c2c1,7.301029995663981
1495664,CHEMBL828300,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 1-10 nM,B,CHEMBL94061,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0,CN(C)C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.0
1495670,CHEMBL831153,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL372246,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,nM,250.0,C=CC(=O)Nc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1N1CCN(C)CC1,6.6020599913279625
1495673,CHEMBL832921,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 50-250 nM,B,CHEMBL365805,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,nM,250.0,C=CC(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1N1CCN(C)CC1,6.6020599913279625
1495677,CHEMBL827827,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 3-5 nM,B,CHEMBL437879,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0,COc1cc2ncnc(Nc3cc(Cl)c(Cl)cc3F)c2cc1OC,8.301029995663981
1495679,CHEMBL832922,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 6.7-20 nM,B,CHEMBL363815,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0,C=CC(=O)Nc1ccc2ncnc(Nc3cc(Cl)c(Cl)cc3F)c2c1,7.698970004336019
1512374,CHEMBL830273,Inhibition of human epidermal growth factor receptor (HER-1),B,CHEMBL195218,=,nM,4200.0,CHEMBL203,Homo sapiens,IC50,uM,4.2,CONC(=O)c1cc(Nc2ncnn3cc(NC(=O)OCCCS(C)(=O)=O)c(C(C)C)c23)c(F)cc1F,5.376750709602099
1601098,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL196018,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09,CCOC(=O)c1cn2ncnc(Nc3ccc(F)c(Cl)c3)c2c1CC,7.045757490560675
1603448,CHEMBL881949,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,B,CHEMBL371888,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,uM,0.059,COc1cc2ncnc(Nc3ccc(OCc4ccccn4)c(C)c3)c2cc1OC,7.229147988357856
1605366,CHEMBL881766,In vitro inhibitory concentration EGF receptor with ATP concentration at 1/2Km,B,CHEMBL401930,=,nM,1600.0,CHEMBL203,Homo sapiens,IC50,nM,1600.0,Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12,5.795880017344075
1607553,CHEMBL857670,Inhibitory concentration of EGFr,B,CHEMBL195029,=,nM,2700.0,CHEMBL203,Homo sapiens,IC50,uM,2.7,COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCOCC5)c(OC)cc4cc23)c(Cl)cc1Cl,5.568636235841013
1664709,CHEMBL863537,Inhibitory activity against HER1,B,CHEMBL370808,=,nM,5200.0,CHEMBL203,Homo sapiens,IC50,uM,5.2,COc1ccc(C#CC(C)(C)N)cc1-c1[nH]nc2nc(Nc3ccc(F)cc3F)ncc12,5.2839966563652006
1677858,CHEMBL862242,Inhibitory activity against EGFR kinase,B,CHEMBL201840,=,nM,12600.0,CHEMBL203,Homo sapiens,IC50,uM,12.6,COC(=O)c1c(OC)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O,4.8996294548824375
1678204,CHEMBL860874,Inhibitory activity against EGFR,B,CHEMBL201307,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8,COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1,6.096910013008056
1681964,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL545315,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1.Cl.Cl,8.522878745280337
1691387,CHEMBL867748,Inhibition of EGFR,B,CHEMBL382862,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0,Brc1ccc2c(c1)CNc1c(Nc3ccccc3)ncnc1O2,5.0
1696689,CHEMBL868329,Inhibitory activity against EGFR,B,CHEMBL203295,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0,COc1cc(OC2CCN(C)CC2)c2c(Nc3ccc(F)c(Cl)c3)ncnc2c1,7.6777807052660805
1697599,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL381306,=,nM,30000.0,CHEMBL203,Homo sapiens,IC50,uM,30.0,Brc1ccc2c(c1)CNc1c(NCc3ccccc3)ncnc1O2,4.522878745280337
1704010,CHEMBL861201,Inhibitory activity against recombinant human EGFR,B,CHEMBL606964,=,nM,545.0,CHEMBL203,Homo sapiens,IC50,nM,545.0,COc1ccc(N2Cc3cnc(Nc4ccc(F)cc4)nc3N([C@@H]3CC[C@@H](O)C3)C2=O)cc1,6.2636034977233574
1705156,CHEMBL863780,Inhibition of EGFR kinase activity,B,CHEMBL206483,=,nM,15000.0,CHEMBL203,Homo sapiens,IC50,uM,15.0,Cc1cccc(-n2ncc3c(NCc4ccc5c(c4)OCO5)ncnc32)c1,4.823908740944319
1709990,CHEMBL861550,Inhibition of EGFR,B,CHEMBL554,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,8.0
1721395,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL336113,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,nM,1000.0,Cc1cccc(Nc2ncnc3ccc(N)cc23)c1,6.0
1758667,CHEMBL866710,Inhibition of EGFR-mediated polyGAT phosphorylation at 10 uM,B,CHEMBL213560,=,nM,710.0,CHEMBL203,Homo sapiens,IC50,uM,0.71,O=C1NC(=O)N(CCc2ccccc2)/C1=C/c1ccc(O)cc1,6.1487416512809245
1778609,CHEMBL912344,Inhibition of Her1,B,CHEMBL364623,=,nM,5200.0,CHEMBL203,Homo sapiens,IC50,nM,5200.0,Cc1cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)nc(C)n1,5.2839966563652006
1779364,CHEMBL854974,Inhibition of recombinant EGFR by ELISA,B,CHEMBL217090,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9,Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2,6.045757490560675
1790429,CHEMBL912717,Inhibition of human EGFR,B,CHEMBL201511,=,nM,32000.0,CHEMBL203,Homo sapiens,IC50,M,0.000032,COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC,4.494850021680094
1790452,CHEMBL856400,Inhibition of EGFR,B,CHEMBL387187,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0,O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1,7.6777807052660805
1800144,CHEMBL910453,Inhibitory activity against EGFR,B,CHEMBL219557,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,nM,230.0,COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN5CCN(C)CC5)c4)c(OC)cc23)c(Cl)cc1Cl,6.638272163982407
1807171,CHEMBL908988,Inhibition of EGFR,B,CHEMBL436137,=,nM,965.0,CHEMBL203,Homo sapiens,IC50,uM,0.965,Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1,6.015472686656207
1815207,CHEMBL908512,Inhibition of EGFR,B,CHEMBL373882,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,nM,25000.0,CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1,4.6020599913279625
1841816,CHEMBL914501,Inhibition of Her1 kinase,B,CHEMBL5416410,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,nM,180.0,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1.O,6.7447274948966935
1846664,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL1204261,=,nM,8.17,CHEMBL203,Homo sapiens,IC50,nM,8.17,CCOc1cc2ncnc(Nc3cccc(F)c3)c2cc1OCC.Cl,8.087777943467584
1856212,CHEMBL919737,Inhibition of EGFR,B,CHEMBL534948,=,nM,2730.0,CHEMBL203,Homo sapiens,IC50,uM,2.73,Cc1cccc(C)c1Nc1ncc(-c2ccc(OCC3CCCN(C)C3)cc2)n2cncc12.Cl,5.5638373529592435
1881004,CHEMBL904734,Inhibition of EGFR tyrosine kinase expressed in A431 cells,B,CHEMBL343352,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2,Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,6.698970004336019
1943156,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL607707,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,9.221848749616356
1951262,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL427671,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,uM,0.081,Cc1ccn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,7.0915149811213505
1980916,CHEMBL898017,Inhibition of EGFR kinase autophosphorylation in A431 cells,B,CHEMBL220037,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03,N#Cc1cnc2ccc(NCc3c[nH]cn3)cc2c1Nc1ccc(F)c(Cl)c1,7.522878745280337
2017697,CHEMBL885861,Inhibition of EGFR,B,CHEMBL391738,=,nM,720.0,CHEMBL203,Homo sapiens,IC50,nM,720.0,COc1cc(Nc2c(C#N)cnc3cc(C#CCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,6.142667503568732
2021342,CHEMBL903494,Inhibition of EGFR,B,CHEMBL188304,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1,Cc1ccn2ncnc(Nc3ccc(F)c(Cl)c3)c12,7.0
2022204,CHEMBL902558,Inhibition of EGFR,B,CHEMBL247468,=,nM,397.0,CHEMBL203,Homo sapiens,IC50,uM,0.397,c1ccc(-c2c(-c3ccc(OCCN4CCCC4)cc3)oc3ncnc(NCCN4CCNCC4)c23)cc1,6.401209493236885
2025985,CHEMBL887090,Inhibition of EGFR by radioactive filtration assay,B,CHEMBL246356,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,nM,25000.0,CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(OC(F)(F)C(F)F)c3)ccc2C)n1,4.6020599913279625
2038871,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL246284,=,nM,61.0,CHEMBL203,Homo sapiens,IC50,uM,0.061,Fc1cccc(Cn2ncc3cc(Nc4ncnn5ccc(COC[C@@H]6CNCCO6)c45)ccc32)c1,7.214670164989233
2045359,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL248044,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,nM,90.0,COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OC,7.045757490560675
2047149,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL250315,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,nM,5600.0,COc1cc2ncnc(C#Cc3ccccc3)c2cc1OC,5.251811972993799
2047569,CHEMBL924156,Inhibition of EGFR,B,CHEMBL249927,=,nM,97.0,CHEMBL203,Homo sapiens,IC50,nM,97.0,O=C(CO)N1CCC[C@@H]1COc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12,7.013228265733755
2080192,CHEMBL929547,Inhibition of EGFR,B,CHEMBL253292,=,nM,380.0,CHEMBL203,Homo sapiens,IC50,uM,0.38,CCN(CC)CCOc1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1,6.42021640338319
2082143,CHEMBL928913,Inhibition of EGFR,B,CHEMBL402011,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,uM,0.18,C[C@@H](Oc1cccc2ncnc(Nc3ccc4c(cnn4Cc4ccccn4)c3)c12)C(=O)N(C)C,6.7447274948966935
2082148,CHEMBL928914,Inhibition of EGF-stimulated human EGFR autophosphorylation in KB cells,B,CHEMBL257411,=,nM,366.0,CHEMBL203,Homo sapiens,IC50,uM,0.366,C[C@@H](Oc1cccc2ncnc(Nc3ccc4c(cnn4Cc4nccs4)c3)c12)C(=O)N1CCOCC1,6.436518914605589
2093098,CHEMBL930778,Inhibition of EGFR,B,CHEMBL428777,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,uM,0.022,C[C@@H](Oc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12)C(=O)N(C)C,7.657577319177793
2098978,CHEMBL947896,Inhibition of EGFR,B,CHEMBL272935,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,uM,0.014,CN1CCN(CCCOc2n[nH]c3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1,7.853871964321762
2132653,CHEMBL921277,Inhibition of EGFR,B,CHEMBL410659,=,nM,9600.0,CHEMBL203,Homo sapiens,IC50,uM,9.6,Nc1nccn2c1c(-c1ccc3ccc(-c4ccccc4)nc3c1)nc2[C@H]1C[C@@H](CN2CCC2)C1,5.017728766960431
2133123,CHEMBL921778,Inhibition of EGFR,B,CHEMBL260861,=,nM,2400.0,CHEMBL203,Homo sapiens,IC50,uM,2.4,COc1cc(Nc2nn3c(N[C@H](CO)Cc4ccccc4)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1,5.619788758288394
2136772,CHEMBL939337,Inhibition of wild type EGFR,B,CHEMBL407534,=,nM,780.0,CHEMBL203,Homo sapiens,IC50,nM,780.0,O=C(O)/C=C/c1cc(CO)ccc1CO,6.107905397309519
2136802,CHEMBL940057,Inhibition of EGFR,B,CHEMBL406845,=,nM,480.0,CHEMBL203,Homo sapiens,IC50,nM,480.0,CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21,6.318758762624412
2136831,CHEMBL937170,Inhibition of ErbB1,B,CHEMBL258940,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0,CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1,8.522878745280337
2137059,CHEMBL937186,Inhibition of wild type EGFR,B,CHEMBL408565,=,nM,13300.0,CHEMBL203,Homo sapiens,IC50,nM,13300.0,O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2,4.876148359032914
2137199,CHEMBL921076,Inhibition of EGFR autophosphorylation,B,CHEMBL76904,=,nM,40000.0,CHEMBL203,Homo sapiens,IC50,nM,40000.0,N#CC(C#N)=Cc1ccc(O)c(O)c1,4.3979400086720375
2164862,CHEMBL929426,Inhibition of EGFR,B,CHEMBL258694,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,nM,150.0,Cc1nnc(-c2cn3ncnc(Nc4cnc5[nH]ccc5c4)c3c2C(C)C)o1,6.823908740944319
2173105,CHEMBL934832,Inhibition of EGFR,B,CHEMBL255871,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008,CO/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(F)c2)c1,8.096910013008056
2181225,CHEMBL974188,Inhibition of human recombinant EGFR kinase expressed in Sf9 insect cells,B,CHEMBL498247,=,nM,10500.0,CHEMBL203,Homo sapiens,IC50,uM,10.5,CCC(C)[C@@H]1[C@@](C)(C(=O)/C=C/OC)[C@H]2[C@H](C)C[C@@](C)(O)C[C@]2(O)C(=O)[C@@]1(C)O,4.978810700930062
2182938,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL145,=,nM,1000000.0,CHEMBL203,Homo sapiens,IC50,10'3 uM,1.0,O=C(O)/C=C/c1ccc(O)c(O)c1,3.0
2194200,CHEMBL978648,Inhibition of EGFR,B,CHEMBL285063,=,nM,0.08,CHEMBL203,Homo sapiens,IC50,nM,0.08,C=CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,10.096910013008056
2199107,CHEMBL996040,Inhibition of EGFR,B,CHEMBL13485,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C,5.522878745280337
2206757,CHEMBL976899,Inhibition of EGFR,B,CHEMBL553,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,9.397940008672037
2228670,CHEMBL1003093,Inhibition of EGFR,B,CHEMBL128000,=,nM,16000.0,CHEMBL203,Homo sapiens,IC50,uM,16.0,O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(O)cc1O,4.795880017344075
2239225,CHEMBL971642,Inhibition of EGFR,B,CHEMBL461311,=,nM,76.0,CHEMBL203,Homo sapiens,IC50,uM,0.076,Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C=O,7.119186407719209
2246100,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL461426,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0,NC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.3979400086720375
2246219,CHEMBL1009326,Inhibition of EGFR by scintillation proximity assay,B,CHEMBL505626,=,nM,63.0,CHEMBL203,Homo sapiens,IC50,nM,63.0,CCN(CC)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.200659450546418
2251516,CHEMBL998566,Inhibition of EGFR,B,CHEMBL521887,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1-c1ccc2ccncc2c1,6.154901959985743
2256127,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL495979,=,nM,109.0,CHEMBL203,Homo sapiens,IC50,nM,109.0,Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5CCCN5)sc34)cc2Cl)c1,6.962573502059376
2256993,CHEMBL1001226,Inhibition of EGFR,B,CHEMBL485745,=,nM,6300.0,CHEMBL203,Homo sapiens,IC50,uM,6.3,Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1,5.200659450546418
2270107,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL507329,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,nM,80.0,O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1,7.096910013008056
2270111,CHEMBL964195,Inhibition of EGFR by SPA assay,B,CHEMBL504117,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0,O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c3s2)C1)N1CCOCC1,7.301029995663981
2270441,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL515598,=,nM,7800.0,CHEMBL203,Homo sapiens,IC50,uM,7.8,c1ccc2sc(-c3ccc(Nc4ncnc5[nH]cnc45)cc3)nc2c1,5.107905397309519
2271252,CHEMBL964130,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL249496,=,nM,270.0,CHEMBL203,Homo sapiens,IC50,nM,270.0,Nc1ncnc2c1c(-c1ccc3nc(Cc4ccccc4)[nH]c3c1)nn2[C@H]1CC[C@H](N2CCOCC2)CC1,6.568636235841013
2301995,CHEMBL949877,Inhibition of EGFR,B,CHEMBL501256,=,nM,93000.0,CHEMBL203,Homo sapiens,IC50,uM,93.0,Nc1ncnc2c1ncn2CC(=O)c1cccnc1,4.031517051446065
2316195,CHEMBL1005068,Displacement of [125I]-TGFalpha from human EGFR in human A431 cell membrane by SPA,B,CHEMBL464721,=,nM,1600.0,CHEMBL203,Homo sapiens,IC50,uM,1.6,CCC(C)/C=C/C(=O)C(=O)/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H]1C[C@@H](O)[C@H](C(=O)O)O1,5.795880017344075
2339008,CHEMBL957461,Inhibition of EGFR expressed in human tumor cells,B,CHEMBL485320,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3,Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccccc3)[nH]c2n1,6.522878745280337
2361179,CHEMBL970655,Inhibition of EGFR,B,CHEMBL505896,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,nM,1700.0,COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,5.769551078621726
2361602,CHEMBL980904,Inhibition of GST-tagged HER1,B,CHEMBL459729,=,nM,21000.0,CHEMBL203,Homo sapiens,IC50,uM,21.0,Cc1cc(C2CCN(CCCF)CC2)cc2[nH]c(-c3c(NCCn4cc(Cl)cn4)cc[nH]c3=O)nc12,4.6777807052660805
2376473,CHEMBL980757,Inhibition of EGFR,B,CHEMBL461571,=,nM,2240.0,CHEMBL203,Homo sapiens,IC50,uM,2.24,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1,5.649751981665837
2390290,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL461792,=,nM,10.08,CHEMBL203,Homo sapiens,IC50,nM,10.08,COC[C@H]1Oc2cc3ncnc(Nc4cccc(Cl)c4)c3cc2O[C@@H]1COC,7.996539467890494
2409521,CHEMBL959256,Inhibition of EGFR,B,CHEMBL523586,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0,NC[C@H](Cc1cccc(F)c1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,5.0
2411800,CHEMBL987693,Inhibition of EGFR,B,CHEMBL470219,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0,Fc1ccc(Nc2ncnc3nc(Nc4ccc(CN5CCCC5)cc4)sc23)cc1Cl,8.397940008672037
2419446,CHEMBL1022371,Inhibition of EGFR,B,CHEMBL523122,=,nM,7130.0,CHEMBL203,Homo sapiens,IC50,uM,7.13,COCCOc1cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c2cc1NC(=O)[C@@H]1CCCN1,5.146910470148135
2467248,CHEMBL991653,Inhibition of EGFR in presence of 100 uM ATP,B,CHEMBL489058,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01,CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1,8.0
2488219,CHEMBL946770,Inhibition of EGFR,B,CHEMBL448929,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0,CCc1cc(Nc2nccc(-c3c(-c4cccc(C(=O)Nc5c(F)cccc5F)c4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1,7.657577319177793
2488851,CHEMBL1028056,Inhibition of EGFR,B,CHEMBL480356,=,nM,3480.0,CHEMBL203,Homo sapiens,IC50,uM,3.48,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(C(=O)NNc4ccccc4)cc32)c(C)c1CCC(=O)O,5.458420756053419
2489169,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL1201179,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1.O,7.958607314841775
2503040,CHEMBL945670,Inhibition of human EGFR tyrosine kinase activity,B,CHEMBL77030,=,nM,1310.0,CHEMBL203,Homo sapiens,IC50,uM,1.31,N#C/C(=C\c1ccc(O)c(O)c1)C(N)=S,5.882728704344236
2527196,CHEMBL984177,Inhibition of EGFR,B,CHEMBL451523,=,nM,5400.0,CHEMBL203,Homo sapiens,IC50,uM,5.4,COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O,5.267606240177032
2560138,CHEMBL986505,Inhibition of EGFR by ELISA,B,CHEMBL477197,=,nM,3400.0,CHEMBL203,Homo sapiens,IC50,uM,3.4,Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2,5.468521082957745
2582012,CHEMBL962243,Inhibition of human EGFR,B,CHEMBL487254,=,nM,9500.0,CHEMBL203,Homo sapiens,IC50,uM,9.5,N=C(Nc1ccccc1)SCCCN1C(=O)C2=C(C1=O)n1ccc3cccc(c31)C1Cc3ccccc3N21,5.022276394711152
2584904,CHEMBL955786,Inhibition of HER1,B,CHEMBL461140,=,nM,3300.0,CHEMBL203,Homo sapiens,IC50,uM,3.3,CN(C)CCOc1ccc(/C=C/c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1,5.481486060122113
2615700,CHEMBL1026506,Inhibition of EGFR,B,CHEMBL31965,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,uM,0.0023,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,8.638272163982407
2629151,CHEMBL1008385,Inhibition of EGFR,B,CHEMBL496388,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0,N#Cc1cnc2c(Cl)cc(NCc3c[nH]nn3)cc2c1Nc1ccc(F)c(Cl)c1,6.0
2655735,CHEMBL1029460,Inhibition of EGFR,B,CHEMBL50,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,6.045757490560675
2661406,CHEMBL1058612,Inhibition of EGFR,B,CHEMBL564829,=,nM,3069.0,CHEMBL203,Homo sapiens,IC50,uM,3.069,CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2,5.513003111568177
2896192,CHEMBL1060165,Inhibition of EGFR,B,CHEMBL327127,=,nM,82.0,CHEMBL203,Homo sapiens,IC50,M,8.2E-8,Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(CO)c3)nc21,7.086186147616283
2934399,CHEMBL1052827,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,B,CHEMBL565714,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0,CCC1=C2C(Nc3ccc4c(cnn4Cc4ccccc4)c3)=NC=NC2N=C1NC(=O)OCCN1CCNCC1,7.6777807052660805
2943647,CHEMBL1044055,Inhibition of Her1 by fluorescence polarization assay,B,CHEMBL571040,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0,C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCOC,7.886056647693163
3072639,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL473556,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5,COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC,5.823908740944319
3084397,CHEMBL1072676,Inhibition of EGFR,B,CHEMBL590109,=,nM,940.0,CHEMBL203,Homo sapiens,IC50,uM,0.94,NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21,6.026872146400302
3103294,CHEMBL1070746,Inhibition of EGFR after 80 mins by radiometric protein kinase assay,B,CHEMBL597492,=,nM,1688.0,CHEMBL203,Homo sapiens,IC50,nM,1688.0,COc1cc(C2=C(c3c[nH]c4ccc(I)cc34)C(=O)NC2=O)cc(OC)c1OC,5.772627557710364
3103919,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL591213,=,nM,9120.0,CHEMBL203,Homo sapiens,IC50,uM,9.12,CCCCCCOC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,5.0400051616715835
3105839,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL589589,=,nM,750.0,CHEMBL203,Homo sapiens,IC50,uM,0.75,CC(C)c1ccc(NC(=O)c2ccc(N(CCCl)CCCl)cc2)cc1,6.1249387366083
3120246,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL597551,=,nM,7.1,CHEMBL203,Homo sapiens,IC50,nM,7.1,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCC(=O)NO,8.148741651280925
3124808,CHEMBL1069630,Inhibition of EGFR,B,CHEMBL602890,=,nM,56000.0,CHEMBL203,Homo sapiens,IC50,uM,56.0,COc1cc(/C=C2\SC(=N)NC2=O)ccc1OCCCOc1cc(C)cc(C)c1,4.251811972993799
3126238,CHEMBL1072146,Inhibition of EGFR,B,CHEMBL591897,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6,CN(CCN/N=N/c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)CCNS(=O)(=O)c1cccc2c(N(C)C)cccc12,6.221848749616356
3126272,CHEMBL1072157,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,B,CHEMBL606403,=,nM,129.0,CHEMBL203,Homo sapiens,IC50,nM,129.0,CC(C)c1nsc(C(=O)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)n1,6.889410289700751
3126308,CHEMBL1072161,Inhibition of EGFR autophosphorylation in human A431 cells after 8 hrs by Western blot,B,CHEMBL604914,=,nM,292.0,CHEMBL203,Homo sapiens,IC50,uM,0.292,O=C(COc1ccccc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.534617148551582
3126313,CHEMBL1072160,Inhibition of EGFR autophosphorylation in human A431 cells after 1 hr by Western blot,B,CHEMBL597402,=,nM,84.0,CHEMBL203,Homo sapiens,IC50,uM,0.084,O=C(COc1c(F)c(F)c(F)c(F)c1F)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.075720713938118
3133686,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL591706,=,nM,32120.0,CHEMBL203,Homo sapiens,IC50,uM,32.12,CCCCN(Cc1cccc(Cl)c1O)C(=O)Nc1ccccc1,4.493224463393357
3195637,CHEMBL1103281,Inhibition of EGFR,B,CHEMBL1087054,=,nM,93500.0,CHEMBL203,Homo sapiens,IC50,uM,93.5,CC1=C(C(=O)Nc2ccc(C)cc2)C(c2ccc(O)cc2O)NC(SCc2ccccc2)=N1,4.029188389127482
3210400,CHEMBL1109425,Inhibition of EGFR after 1 hr,B,CHEMBL1081198,=,nM,50000.0,CHEMBL203,Homo sapiens,IC50,uM,50.0,O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1,4.301029995663981
3222529,CHEMBL1116652,Inhibition of EGFR in human A431 cells by HTRF assay,B,CHEMBL1087368,=,nM,1160.0,CHEMBL203,Homo sapiens,IC50,uM,1.16,CCN(CC)CCNC(=O)c1[nH]c2cnnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1C,5.935542010773082
3222903,CHEMBL1113143,Inhibition of EGFR autophosphorylation in human A431 cells,B,CHEMBL1080815,=,nM,2700.0,CHEMBL203,Homo sapiens,IC50,uM,2.7,Clc1cccc(Nc2ncnc3ccc(Cl)cc23)c1,5.568636235841013
3240704,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1091613,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,nM,240.0,O=C(Nc1cccc(-c2nc3sccn3c2-c2ccncc2)c1)c1ccccc1Cl,6.619788758288394
3240764,CHEMBL1108835,Inhibition of EGFR intracellular phosphorylation in human A431 cells by ELISA,B,CHEMBL1090357,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,nM,220.0,CN(C)CCc1ccc(Nc2nccc(-c3c(-c4cccc(NC(=O)c5c(F)cccc5F)c4)nc4sccn34)n2)cc1,6.657577319177793
3242697,CHEMBL1115349,Inhibition of EGFR in human A431 cells by phosphotyrosine cell-based ELISA,B,CHEMBL1093099,=,nM,15070.0,CHEMBL203,Homo sapiens,IC50,uM,15.07,Nc1nc(N)c2c(n1)[nH]c1cccc(Sc3ccccc3)c12,4.821886747685368
3261308,CHEMBL1105218,Inhibition of EGFR Leu858Arg and Thr790Met mutant by HTRF assay,B,CHEMBL304929,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,nM,140.0,C#Cc1cccc(Nc2ncnc3cc(OC)c(OC)cc23)c1,6.853871964321762
3261319,CHEMBL1105217,Inhibition of EGFR Leu858Arg mutant by HTRF assay,B,CHEMBL1092250,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0,C#Cc1cccc(Nc2ccnc3cc(OC)c(OC)cc23)c1,8.397940008672037
3277999,CHEMBL1117422,Inhibition of EGFR,B,CHEMBL1088240,=,nM,3300.0,CHEMBL203,Homo sapiens,IC50,uM,3.3,COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,5.481486060122113
3288470,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL1098119,=,nM,1630.0,CHEMBL203,Homo sapiens,IC50,uM,1.63,Cl.NCCc1cn(CCCCCc2ccccc2)c2ccc(OCCc3ccc(O)cc3)cc12,5.787812395596042
3288542,CHEMBL1105619,Noncompetitive inhibition of EGFR after 30 mins by chemiluminescence ELISA in presence of 25 uM ATP,B,CHEMBL1098120,=,nM,1010.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.01,Cl.NC1CCc2c(c3cc(OCCc4ccc(O)cc4)ccc3n2CCCCCc2ccccc2)C1,5.995678626217358
3299618,CHEMBL1112818,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,B,CHEMBL1095761,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2,Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1,6.698970004336019
3357155,CHEMBL1174225,Inhibition of human EGFR autophosphorylation expressed in Sf9 cells DELFIA assay,B,CHEMBL1171792,=,nM,85.0,CHEMBL203,Homo sapiens,IC50,uM,0.085,Cc1ccc(Br)c2c(C#N)cc(C(=O)C3CC3)n12,7.070581074285707
3359793,CHEMBL1177355,Inhibition EGFR,B,CHEMBL1172957,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0,NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1,5.0
3359855,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173324,=,nM,13370.0,CHEMBL203,Homo sapiens,IC50,uM,13.37,NC(=S)N1N=C(c2ccc(Br)c(Br)c2)CC1c1ccccc1F,4.873868592738016
3364619,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1172802,=,nM,4120.0,CHEMBL203,Homo sapiens,IC50,uM,4.12,Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1ccc(F)cc1,5.3851027839668655
3365210,CHEMBL1176122,Inhibition of GST-tagged EGFR expressed in Escherichia coli,B,CHEMBL1172781,=,nM,223.0,CHEMBL203,Homo sapiens,IC50,nM,223.0,OC[C@@H](Nc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12)c1ccccc1,6.651695136951839
3365217,CHEMBL1176123,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL1172843,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,nM,28.0,C=CC(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,7.552841968657781
3419556,CHEMBL1226208,Inhibition of human recombinant EGFR expressed in baculovirus-infected Sf9 cells by radioactive phosphotransfer assay,B,CHEMBL1221700,=,nM,689.0,CHEMBL203,Homo sapiens,IC50,uM,0.689,C=CC(=O)Nc1ccc2ncnc(Nc3ccc(C(C)(C)C)cc3)c2c1,6.161780778092374
3436055,CHEMBL1246645,Inhibition of EGFR autophosphorylation in human A431 cells,B,CHEMBL1243284,=,nM,8.12,CHEMBL203,Homo sapiens,IC50,nM,8.12,CNC/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cc1OCCF,8.090443970758825
3436059,CHEMBL1249168,Inhibition of EGFR,B,CHEMBL1243346,=,nM,4.05,CHEMBL203,Homo sapiens,IC50,nM,4.05,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/c1cn(CCF)nn1,8.39254497678533
3440726,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242285,=,nM,249.0,CHEMBL203,Homo sapiens,IC50,uM,0.249,CC(C)n1nc(-c2cc(O)cc(Br)c2)c2c(N)ncnc21,6.603800652904264
3446243,CHEMBL1244583,Inhibition of EGFR T790M mutant,B,CHEMBL288441,=,nM,491.0,CHEMBL203,Homo sapiens,IC50,nM,491.0,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,6.308918507877031
3468957,CHEMBL1252156,Inhibition of EGFR expressed in human A431 cells,B,CHEMBL499344,=,nM,1670.0,CHEMBL203,Homo sapiens,IC50,uM,1.67,Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccccc3)[nH]c2n1,5.777283528852417
3503208,CHEMBL1261159,Inhibition of EGFR,B,CHEMBL1257795,=,nM,10900.0,CHEMBL203,Homo sapiens,IC50,uM,10.9,N#Cc1ccc2c(c1)C(c1ccccc1F)=Nc1c[nH]nc1N2,4.962573502059376
3521868,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1271950,=,nM,720.0,CHEMBL203,Homo sapiens,IC50,uM,0.72,OC[C@@H](Nc1ncnc2sc3c(c12)CCCC3)c1ccccc1,6.142667503568732
3521892,CHEMBL1273339,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL1272061,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1,C=CC(=O)N1CCc2c(sc3ncnc(N[C@H](CO)c4ccccc4)c23)C1,7.0
3556136,CHEMBL1285874,Inhibition of EGFR,B,CHEMBL1276179,=,nM,173.0,CHEMBL203,Homo sapiens,IC50,nM,173.0,CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1,6.761953896871205
5112196,CHEMBL1640694,Inhibition of EGFR by flash plate based radioactive enzyme assay,B,CHEMBL1630107,=,nM,2.5,CHEMBL203,Homo sapiens,IC50,uM,0.0025,O=C(/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)NO,8.602059991327963
5112367,CHEMBL1640839,Inhibition of EGF-induced EGFR phosphorylation in human CAL27 cells overexpressing EGFR after 16 hrs by Western blot,B,CHEMBL1630109,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5,O=C(/C=C/c1cccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)c1)NO,6.301029995663981
5133828,CHEMBL1646349,Inhibition of EGFR by HTRF assay,B,CHEMBL1641991,=,nM,20800.0,CHEMBL203,Homo sapiens,IC50,uM,20.8,CCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1,4.681936665037238
5138055,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL1645462,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,7.494850021680094
5249865,CHEMBL1687360,Inhibition of EGFR,B,CHEMBL1684800,=,nM,101.4,CHEMBL203,Homo sapiens,IC50,nM,101.4,COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1,6.993962045002683
5293856,CHEMBL1697113,Inhibition of EGFR after 60 mins by radiometric assay,B,CHEMBL1448,=,nM,10500.0,CHEMBL203,Homo sapiens,IC50,uM,10.5,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,4.978810700930062
5310425,CHEMBL1693590,Inhibition of EGFR,B,CHEMBL1688860,=,nM,4900.0,CHEMBL203,Homo sapiens,IC50,nM,4900.0,CN(C)Cc1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1,5.309803919971486
6154882,CHEMBL1762895,Inhibition of EGFR,B,CHEMBL1762110,=,nM,3580.0,CHEMBL203,Homo sapiens,IC50,uM,3.58,CC(=O)NC[C@H]1CC[C@H](c2nc(-c3cc4ccccc4[nH]3)c3c(N)nccn32)CC1,5.446116973356125
6157884,CHEMBL1764782,Inhibition of EGFR,B,CHEMBL1760035,=,nM,853.0,CHEMBL203,Homo sapiens,IC50,uM,0.853,COc1cc(Nc2nccc(Nc3cnc4ccccc4c3)n2)cc(OC)c1OC,6.069050968832477
6219885,CHEMBL1785573,Inhibition of human EGFR using poly[Glu:Tyr] by Hotspot assay,B,CHEMBL1784637,=,nM,736.0,CHEMBL203,Homo sapiens,IC50,nM,736.0,CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C,6.133122185662501
6268161,CHEMBL1805338,Inhibition of EGFR,B,CHEMBL1270795,=,nM,5048.0,CHEMBL203,Homo sapiens,IC50,nM,5048.0,CSc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1,5.296880653763922
6315899,CHEMBL1817212,Inhibition of EGFR after 1 hrs by luminescence assay,B,CHEMBL1812374,=,nM,1929.0,CHEMBL203,Homo sapiens,IC50,uM,1.929,Cc1ccc(-c2nc3cc(NC(=O)CCl)ccc3[nH]2)cc1,5.7146677723561154
6321174,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812431,=,nM,1210.0,CHEMBL203,Homo sapiens,IC50,uM,1.21,O=C(/C=C/c1ccc(Cl)cc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,5.91721462968355
6327067,CHEMBL1820121,Inhibition of EGFR-induced AP1 activation in human HeLa cells preincubated for 1 hr prior to EGF stimulation by luciferase reporter gene assay,B,CHEMBL1817964,=,nM,160.0,CHEMBL203,Homo sapiens,IC50,uM,0.16,C/C=C(\C)C(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)/C=C(C)/C=C/CC(C)/C=C/c1oc(OC)c(C)c(=O)c1C,6.795880017344075
6340168,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821862,=,nM,1730.0,CHEMBL203,Homo sapiens,IC50,uM,1.73,Cc1ccc(C2=NN(c3nc(-c4ccccc4)cs3)C(c3ccc(F)cc3)C2)cc1C,5.761953896871205
6356806,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830257,=,nM,22360.0,CHEMBL203,Homo sapiens,IC50,uM,22.36,NC(=S)N/N=C(/C=C/c1ccccc1F)c1ccccc1,4.650528200785614
6358465,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828860,=,nM,2940.0,CHEMBL203,Homo sapiens,IC50,uM,2.94,Cc1ncc([N+](=O)[O-])n1CC(=O)NS(=O)(=O)c1ccccc1,5.531652669587842
6358549,CHEMBL1831702,Inhibition of EGFR,B,CHEMBL1173718,=,nM,620.0,CHEMBL203,Homo sapiens,IC50,uM,0.62,Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1ccc(-c2ccccc2)cc1,6.2076083105017466
7599140,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL1200558,=,nM,5377.0,CHEMBL203,Homo sapiens,IC50,uM,5.377,CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1,5.2694599635228805
7853989,CHEMBL1912180,Inhibition of human EGFR,B,CHEMBL1910268,=,nM,93300.0,CHEMBL203,Homo sapiens,IC50,uM,93.3,N#Cc1cc2c(N)ncnc2nc1NCCO,4.0301183562535
7930439,CHEMBL1919050,Inhibition of EGFR preincubated for 60 mins measured after 60 mins by TR-FRET Assay,B,CHEMBL1916891,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4,Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12,8.853871964321762
7931077,CHEMBL1919256,Inhibition of ErbB1 relative to control,B,CHEMBL1873475,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,nM,5.6,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,8.2518119729938
7943904,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914653,=,nM,3.7,CHEMBL203,Homo sapiens,IC50,nM,3.7,Br.C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccccc1,8.431798275933005
7957745,CHEMBL1932379,Inhibition of EGFR autophosphorylation in EGF-stimulated human A431 cells after 1 hr by immunoblotting,B,CHEMBL1928309,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3,O=C(c1cc2ccccc2[nH]1)c1cc2c(Nc3cccc(Cl)c3)ncnc2s1,6.522878745280337
7959054,CHEMBL1931161,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,B,CHEMBL1929312,=,nM,34250.0,CHEMBL203,Homo sapiens,IC50,uM,34.25,Cc1ccc(-c2nnc(SCc3ccccc3)o2)c(O)c1,4.465339424171556
7959216,CHEMBL1930721,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",B,CHEMBL1928311,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0,O=C(c1cc2cc(O)ccc2[nH]1)c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,7.619788758288394
7959734,CHEMBL1932841,Inhibition of EGFR,B,CHEMBL103667,=,nM,3800.0,CHEMBL203,Homo sapiens,IC50,uM,3.8,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,5.42021640338319
7963942,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL1928944,=,nM,1204.0,CHEMBL203,Homo sapiens,IC50,nM,1204.0,O=[N+]([O-])c1cccc(Oc2cc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncn2)c1,5.919373513078194
7968505,CHEMBL1932339,Inhibition of EGFR tyrosine kinase activity in EGF-stimulated human A431 cells after 60 mins by ELISA,B,CHEMBL1095464,=,nM,9190.0,CHEMBL203,Homo sapiens,IC50,uM,9.19,Cc1ccccc1Cc1cc2c(Nc3cccc(Br)c3)nc(N)nc2[nH]1,5.036684488613889
7978864,CHEMBL1930231,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,B,CHEMBL1928707,=,nM,3220.0,CHEMBL203,Homo sapiens,IC50,uM,3.22,Oc1ccccc1CNc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,5.492144128304169
7995654,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL1934621,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,uM,0.65,Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#Cc1ccccc1,6.187086643357144
8019345,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1916951,=,nM,24830.0,CHEMBL203,Homo sapiens,IC50,uM,24.83,Cc1ccc(S(=O)(=O)NC(=O)c2cccnc2)cc1,4.605023280445436
8025209,CHEMBL1947770,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,B,CHEMBL1946843,=,nM,25900.0,CHEMBL203,Homo sapiens,IC50,uM,25.9,CN(C)c1nc(N/N=C/c2cc(Br)c(O)c(Br)c2O)nc(Nc2ccc(F)cc2)n1,4.586700235918748
8030298,CHEMBL1955670,Inhibition of EGFR,B,CHEMBL1950289,=,nM,380.0,CHEMBL203,Homo sapiens,IC50,uM,0.38,O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1,6.42021640338319
8037535,CHEMBL1954388,Inhibition of EGFR,B,CHEMBL1951415,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,nM,150.0,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1,6.823908740944319
8039804,CHEMBL1952840,Inhibition of human recombinant His-tagged intracellular domain of EGFR using biotin-EEEEYFELV as substrate by HTRF assay,B,CHEMBL1952210,=,nM,310.0,CHEMBL203,Homo sapiens,IC50,nM,310.0,COc1ccc(N2Cc3cnc(Nc4ccccc4)nc3N([C@@H]3CC[C@@H](O)C3)C2=O)cc1,6.508638306165727
8048992,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958019,=,nM,3380.0,CHEMBL203,Homo sapiens,IC50,uM,3.38,O=C1CSC(N2N=C(c3ccccc3)CC2c2ccccc2)=N1,5.471083299722345
8058278,CHEMBL1959298,Inhibition of EGFR,B,CHEMBL1956886,=,nM,19770.0,CHEMBL203,Homo sapiens,IC50,uM,19.77,Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(Cl)c(Cl)c3)[nH]c2n1,4.703993330686328
8060112,CHEMBL1961280,"Inhibition of human recombinant EGF-R expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting",B,CHEMBL6246,=,nM,690.0,CHEMBL203,Homo sapiens,IC50,uM,0.69,O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,6.161150909262744
10844877,CHEMBL2015060,"Inhibition of wild type EGFR using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting",B,CHEMBL2011291,=,nM,113.0,CHEMBL203,Homo sapiens,IC50,uM,0.113,Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1c(Cl)cc(Cl)cc1Cl,6.94692155651658
10855796,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL94191,=,nM,4300.0,CHEMBL203,Homo sapiens,IC50,uM,4.3,COc1cc2ncnc(Nc3ccccc3)c2cc1OC,5.366531544420414
10883601,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL1229592,=,nM,6.18,CHEMBL203,Homo sapiens,IC50,nM,6.18,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1,8.209011524911185
10888036,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031297,=,nM,0.28,CHEMBL203,Homo sapiens,IC50,nM,0.28,CN(C)CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.55284196865778
10890024,CHEMBL2034705,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL2029689,=,nM,9700.0,CHEMBL203,Homo sapiens,IC50,uM,9.7,O=S(=O)(c1ccc(/N=C/c2cc(Br)ccc2O)cc1)N1CCCCC1,5.013228265733755
10896851,CHEMBL2038917,Inhibition of EGFR T790M mutant preincubated for 10 mins followed by incubation for 30 mins by fluorescence polarization assay,B,CHEMBL2035810,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2,C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1,8.494850021680094
10940862,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047015,=,nM,2340.0,CHEMBL203,Homo sapiens,IC50,uM,2.34,O=C(CCCCCC(=O)Nc1ccc(O)c(C(=O)Nc2ccccc2)c1)NO,5.6307841425898575
10949867,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048912,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6,CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21,8.585026652029182
10967414,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064372,=,nM,78.0,CHEMBL203,Homo sapiens,IC50,uM,0.078,O=c1oc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc2n1CCCN1CCOCC1,7.107905397309519
10975682,CHEMBL2064929,Inhibition of EGFR in presence of 10 uM ATP,B,CHEMBL1990583,=,nM,2090.0,CHEMBL203,Homo sapiens,IC50,nM,2090.0,Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12,5.679853713888946
10988317,CHEMBL2071758,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,B,CHEMBL2070190,=,nM,1630.0,CHEMBL203,Homo sapiens,IC50,uM,1.63,O=C(Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)c1cccc2c1OCCO2,5.787812395596042
10991148,CHEMBL2072949,Inhibition of human EGFR using poly glu-Tyr as substrate after 30 mins,B,CHEMBL2070045,=,nM,510.0,CHEMBL203,Homo sapiens,IC50,uM,0.51,COc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl,6.292429823902063
11020078,CHEMBL2089890,Inhibition of EGFR,B,CHEMBL2086760,=,nM,137.0,CHEMBL203,Homo sapiens,IC50,nM,137.0,CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(Cl)cc2)c2ncc[nH]2)C(=O)N3)CC1,6.863279432843593
11022065,CHEMBL2090277,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,B,CHEMBL1198361,=,nM,85.0,CHEMBL203,Homo sapiens,IC50,nM,85.0,Brc1cccc(Nc2ncnc3cc4c(cc23)OCCCO4)c1,7.070581074285707
11022080,CHEMBL2090278,Inhibition of EGFR-mediated intracellular tyrosine phosphorylation in EGF-stimulated human A431 cells after 2.5 hrs by SDS-PAGE analysis,B,CHEMBL2087355,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0,Brc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,7.301029995663981
12036052,CHEMBL2150609,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,B,CHEMBL2148044,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0,CS(=O)(=O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,7.823908740944319
12057080,CHEMBL2154039,Inhibition of recombinant EGFR catalytic domain in presence of 1 uM radiolabeled ATP,B,CHEMBL2152704,=,nM,1620.0,CHEMBL203,Homo sapiens,IC50,uM,1.62,Cc1ccc(O)cc1-n1c(=O)c2c(c3c(N)ncnc31)CCCC2,5.790484985457369
12060770,CHEMBL2156898,Inhibition of EGFR,B,CHEMBL2152252,=,nM,739.0,CHEMBL203,Homo sapiens,IC50,nM,739.0,CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cnc1N,6.131355561605174
12077635,CHEMBL2162537,Inhibition of EGFR,B,CHEMBL2159053,=,nM,10490.0,CHEMBL203,Homo sapiens,IC50,uM,10.49,COc1ccc(C2=NN(C(=O)c3ccc(Cl)cc3O)C(c3ccc(Cl)cc3)C2)cc1,4.979224511806442
12150547,CHEMBL2188083,Inhibition of EGFR in human NCI-H1975 cells assessed as reduction in ERK phosphorylation incubated for 8 hrs by Western blotting method,B,CHEMBL2178352,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4,CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1,6.3979400086720375
12150690,CHEMBL2183197,Inhibition of EGFR L858R/T790M mutant,B,CHEMBL2178368,=,nM,978.0,CHEMBL203,Homo sapiens,IC50,uM,0.978,CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)[nH]c4n3)cc2)CC1,6.009661145212399
12165631,CHEMBL2208630,Inhibition of human EGFR kinase activity,B,CHEMBL111038,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,nM,190.0,COc1cc2ncc(C#N)c(Nc3cccc(Br)c3)c2cc1OC,6.721246399047171
12165668,CHEMBL2208688,Inhibition of HER1,B,CHEMBL2205030,=,nM,5400.0,CHEMBL203,Homo sapiens,IC50,uM,5.4,O=S1(=O)N=S(c2ccc(Br)cc2)c2ccncc21,5.267606240177032
12205227,CHEMBL2217241,Inhibition of GST-tagged EGFR expressed in sf9 cells by ELISA,B,CHEMBL2105719,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O,8.221848749616356
12205231,CHEMBL2217238,Inhibition of EGF-induced autophosphorylation of EGFR in human A431 cells,B,CHEMBL91867,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0,CC#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.301029995663981
12205232,CHEMBL2217237,Inhibition of EGFR,B,CHEMBL1173655,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,9.301029995663981
12629537,CHEMBL2319132,Inhibition of EGFR (unknown origin),B,CHEMBL2312304,=,nM,4090.0,CHEMBL203,Homo sapiens,IC50,uM,4.09,O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1,5.388276691992658
12631697,CHEMBL2317775,Inhibition of EGFR (unknown origin) in presence of ATP,B,CHEMBL2312654,=,nM,590.0,CHEMBL203,Homo sapiens,IC50,uM,0.59,Cc1cc(-c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)on1,6.229147988357856
12655314,CHEMBL2328801,Inhibition of human wild type EGFR expressed in Sf9 cells using [gamma32P]-ATP after 10 mins by scintillation counting,B,CHEMBL2322330,=,nM,6.9,CHEMBL203,Homo sapiens,IC50,nM,6.9,O=C(Nc1cccc(Oc2ccc(Nc3ncnc4ccn(CCOCCO)c34)cc2Cl)c1)NC1CCCCC1,8.161150909262744
12674062,CHEMBL2344161,Inhibition of EGFR (unknown origin),B,CHEMBL2333163,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6,O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(Oc2ccc(CCNC(=O)/C(Cc3cc(Br)c(O)c(-c4cc(C/C(=N\O)C(=O)NCCc5ccc(O)c(Br)c5)cc(Br)c4O)c3)=N/O)cc2Br)c1)=N/O,6.221848749616356
12692760,CHEMBL2343569,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,CHEMBL535,=,nM,172100.0,CHEMBL203,Homo sapiens,IC50,uM,172.1,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,3.7642191296724397
12697484,CHEMBL2343159,Inhibition of EGFR (unknown origin) after 20 mins by scintillation counting,B,CHEMBL2332119,=,nM,2600.0,CHEMBL203,Homo sapiens,IC50,uM,2.6,NC(=O)C1=C(N)C(=O)C=C(Nc2ccccc2O)C1=O,5.585026652029182
12712337,CHEMBL2341278,Inhibition of EGFR (unknown origin),B,CHEMBL2333986,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0,COc1cc2ncnc(Nc3ccccc3C(F)(F)F)c2cc1OC,5.0
12712340,CHEMBL2341279,Inhibition of EGFR in human A431 cells,B,CHEMBL301018,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC,8.045757490560675
12712341,CHEMBL2341281,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,B,CHEMBL294034,=,nM,60.2,CHEMBL203,Homo sapiens,IC50,nM,60.2,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCn1ccnc1,7.220403508742176
12713623,CHEMBL2351374,"Inhibition of EGFR tyrosine kinase (unknown origin) using poly (Glu,Tyr) as substrate after 30 mins by ADP-GloTM assay",B,CHEMBL2347231,=,nM,61.0,CHEMBL203,Homo sapiens,IC50,uM,0.061,NC(=O)Nc1ccc2ncnc(Nc3ccc(Cl)cc3)c2c1,7.214670164989233
12728106,CHEMBL2351562,Inhibition of human N-terminal DYKDDDD-tagged EGFR cytoplasmic domain (669 to 1210) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,B,CHEMBL1614725,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0,CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,7.638272163982407
13297469,CHEMBL2383984,Inhibition of wild type EGFR (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381511,=,nM,292.0,CHEMBL203,Homo sapiens,IC50,uM,0.292,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(CC(=O)OCCCCCCOc5no[n+]([O-])c5S(=O)(=O)c5ccccc5)CC4)cc3OC)ncc2Cl)c1,6.534617148551582
13322639,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385993,=,nM,6000.0,CHEMBL203,Homo sapiens,IC50,uM,6.0,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1C(=O)Nc1nccc(-c2cccc(F)c2)n1,5.221848749616356
13367213,CHEMBL2406344,Inhibition of EGFR (unknown origin) after 60 mins,B,CHEMBL2403108,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9,Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1,6.045757490560675
13391023,CHEMBL2412606,Inhibition of human EGFR kinase domain expressed in baculovirus/Sf21 system by ELISA,B,CHEMBL2408045,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0,CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1,7.920818753952375
13414494,CHEMBL2422326,Inhibition of EGFR (unknown origin),B,CHEMBL2419762,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,uM,0.027,Cl.c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCCO5)c2)cc1,7.568636235841013
13443186,CHEMBL2427710,Inhibition of wild type human EGFR after 50 mins by HTRF assay,B,CHEMBL2426280,=,nM,790.0,CHEMBL203,Homo sapiens,IC50,uM,0.79,COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(-c2c[nH]c3ccccc23)n1,6.102372908709558
13443221,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2426279,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3,C=CC(=O)Nc1cc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)cc1N1CCN(C)CC1,5.886056647693163
13446031,CHEMBL2427158,Inhibition of EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426248,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,uM,2.3,COc1ccc(NC(=O)CCCN(C)C)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,5.638272163982407
13452932,CHEMBL2429426,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,B,CHEMBL2425088,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,uM,0.19,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CC2(CCO2)C1,6.721246399047171
13484280,CHEMBL2437777,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) (4:1) as substrate after 30 mins by spectrophotometric analysis",B,CHEMBL2435999,=,nM,90.05,CHEMBL203,Homo sapiens,IC50,nM,90.05,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C)cc5)ccn4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,7.0455162828444475
13492149,CHEMBL2444968,Inhibition of wild type EGFR in human A431 cells assessed as growth inhibition after 48 hrs by MTT assay,B,CHEMBL2441567,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9,CN(C)C/C=C/C(=O)N1CCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21,6.045757490560675
13492173,CHEMBL2444969,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins prior to ATP addition measured after 30 mins by HTRF method,B,CHEMBL2441568,=,nM,1.29,CHEMBL203,Homo sapiens,IC50,nM,1.29,Fc1ccc(Nc2ncnc3cc4c(cc23)NCCO4)cc1Cl,8.88941028970075
13826432,CHEMBL3088500,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL3086102,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0,C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,8.522878745280337
13868165,CHEMBL3101602,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,CHEMBL3098312,=,nM,67200.0,CHEMBL203,Homo sapiens,IC50,uM,67.2,COc1cc2nc(Cl)nc(Nc3ccc(S(=O)(=O)N(C)C)cc3)c2cc1OC,4.172630726946175
13973092,CHEMBL3136749,Inhibition of EGFR (unknown origin),B,CHEMBL3134612,=,nM,2145.0,CHEMBL203,Homo sapiens,IC50,uM,2.145,COc1cc(Nc2nccc(-c3ccc(Cl)cc3)n2)cc(OC)c1OC,5.668572703479257
13973380,CHEMBL3134653,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting",B,CHEMBL3133821,=,nM,270.0,CHEMBL203,Homo sapiens,IC50,nM,270.0,Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1,6.568636235841013
13973662,CHEMBL3136336,Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay,B,CHEMBL3133758,=,nM,165.0,CHEMBL203,Homo sapiens,IC50,nM,165.0,CCN(CCO)CCCOc1ccc2c(Nc3cccc(NC(=O)Nc4ccc(F)c(Cl)c4)c3)ncnc2c1,6.782516055786093
14537513,CHEMBL3223148,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,B,CHEMBL3219502,=,nM,490.0,CHEMBL203,Homo sapiens,IC50,uM,0.49,COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1B1OC(C)(C)C(C)(C)O1,6.309803919971486
14543393,CHEMBL3226013,Inhibition of recombinant EGFR (unknown origin) using poly-Glu-Tyr peptide as substrate,B,CHEMBL3217993,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033,Nc1ccccc1NC(=O)c1ccc(COc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)cc1,7.481486060122113
14548150,CHEMBL3223204,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Y12-Sox peptide as substrate preincubated for 30 mins by fluorescence assay,B,CHEMBL3218346,=,nM,5.4,CHEMBL203,Homo sapiens,IC50,nM,5.4,C=CC(=O)Nc1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1,8.267606240177031
14553219,CHEMBL3223623,Inhibition of EGFR (unknown origin),B,CHEMBL1081312,=,nM,260.0,CHEMBL203,Homo sapiens,IC50,uM,0.26,Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1,6.585026652029182
14566291,CHEMBL3240620,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3234864,=,nM,10350.0,CHEMBL203,Homo sapiens,IC50,uM,10.35,Cc1ncc([N+](=O)[O-])n1CC(=O)N/N=C/c1cc2ccccc2nc1Oc1ccccc1,4.985059650207064
14574799,CHEMBL3241595,Inhibition of EGFR (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237931,=,nM,525.0,CHEMBL203,Homo sapiens,IC50,uM,0.525,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)CCN3CCCC3)c2)n1,6.279840696594043
14574927,CHEMBL3240469,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3237938,=,nM,18020.0,CHEMBL203,Homo sapiens,IC50,uM,18.02,Cc1nn(-c2ccccc2)c(Cl)c1C1C(C#N)=C(N)N(c2cccnc2)C2=C1C(=O)CCC2,4.7442452133569555
14586655,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233759,=,nM,4997.0,CHEMBL203,Homo sapiens,IC50,uM,4.997,COC(=O)CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,5.301290650557413
14586700,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233761,=,nM,1803.0,CHEMBL203,Homo sapiens,IC50,uM,1.803,CN(C)CCCC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,5.744004273277598
14652512,CHEMBL3266279,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,B,CHEMBL3263959,=,nM,7670.0,CHEMBL203,Homo sapiens,IC50,uM,7.67,COc1cc2c(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,5.115204636051019
14652530,CHEMBL3266280,Inhibition of recombinant EGFR L858R mutant (unknown origin) using poly-GT peptide as substrate after 1 hr by Transcreener assay,B,CHEMBL3263960,=,nM,2895.0,CHEMBL203,Homo sapiens,IC50,uM,2.895,COc1cc2c(Oc3ccc(NS(=O)(=O)c4cccc(-c5ccoc5)c4)cc3F)ccnc2cc1OCCCN1CCOCC1,5.538351431936545
14655699,CHEMBL3267504,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,B,CHEMBL3263359,=,nM,3960.0,CHEMBL203,Homo sapiens,IC50,uM,3.96,Cc1ccc(C2=NN(C3=NC(c4ccccc4)CS3)C(c3cccc4ccccc34)C2)cc1C,5.402304814074488
14730368,CHEMBL3292439,Inhibition of EGFR (unknown origin) after 1 hr by HTRF assay,B,CHEMBL3290142,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0,C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1,7.958607314841775
14742029,CHEMBL3294216,Inhibition of EGF receptor (unknown origin),B,CHEMBL3287898,=,nM,7500.0,CHEMBL203,Homo sapiens,IC50,uM,7.5,CCc1ccccc1NC(=O)N1C[C@@H](C)Oc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,5.1249387366083
14753620,CHEMBL3300694,Inhibition of EGFR (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis,B,CHEMBL3040861,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002,c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCO5)c2)cc1,8.698970004336019
14926877,CHEMBL3391161,Inhibition of EGFR kinase (unknown origin) using poly(Glu:Tyr) as substrate,B,CHEMBL3347498,=,nM,850.0,CHEMBL203,Homo sapiens,IC50,uM,0.85,OB(O)c1ccc(COc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)cc1,6.070581074285707
14974582,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360602,=,nM,0.77,CHEMBL203,Homo sapiens,IC50,nM,0.77,COc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCn1ccnc1[N+](=O)[O-],9.113509274827518
14983517,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355873,=,nM,3.05,CHEMBL203,Homo sapiens,IC50,nM,3.05,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCn1ccnc1[N+](=O)[O-],8.515700160653214
14992852,CHEMBL3372237,Inhibition of recombinant EGFR (unknown origin) after 60 mins by z'-lyte kinase assay,B,CHEMBL3361128,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0,O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21,4.0
15073002,CHEMBL3389020,Inhibition of EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426288,=,nM,91.0,CHEMBL203,Homo sapiens,IC50,uM,0.091,COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,7.040958607678906
15073018,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353410,=,nM,480000.0,CHEMBL203,Homo sapiens,IC50,uM,480.0,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,3.318758762624413
15078039,CHEMBL3384643,Inhibition of EGFR (unknown origin),B,CHEMBL3358006,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1,C[C@@H]1CN(c2nc(C(F)(F)F)no2)CCN1c1ncc(OCc2ccc(CS(C)(=O)=O)cc2F)cn1,5.6777807052660805
15105145,CHEMBL3382433,Inhibition of EGFR (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay,B,CHEMBL3335244,=,nM,88670.0,CHEMBL203,Homo sapiens,IC50,uM,88.67,COc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O,4.052223291535261
15139266,CHEMBL3385132,Inhibition of EGFR (unknown origin),B,CHEMBL1230609,=,nM,2990.0,CHEMBL203,Homo sapiens,IC50,nM,2990.0,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,5.52432881167557
15146897,CHEMBL3395991,Inhibition of human full length HER1 assessed as phosphorylation state by ELISA assay,B,CHEMBL3393072,=,nM,8490.0,CHEMBL203,Homo sapiens,IC50,uM,8.49,O=C(Cc1c[nH]c2ccccc12)NNC(=S)Nc1ncccc1Br,5.071092309756048
15156222,CHEMBL3399407,Inhibition of EGFR (unknown origin),B,CHEMBL3397275,=,nM,1210.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.21,Clc1cc(Nc2ncnc3ccc(NC4=NC[C@H](COc5ccccc5)O4)cc23)ccc1OCc1nccs1,5.91721462968355
15175179,CHEMBL3404061,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,CHEMBL3297898,=,nM,68.2,CHEMBL203,Homo sapiens,IC50,nM,68.2,COc1ccc(N(C)c2nc(C)nc3oc(C)cc23)cc1,7.166215625343521
15197519,CHEMBL3412565,Inhibition of EGFR intracellular domain (unknown origin) purified from a baculovirus expression system using Biotin-(amino hexonoic acid)-EEEEYFELVAKKK-CONH2 as substrate after 10 mins by scintillation counting in presence of [gamma-33P]ATP,B,CHEMBL3409484,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025,CS(=O)(=O)CCNCc1ccc(-c2cc3c(Nc4ccc(OCc5ccccc5)cc4)ncnc3cn2)o1,7.6020599913279625
15229658,CHEMBL3418214,Inhibition of EGFR (unknown origin) after 40 mins by scintillation proximity assay,B,CHEMBL3416636,=,nM,372.0,CHEMBL203,Homo sapiens,IC50,nM,372.0,Nc1cnc(C#Cc2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cn1,6.429457060118103
15229667,CHEMBL3418212,Inhibition of human GST-tagged EGFR expressed in baculovirus-infected insect Sf9 cells using biotinylating polyGluTyr as substrate after 1 hr by scintillation counting analysis in presence of [gamma-33P]-ATP,B,CHEMBL3416629,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0,C#Cc1cccc(N2C(=O)Nc3c(C(=O)Nc4ccc(CN5CCCC5)cc4)sc4ncnc2c34)c1,7.585026652029182
15253807,CHEMBL3429887,Inhibition of human EGFR,B,CHEMBL3426225,=,nM,3518.0,CHEMBL203,Homo sapiens,IC50,uM,3.518,CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21,5.453704164878557
15257009,CHEMBL3430219,Inhibition of wild type N-terminal His6-tagged human EGFR kinase domain (702 to 1016 residues) expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425655,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,uM,7.0,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(C#N)=C/c3ccc(F)cc3)c2)n1,5.154901959985743
15628370,CHEMBL3588418,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,B,CHEMBL3586189,=,nM,13200.0,CHEMBL203,Homo sapiens,IC50,uM,13.2,O=C1N=C(N2CCC[C@H]2C(=O)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)S/C1=C/c1ccc(-c2ccccc2)cc1,4.87942606879415
15666991,CHEMBL3603321,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte assay,B,CHEMBL3601223,=,nM,409.0,CHEMBL203,Homo sapiens,IC50,nM,409.0,C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1,6.388276691992658
15684498,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604927,=,nM,3900.0,CHEMBL203,Homo sapiens,IC50,uM,3.9,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Oc3cccc([N+](=O)[O-])c3)n2)n[nH]1,5.4089353929735005
15685133,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604919,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,uM,2.8,C=CC(=O)Nc1cccc(-c2nccc(Nc3cc(C)[nH]n3)n2)c1,5.552841968657781
15689326,CHEMBL3609988,Inhibition of EGFR E746-A750 deletion mutant in human PC9 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608432,=,nM,6651.0,CHEMBL203,Homo sapiens,IC50,nM,6651.0,C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3C)c3ncn(C(C)C)c3n2)C[C@H]1F,5.17711305216585
15689330,CHEMBL3609987,Inhibition of EGFR L858R/T790M double mutant in human H1975 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608434,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0,C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(CC)nc3OC)c3ncn(C)c3n2)C[C@H]1F,8.221848749616356
15689338,CHEMBL3609989,Inhibition of EGFR L858R mutant in human H3255 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608429,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0,C=CC(=O)N[C@@H]1CN(c2nc(Nc3cnn(C)c3)c3ncn(C(C)C)c3n2)C[C@H]1F,8.698970004336019
15698265,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612585,=,nM,780.0,CHEMBL203,Homo sapiens,IC50,uM,0.78,CCOC(=O)CCCn1c(=O)oc2cc3ncnc(Nc4ccc(OCc5nccc(OCC(F)(F)F)c5C)cc4)c3cc21,6.107905397309519
15743407,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3621220,=,nM,102.2,CHEMBL203,Homo sapiens,IC50,nM,102.2,C=CC(=O)Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1OCCOC,6.990549104201306
15745890,CHEMBL3624464,Inhibition of EGFR exon19 deletion mutant (unknown origin) by HTRF assay in presence of Km of ATP,B,CHEMBL3623290,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C,9.698970004336019
15771533,CHEMBL3635658,Inhibition of EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells after 60 mins by mesoscale multiplex assay,B,CHEMBL3633141,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0,C=CC(=O)Nc1cc(Nc2cncc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.823908740944319
16260061,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699581,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3OC)ncc2C(F)(F)F)c1,8.259637310505756
16269750,CHEMBL3705968,"ELISA-Based Kinase Assay: Inhibition of erbB tyrosine kinase activity was assessed using an ELISA-based receptor tyrosine kinase assay. Kinase reactions (50 mM HEPES, pH 7.4, 125 mM NaCl, 10 mM MgCl2, 100 μM sodium orthovanadate, 2 mM dithiothreitol, 20 uM ATP, test compound or vehicle control and 1-5 nM GST-erbB per 50 uL reaction) were run in 96-well plates coated with 0.25 mg/ml poly-Glu-Tyr (Sigma). The reactions were incubated for 6 minutes at room temperature while shaking. Kinase reactions were stopped by removal of reaction mixture, then wells were washed with wash buffer comprising 3% Bovine Serum Albumin and 0.1% Tween 20 in Phosphate Buffered Saline (PBS). Phosphorylated tyrosine residues were detected by adding 0.2 μg/ml anti-phosphotyrosine antibody (Oncogene Ab-4; 50 μL/well) coupled to Horse Radish Peroxidase (HRP) for 25 minutes while shaking at room temperature.",B,CHEMBL3680375,=,nM,11.35,CHEMBL203,Homo sapiens,IC50,nM,11.35,O=C(/C=C/CN1CCCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,7.945004138470859
16390277,CHEMBL3737956,Inhibition of EGFR phosphorylation in human NCI-H1975 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL3735952,=,nM,880.0,CHEMBL203,Homo sapiens,IC50,uM,0.88,COC1CCN(c2nccc(Nc3cc4[nH]cnc4cn3)n2)CC1,6.055517327849832
16390300,CHEMBL3737962,Inhibition of EGFR T790M/del (746 to 750) deletion mutant phosphorylation in erlotinib-resistant human PC9 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL3736121,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0,CO[C@H]1CCN(c2nccc(Nc3cc4c(cn3)nc([C@@H](C)O)n4[C@H](C)C(F)(F)F)n2)C[C@H]1F,7.568636235841013
16395721,CHEMBL3745460,Inhibition of wild-type EGFR tyrosine kinase (unknown origin) assessed as ATP level by luminescence analysis,B,CHEMBL3740144,=,nM,8.4,CHEMBL203,Homo sapiens,IC50,nM,8.4,CN1CCN(Cc2ccc(NC(=O)Nc3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)cc2)CC1,8.075720713938118
16395727,CHEMBL3745461,Inhibition of EGFR tyrosine kinase L858R mutant (unknown origin) assessed as ATP level by luminescence analysis,B,CHEMBL3741473,=,nM,10.5,CHEMBL203,Homo sapiens,IC50,nM,10.5,O=C(Nc1ccc(CN2CCCCC2)cc1)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1,7.978810700930062
16398677,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3739750,=,nM,4670.0,CHEMBL203,Homo sapiens,IC50,uM,4.67,CC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1,5.330683119433888
16404680,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3740577,=,nM,860.0,CHEMBL203,Homo sapiens,IC50,uM,0.86,C=CC(=O)Nc1cccc(Nc2nc(N/N=C/c3ccc(F)cc3)ncc2Cl)c1,6.0655015487564325
16404735,CHEMBL3743367,Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3740257,=,nM,11750.0,CHEMBL203,Homo sapiens,IC50,uM,11.75,C=CC(=O)Nc1cccc(Nc2nc(N/N=C(\C)c3ccc(F)cc3F)ncc2Cl)c1,4.9299621333922445
16410641,CHEMBL3745491,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,B,CHEMBL3741490,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001,C#Cc1cccc(Nc2ncnc3cc(OCCO)c(OCCOC)cc23)c1,9.0
16416924,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3746473,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6,CC(=O)N1N=C(c2ccc([N+](=O)[O-])cc2)CC1c1ccc(C(=O)OCCn2c([N+](=O)[O-])cnc2C)cc1,6.221848749616356
16435150,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3754722,=,nM,290.46,CHEMBL203,Homo sapiens,IC50,nM,290.46,COc1cc(NC(=O)Nc2ccncc2)cc(-c2cncnc2)c1OC,6.536913666975467
16443117,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3752365,=,nM,78.0,CHEMBL203,Homo sapiens,IC50,nM,78.0,C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC(C)C)nc32)c1,7.107905397309519
16451653,CHEMBL3761494,Inhibition of EGFR T790M/L858R mutant autophosphorylation in human H1975 cells,B,CHEMBL3758502,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6,CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21,6.221848749616356
16457535,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759815,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0,C[C@@H](Nc1ncnc2sc(-c3ccc(CO)cc3F)cc12)c1ccccc1,7.886056647693163
16461806,CHEMBL3760417,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,CHEMBL1336,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,7.096910013008056
16479888,CHEMBL3766407,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by addition of substrate by mobility shift assay,B,CHEMBL3763360,=,nM,9.1,CHEMBL203,Homo sapiens,IC50,nM,9.1,COc1ccc(/C=C/C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2O[C@H]2CCOC2)cc1,8.040958607678906
16496308,CHEMBL3779159,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay",B,CHEMBL3774451,=,nM,582.17,CHEMBL203,Homo sapiens,IC50,nM,582.17,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1nnn(-c2ccc(F)cc2)c1C(F)(F)F,6.23495017809705
16532744,CHEMBL3789485,Inhibition of EGFR Del ex19 mutant phosphorylation in human HCC827 cells after 1 hr by Western blot analysis,B,CHEMBL3545308,=,nM,187.0,CHEMBL203,Homo sapiens,IC50,nM,187.0,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1,6.728158393463501
16532768,CHEMBL3789506,Inhibition of EGFR L858R/T790M double mutant in human NCI-H1975 cells assessed as suppression of cell proliferation,B,CHEMBL3787344,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0,Cc1cc(C(=O)Nc2nc3cccc(Cl)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1,7.6020599913279625
16532773,CHEMBL3789747,Inhibition of EGFR Del ex19 mutant in human PC9 cells assessed as suppression of cell proliferation,B,CHEMBL3663929,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0,C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1,8.096910013008056
16539480,CHEMBL3789407,Inhibition of Her1 (unknown origin),B,CHEMBL3787112,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,uM,2.3,Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,5.638272163982407
16540069,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3787662,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3[nH]ccc23)c1,8.397940008672037
16540164,CHEMBL3790969,Inhibition of EGFR deletion/T790M mutant autophosphorylation in human PC9-DRH cells after 2 hrs by sandwich ELISA,B,CHEMBL3786098,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0,C=CC(=O)N1C[C@H](COc2nc(Nc3cnn(C)c3)nc3[nH]cc(Cl)c23)[C@@H](OC)C1,8.154901959985743
16540763,CHEMBL3789980,Inhibition of EGFR (unknown origin) in presence of [gamma33P]ATP,B,CHEMBL1614712,=,nM,5200.0,CHEMBL203,Homo sapiens,IC50,uM,5.2,Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,5.2839966563652006
16562719,CHEMBL3802284,Inhibition of EGFR (746 to 750) deletion mutant (unknown origin) using peptide substrate incubated for 30 mins by europium donor dye-based plate reader analysis,B,CHEMBL3799585,=,nM,8000.0,CHEMBL203,Homo sapiens,IC50,uM,8.0,CCCC(=O)Nc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\O)C(=O)N2,5.096910013008056
16577164,CHEMBL3804124,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,B,CHEMBL3800262,=,nM,57000.0,CHEMBL203,Homo sapiens,IC50,uM,57.0,CC(=O)c1cccc(NC(=O)c2cc3ccccc3[nH]2)c1,4.2441251443275085
16581378,CHEMBL3804024,Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3797606,=,nM,271.6,CHEMBL203,Homo sapiens,IC50,nM,271.6,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2SC)c1,6.566070234391536
16588546,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805218,=,nM,25.86,CHEMBL203,Homo sapiens,IC50,nM,25.86,Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c4c(c23)OCCO4)cc1Cl,7.587371479455625
16588590,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806292,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,nM,1000.0,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2c2c1OCCO2,6.0
16589317,CHEMBL3807568,Inhibition of recombinant His6-tagged EGFR (unknown origin) cytoplasmic domain (645 to 1186 residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3805508,=,nM,7920.0,CHEMBL203,Homo sapiens,IC50,uM,7.92,c1ccc(COc2cccc(C3CC(c4ccc5c(c4)OCCO5)=NN3c3ccccc3)c2)cc1,5.101274818410507
16593614,CHEMBL3811753,Inhibition of GST-tagged human recombinant EGFR (668 to1210 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate,B,CHEMBL3808884,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0,COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1,7.823908740944319
16609940,CHEMBL3817134,Inhibition of recombinant N-terminal GST-tagged human EGFR T790M/L858R double mutant using biotinylated TK substrate incubated for 50 mins by HTRF assay,B,CHEMBL3815045,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05,CCn1c(-c2nc(-c3cnn(C4CCN(C)CC4)c3)cnc2N)nc2ccccc21,7.301029995663981
16612183,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3814959,=,nM,0.803,CHEMBL203,Homo sapiens,IC50,nM,0.803,NC(=O)Nc1ccc2ncnc(Nc3ccc(Br)cc3)c2c1,9.09528445472132
16612269,CHEMBL3815445,Inhibition of EGFR L858R/T790M double mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814846,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1,CC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,5.6777807052660805
16619740,CHEMBL3820194,Inhibition of EGFR T790M mutant (unknown origin) preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818364,=,nM,110.6,CHEMBL203,Homo sapiens,IC50,nM,110.6,CCOc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)[C@H]1COC(=O)N1,6.956244873031321
16631000,CHEMBL3820192,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818547,=,nM,1.06,CHEMBL203,Homo sapiens,IC50,nM,1.06,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)[C@@H]1COC(=O)N1,8.97469413473523
16639380,CHEMBL3826532,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate incubated for 30 mins by HTRF assay",B,CHEMBL3823520,=,nM,529.4,CHEMBL203,Homo sapiens,IC50,nM,529.4,COc1cc2c(Oc3ccc(NC(=O)c4cn(-c5ccccc5Cl)nn4)cc3F)ccnc2cc1OCCCN1CCCCC1,6.276216063034671
16655123,CHEMBL3830418,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M/L858R double mutant (696 residues) expressed in insect Sf21 cells using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA",B,CHEMBL3735648,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,nM,350.0,CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21,6.455931955649724
16655513,CHEMBL3829377,Inhibition of cytoplasmic GST-tagged human recombinant EGFR expressed in baculovirus system by z-lyte assay,B,CHEMBL3828269,=,nM,2.97,CHEMBL203,Homo sapiens,IC50,nM,2.97,Cn1cc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cn1,8.527243550682787
16668203,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3948084,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017,CCC(=O)Nc1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cc1OC,7.769551078621726
16739552,CHEMBL3857083,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BA/F3 cells assessed as reduction in cell viability after 48 hrs by XTT assay,B,CHEMBL3901622,=,nM,217.0,CHEMBL203,Homo sapiens,IC50,nM,217.0,C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1,6.663540266151471
16752236,CHEMBL3860363,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,B,CHEMBL3965075,=,nM,470.0,CHEMBL203,Homo sapiens,IC50,uM,0.47,CCOCc1ccc2c(c1)nc(NC(=O)c1cccc(C(F)(F)F)c1)n2[C@H]1CC[C@H](O)CC1,6.327902142064283
16752254,CHEMBL3860368,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,B,CHEMBL3972316,=,nM,1.39,CHEMBL203,Homo sapiens,IC50,nM,1.39,C=CC(=O)N1CCCC[C@@H](n2c(NC(=O)c3cccc(C(F)(F)F)c3)nc3cccc(C)c32)C1,8.856985199745905
16752335,CHEMBL3860367,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,B,CHEMBL3966111,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05,C=CC(=O)NCCCn1c(NC(=O)c2cccc(C(F)(F)F)c2)nc2cc(C)ccc21,7.301029995663981
16752352,CHEMBL3860366,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 0 mins followed by 1 mM ATP addition by HTRF assay,B,CHEMBL3901943,=,nM,830.0,CHEMBL203,Homo sapiens,IC50,uM,0.83,C=CC(=O)N1CCCCC(n2c(NC(=O)c3cccc(C(F)(F)F)c3)nc3cc(C)ccc32)C1,6.080921907623926
16752368,CHEMBL3860372,Inhibition of EGFR L858R/T790M mutant (unknown origin) phosphorylation expressed in mouse NIH/3T3 cells incubated for 3 hrs by ELISA method,B,CHEMBL3953221,=,nM,41.4,CHEMBL203,Homo sapiens,IC50,nM,41.4,C=CC(=O)N[C@H]1CCC[C@@H](n2c(NC(=O)c3cccc(C(F)(F)F)c3)nc3cc(C)ccc32)C1,7.382999658879101
16756448,CHEMBL3861200,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,B,CHEMBL3947759,=,nM,106.0,CHEMBL203,Homo sapiens,IC50,nM,106.0,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCn4ccnc4)cc3)ncc2Cl)c1,6.97469413473523
16808361,CHEMBL3870418,Inhibition of EGFR (unknown origin) using peptide as substrate after 60 mins by HTRF assay,B,CHEMBL3921664,=,nM,570.0,CHEMBL203,Homo sapiens,IC50,nmol/L,570.0,CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2ccc(F)cc2)ncc1Cl,6.2441251443275085
16808781,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3924500,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0,S=C(NNc1nncc2ccccc12)Nc1ccccc1,7.187086643357144
16811346,CHEMBL3870703,Inhibition of recombinant human amino-terminal GST-His6-fused EGFR expressed in baculovirus expression system assessed as phosphorylation using Biotin-PTP1B as substrate by HTScan assay,B,CHEMBL598797,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4,C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1,8.619788758288394
16811349,CHEMBL3870719,"Inhibition of recombinant human GST-fused EGFR (668 to 1211 residues) assessed as phosphotyrosine formation using poly(Glu:Tyr, 4:1) as substrate and ATP measured after 6 mins",B,CHEMBL3890526,=,nM,670.0,CHEMBL203,Homo sapiens,IC50,nM,670.0,COc1cc(Nc2ncnc3ccc(-c4ccc(CN5C[C@@H]6[C@@H](CO)[C@@H]6C5)cc4)cc23)ccc1Oc1ccccc1,6.173925197299173
16811352,CHEMBL3870717,Inhibition of EGFR (unknown origin),B,CHEMBL2103842,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0,C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1,8.154901959985743
16829736,CHEMBL3874958,Inhibition of EGFR (unknown origin),B,CHEMBL3931223,=,nM,690.0,CHEMBL203,Homo sapiens,IC50,nM,690.0,COc1cc2c(Oc3ccc(NC(=O)c4cn(-c5ccccc5OC)cn4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,6.161150909262744
16835838,CHEMBL3875840,Inhibition of human EGFR using poly (Glu:Tyr) as substrate measured for 1.5 hrs by oregon green 488 dye-based fluorescence assay,B,CHEMBL3883652,=,nM,11000.0,CHEMBL203,Homo sapiens,IC50,uM,11.0,Cc1cccc(Nc2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c1,4.958607314841775
16837433,CHEMBL3876067,Inhibition of human recombinant GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system,B,CHEMBL3884319,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0,CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21,5.0
16894422,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL598377,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCCC(=O)NO,8.508638306165727
16895175,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3965391,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0,C=CC(=O)N1CC[C@H](Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OC)C1,8.522878745280337
16906039,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3983201,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0,COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(-c2ccc(C(F)(F)F)cc2)n1,7.301029995663981
17601741,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676392,=,nM,956.0,CHEMBL203,Homo sapiens,IC50,nM,956.0,C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCOCCOC(=O)CC(=O)O,6.0195421077238995
17607121,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655336,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0,O=C(/C=C/CN1CCCOCC1)N1CCc2c(sc3ncnc(Nc4ccc(F)c(Cl)c4)c23)C1,9.0
17657269,CHEMBL3705672,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 μM Na3VO4, 1.25 M DTT (1000×) and 20 μM ATP at 25° C., for 45 minutes.",B,CHEMBL3647417,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,nM,48.0,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@@H]1CCCN1C,7.318758762624412
17658531,CHEMBL3705522,"In Vitro Kinase Assay: In vitro kinase analysis was performed by using HTScan EGF Receptor Kinase Assay Kit (#7909) and HTScan HER2/ErbB2 Kinase Assay Kit (#7058) from Cell Signaling Technology Company. Operation steps refer to the specification of the used kits, and the method was used to measure the inhibition effects of the compound to be tested on substrate peptide phosphorylation of EGFR or Her2 receptor tyrosine kinase. At room temperature, ATP and substrate peptide as well as the compound to be tested were incubated in kinase reaction buffer, after a period of incubation, a stop buffer was added to terminate the reaction and the sample was transferred to a streptavidin-coated 96-well plate, the plate was washed and the phosphorylation level of substrate peptide was detected by using HRP-marked antibody against substrate phosphorylation, colorated with TMB, terminated the reaction with 2M sulfuric acid. Absorption at 450 nm wavelength was detected, and IC50 value (μM) was calculated.",B,CHEMBL3040566,=,nM,2.71,CHEMBL203,Homo sapiens,IC50,nM,2.71,NS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,8.567030709125595
17694618,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663921,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)c(C(N)=O)nc2CC)c1,8.886056647693163
17698843,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL4113919,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0,CC(C)n1c(Nc2ccccc2)nc2cnc(Nc3ccc(C(=O)N[N+]4=CCN(C)CC4)cc3)nc21,8.096910013008056
17721221,CHEMBL3887593,"Time-Resolved Fret (TR-FRET) Assay: 1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dilutions of 10 fold from 100 micoM are used. Kinase activity was determined with time-resolved Fret (TR-FRET) assay (LanthaScreen® kinase activity assay, from InVitrogen).2) The assay is performed in a Black 384-well plate (from Corning). The kinase and the compound was incubated for 30 mM at room temperature. ATP (1 mM) and fluorescein-poly GT were added, and the reaction was incubated for 15 mM. Detection agent SA-XL665 (from Cisbio Assay) and TK Ab-Cryptate detection antibody (from InVitrogen) were added to stop the reaction.3) The 384-well plate was sealed and incubated for 1 hour. The fluorescence was then measured at 620 nM (Cryptate) and 665 nM (XL655) wavelength.4) Each concentration of compound was done in triplicate, and vehicle (without compound) and a positive control were used.",B,CHEMBL4112924,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4,CO[C@@H]1COC2C1OC[C@H]2Oc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,9.397940008672037
17734085,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3903641,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccccc3OC)ncc2C(F)(F)F)c1,6.698970004336019
17775377,CHEMBL3888589,"Enzyme Assay: A431 Cell Line: 1. 5×103 cells per well in 100 μl of medium were seeded in 96-well plate, here the medium contained 5% FBS2. 24 hours later, 100 μl fresh medium was added with various concentrations of compounds into each well, while the medium here was free of FBS.3. After the cells were treated with compounds for 72 hours, 20 μl MTT (5 mg/ml) was added into each well, and then the assay plate was incubated at 37° C. for 4 more hours.4. The assay plate was centrifuged at 800 g for 10 min. The medium was aspirated, 150 μl DMSO was added into each well. The plate was gently shaken for 10 min.5. The absorbance at 570 nm was measured on the plate reader.6. IR %=(WC−WT)/WC×100%.",B,CHEMBL3622645,=,nM,3099.0,CHEMBL203,Homo sapiens,IC50,nM,3099.0,C#Cc1cccc(Nc2ncnc3cc(O[C@H]4CCOC4)c(NC(=O)/C=C/CN(C)C)cc23)c1,5.508778423760717
17775382,CHEMBL3888591,"Luminescence Kinase Assay: The assay was performed using Kinase-Glo Plus luminescence kinase assay kit (Promega). The compounds were diluted in 10% DMSO and 5 μl of the dilution was added to a 50 μl reaction so that the final concentration of DMSO is 1% in all of reactions. All of the enzymatic reactions were conducted at 30° C. for 25 minutes. The 50 μl reaction mixture contains 40 mM Tris, pH 7.4, 10 mM MgCl2, 0.1 mg/ml BSA, 1 mM DTT, 0.2 mg/ml Poly (Glu, Tyr) substrate, 10 μM ATP and EGFR (Table 2.3.1). After the enzymatic reaction, 50 μl of Kinase-Glo Plus Luminescence kinase assay solution (Promega) was added to each reaction and incubate the plate for 5 minutes at room temperature. Luminescence signal was measured using a BioTek Synergy 2 microplate reader. EGFR activity assays were performed in duplicate at each concentration.",B,CHEMBL3622672,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0,C#Cc1cccc(Nc2ncnc3cc(OC)c(NC(=O)/C=C/CN4CCCCC4)cc23)c1,7.657577319177793
17779176,CHEMBL3888772,"Omnia Assay: Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1× kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10× stock, KB002A) and 0.2 mM DTT (DS001A). 5 μL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25°ree; C. with a 0.5 μL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 μL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.).",B,CHEMBL3967836,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NC4CN(C(=O)OC(C)(C)C)C4)cc3OC)ncc2C(F)(F)F)c1,8.301029995663981
17780693,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 μL of the test compounds and 10 μL solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 μL solution containing 20 mM HEPES, 2 mM MnCl2, 100 μM Na3VO4, 1 mM DTT buffer, and 20 μL of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 μL anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%−[(negative control)/(positive control−negative control)].",B,CHEMBL2316140,=,nM,1680.0,CHEMBL203,Homo sapiens,IC50,nM,1680.0,COc1cc(/C=C2\CCC/C(=C\c3ccccc3)C2=O)cc(OC)c1,5.774690718274137
17791532,CHEMBL3889034,Inhibition Assay: Inhibition of recombinant EGFR tyrosine kinase using exogenous substrate.,B,CHEMBL253969,=,nM,5853.4,CHEMBL203,Homo sapiens,IC50,nM,5853.4,NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1,5.232591796771347
17956893,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4077956,=,nM,9.2,CHEMBL203,Homo sapiens,IC50,nM,9.2,NP(=O)(Oc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)N(CCCl)CCCl,8.036212172654444
17967041,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4103370,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,uM,0.081,Clc1ccc(-c2nnc(Cc3nc4ccccc4[nH]3)o2)cc1,7.0915149811213505
17979737,CHEMBL3998244,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,B,CHEMBL4098409,=,nM,167.1,CHEMBL203,Homo sapiens,IC50,nM,167.1,COc1ccc2c(c1)CCN2c1nc(C)nc2c(Cc3ccccc3)c[nH]c12.Cl,6.777023550106609
17979966,CHEMBL3998355,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL4092990,=,nM,16.8,CHEMBL203,Homo sapiens,IC50,nM,16.8,C=CC(=O)Nc1ccc(CN(C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)cc1,7.774690718274137
17989460,CHEMBL3999845,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,CHEMBL4100647,=,nM,11.42,CHEMBL203,Homo sapiens,IC50,nM,11.42,CC1(C)OOC2(CCC(C(=O)Nc3ccc4ncnc(Nc5cccc(Cl)c5)c4c3)CC2)OO1,7.942333896090171
18003765,CHEMBL4002953,"Inhibition of recombinant EGFR (unknown origin) using poly (Glu4, Tyr) as substrate after 60 mins by ADP-glo kinase assay",B,CHEMBL4105434,=,nM,23700.0,CHEMBL203,Homo sapiens,IC50,uM,23.7,CCCCOC(=O)c1c(-c2ccccc2)nn2ccccc12,4.6252516539898965
18029896,CHEMBL4007193,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells preincubated for 60 mins followed by EGF induction measured after 10 mins by ELISA,B,CHEMBL4060383,=,nM,20000.0,CHEMBL203,Homo sapiens,IC50,uM,20.0,Nc1nc(N)c2c(n1)[nH]c1cccc(Sc3ccc4ccccc4c3)c12,4.698970004336019
18039937,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4079566,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7,C=CC(=O)Nc1cc(Nc2n[nH]c3ccc(-c4cccc5ccccc45)cc23)c(OC)cc1N(C)CCN(C)C,8.568636235841012
18039958,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4097594,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0,C=CC(=O)Nc1cc(Nc2n[nH]c3ccc(-c4ccc(F)cc4)cc23)c(OC)cc1N(C)CCN(C)C,8.698970004336019
18048449,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4088718,=,nM,17.2,CHEMBL203,Homo sapiens,IC50,nM,17.2,S=C(NCc1ccccc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.764471553092451
18048729,CHEMBL4011075,Inhibition of human recombinant GST-tagged EGFR (668 to 1210 residues) cytoplasmic domain expressed in baculovirus expression system,B,CHEMBL4078182,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,nM,41.0,S=C(Nc1cccc(Cl)c1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.3872161432802645
18052742,CHEMBL4011794,Inhibition of EGFR (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,CHEMBL4071058,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,uM,0.0032,CC(C)(C)OC(=O)NCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.494850021680094
18060514,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4102577,=,nM,6.8,CHEMBL203,Homo sapiens,IC50,nM,6.8,CCC(=O)Nc1cccc(Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c1,8.167491087293763
18060536,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL321494,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,nM,130.0,CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,6.886056647693163
18085948,CHEMBL4018631,"Inhibition of recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4105329,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1,Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12,8.508638306165727
18086083,CHEMBL4018689,Inhibition of EGFR exon 19 deletion mutant in human HCC827 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay,B,CHEMBL4062877,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4,Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12,9.397940008672037
18117552,CHEMBL4025907,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,B,CHEMBL4083815,=,nM,7230.0,CHEMBL203,Homo sapiens,IC50,uM,7.23,O=c1c2ccccc2nc(-c2ccccc2)n1-c1nnc(-c2ccccc2Cl)s1,5.140861702705469
18117869,CHEMBL4025984,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",B,CHEMBL4081703,=,nM,22.4,CHEMBL203,Homo sapiens,IC50,nM,22.4,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(/C=C/c4cc(C)cc(C)c4)cc3)ncc2Cl)c1,7.649751981665837
18152584,CHEMBL4034169,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay",B,CHEMBL4066684,=,nM,725.3,CHEMBL203,Homo sapiens,IC50,nM,725.3,Cc1cc(=O)n(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1,6.139482322538254
18154935,CHEMBL4034720,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate measured after 10 mins by mobility shift assay,B,CHEMBL4064776,=,nM,56.0,CHEMBL203,Homo sapiens,IC50,nM,56.0,O=C(N/N=C/c1ccc(O)cc1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,7.251811972993799
18155514,CHEMBL4034792,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,B,CHEMBL4100075,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1,Cc1nc(C)c(/C=C2\CC(C)C/C(=C\c3nc(C)c(C)nc3C)C2=O)nc1C,5.958607314841775
18172231,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4071474,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5,C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,9.301029995663981
18189804,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4094527,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5,C=CC(=O)N1CCC[C@@H](n2ncc3c(N)ncnc32)C1,5.6020599913279625
18232358,CHEMBL4050456,Inhibition of recombinant human GST-tagged EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL4068839,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,nM,5.3,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(OCc4ccccn4)c(Cl)c3)c3c(N)ncnc32)C1,8.275724130399212
18243178,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4071494,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,nM,1300.0,Oc1ccc(-c2nc(-c3ccco3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1,5.886056647693163
18243230,CHEMBL4052481,Inhibition of recombinant human N-terminally GST-tagged EGFR L858R/T790M/C797S triple mutant expressed in baculovirus in Sf9 insect cells preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4097627,=,nM,782.0,CHEMBL203,Homo sapiens,IC50,nM,782.0,Oc1cccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)c1,6.106793246940152
18243256,CHEMBL4052484,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL4101719,=,nM,6.47,CHEMBL203,Homo sapiens,IC50,nM,6.47,OCCCc1nc(-c2ccc(F)cc2)c(-c2ccnc3[nH]c(-c4ccccc4)cc23)[nH]1,8.1890957193313
18248384,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4069277,=,nM,188.2,CHEMBL203,Homo sapiens,IC50,nM,188.2,C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C(C)=O,6.725380380908762
18248399,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4081429,=,nM,427.7,CHEMBL203,Homo sapiens,IC50,nM,427.7,C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N1CCNC(=O)C1,6.368860749743189
18267650,CHEMBL4057894,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay",B,CHEMBL4082724,=,nM,980.83,CHEMBL203,Homo sapiens,IC50,nM,980.83,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,6.008406259143765
18268993,CHEMBL4058124,Inhibition of recombinant human N-terminal GST-tagged EGFR (696 to end residues) expressed in baculovirus Sf21 insect cells preincubated for 5 mins followed by substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay,B,CHEMBL4095253,=,nM,642.7,CHEMBL203,Homo sapiens,IC50,nM,642.7,C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21,6.1919917000896
18299296,CHEMBL4124414,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4125764,=,nM,4.7,CHEMBL203,Homo sapiens,IC50,nM,4.7,C=CC(=O)N[C@@H]1CCN(c2nc(Nc3ccccc3)nc3cnc(Nc4ccc(N5CCN(C)CC5)cn4)cc23)C1,8.327902142064282
18299315,CHEMBL4124416,"Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4127809,=,nM,285.0,CHEMBL203,Homo sapiens,IC50,nM,285.0,C=CC(=O)N[C@H]1CCN(c2nc(Nc3ccccc3)nc3cnc(Nc4ccc(N5CCN(C)CC5)cn4)cc23)C1,6.54515513999149
18304093,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4126797,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,nM,46.0,C=CC(=O)Nc1cccc(-n2c(=O)n(C)c(=O)c3cnc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)nc32)c1,7.337242168318426
18308314,CHEMBL4131304,Inhibition of recombinant human His-tagged EGFR (1 to 645 residues) expressed in HEK293 cells using Tyr66-biotinylated PTP1B peptide as substrate preincubated for 5 mins followed by substrate addition measured after 1 hr by ELISA,B,CHEMBL4168235,=,nM,3.62,CHEMBL203,Homo sapiens,IC50,nM,3.62,COc1cc2c(Nc3ccc(C#N)cc3)ncnc2cc1OCCCN1CCC(c2ccccc2)CC1,8.441291429466835
18311468,CHEMBL4132129,Inhibition of EGFR1 (unknown origin) after 1 hr in presence of adenosine 5'[gamma-33P]triphosphate by microbeta microplate counting method,B,CHEMBL4171764,=,nM,2.61,CHEMBL203,Homo sapiens,IC50,nM,2.61,Brc1cccc(Nc2ncnc3sc4c(c23)CCCC4)c1,8.58335949266172
18324904,CHEMBL4135134,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus virus expression system after 1 hr by ELISA,B,CHEMBL4166412,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11,NS(=O)(=O)c1ccc(-n2c(SCC(=O)Nc3cnc4ccccc4c3)nc3cc4ccccc4cc3c2=O)cc1,6.958607314841775
18328500,CHEMBL4135864,Inhibition of EGFR (unknown origin),B,CHEMBL4171543,=,nM,8.7,CHEMBL203,Homo sapiens,IC50,nM,8.7,C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)cn1,8.060480747381382
18332217,CHEMBL4136451,Inhibition of recombinant human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay,B,CHEMBL4166436,=,nM,865.0,CHEMBL203,Homo sapiens,IC50,nM,865.0,COc1cc(-n2cc(CN3C[C@@H](C)N[C@@H](C)C3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,6.062983892535186
18343070,CHEMBL4139114,Inhibition of human A431 cells derived EGFR by ELISA,B,CHEMBL4163321,=,nM,320.0,CHEMBL203,Homo sapiens,IC50,uM,0.32,CN(CCN(C)Cc1ccc(C(=O)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)cc1)CCn1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21,6.494850021680094
18356034,CHEMBL4140585,Inhibition of EGFR (unknown origin),B,CHEMBL4160854,=,nM,5400.0,CHEMBL203,Homo sapiens,IC50,uM,5.4,Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4cc(Br)ccc4OC(F)(F)F)cc3)c12,5.267606240177032
18379696,CHEMBL4145703,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant expressed in Baculovirus expression system using Tyr 4 peptide as substrate after 1 hr in presence of ATP by Z-LYTE assay,B,CHEMBL4159909,=,nM,3.6,CHEMBL203,Homo sapiens,IC50,nM,3.6,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1,8.443697499232712
18390495,CHEMBL4147642,"Inhibition of EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL2105717,=,nM,3110.0,CHEMBL203,Homo sapiens,IC50,umol/L,3.11,COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,5.507239610973163
18415118,CHEMBL4152882,Inhibition of EGFR exon 19 deletion and L858R mutant phosphorylation in human NCI-H1975 cells,B,CHEMBL3786343,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1,7.7447274948966935
18423618,CHEMBL4154496,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4162767,=,nM,33.1,CHEMBL203,Homo sapiens,IC50,nM,33.1,C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3-n3nccn3)n2)c(OC)cc1N(C)CCN(C)C,7.480172006224281
18427553,CHEMBL4155049,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4162882,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0,CC/C=C/C(=O)Nc1cc2c(N3CCc4ccccc43)ncnc2cc1OC,7.769551078621726
18439532,CHEMBL4156805,Inhibition of EGFR in human MCF7 cell lysates after 24 to 48 hrs by ELISA,B,CHEMBL4167162,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0,O=C(CN1CCCC1)Nc1ccc2ncnc(Nc3ccc(Cl)cc3)c2c1,7.494850021680094
18450557,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4213400,=,nM,78.0,CHEMBL203,Homo sapiens,IC50,nM,78.0,CC(C)C(CO)Nc1nc(Nc2ccc(N3CCNCC3)cc2)c2ncn(C(C)C)c2n1,7.107905397309519
18485984,CHEMBL4186277,Inhibition of EGFR L858R/T790M mutant (unknown origin),B,CHEMBL4214567,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0,O=C(Nc1nccs1)C(c1cc(F)ccc1O)N1Cc2ccccc2C1=O,8.522878745280337
18485992,CHEMBL4186280,Inhibition of wild type N-terminal GST-fused human EGFR cytoplasmic domain expressed in baculovirus expression system using TK-substrate after 25 mins by HTRF KinEASE-TK assay,B,CHEMBL4094959,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,nM,35.0,C=CC(=O)N1CCC[C@@H](n2nc(-c3cn(C)c4ccccc34)c3c(N)ncnc32)C1,7.455931955649724
18486008,CHEMBL4186284,Inhibition of wild type recombinant N-terminal GST-tagged human EGFR catalytic domain expressed in Sf9 insect cells using poly-Glu-Tyr (4:1) as substrate after 2 hrs in presence of [gamma-33P]-ATP by filter-binding method,B,CHEMBL1328065,=,nM,24300.0,CHEMBL203,Homo sapiens,IC50,uM,24.3,Oc1ccccc1-c1nc(NCc2cccnc2)c2ccccc2n1,4.614393726401688
18487170,CHEMBL4186567,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4215703,=,nM,6900.0,CHEMBL203,Homo sapiens,IC50,nM,6900.0,Cc1cc(=O)n(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ncnc3ccsc23)c(F)c1,5.161150909262744
18499364,CHEMBL4188985,"Inhibition of wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,CHEMBL3809489,=,nM,3900.0,CHEMBL203,Homo sapiens,IC50,uM,3.9,Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2,5.4089353929735005
18514732,CHEMBL4192705,Inhibition of recombinant human C-terminal His-tagged EGFR (1 to 645 residues) expressed in HEK293 cells by ELISA,B,CHEMBL4173696,=,nM,20.72,CHEMBL203,Homo sapiens,IC50,nM,20.72,C/C=C/c1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(OCCCN4CCOCC4)cc23)cc1,7.683610248926804
18523811,CHEMBL4194205,Inhibition of EGFR (unknown origin),B,CHEMBL4210100,=,nM,267.6,CHEMBL203,Homo sapiens,IC50,nM,267.6,COc1cc2c(cc1OC)Nc1ncnc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c1NC2,6.572513890904214
18535068,CHEMBL4196285,Inhibition of His6-tagged EGFR (unknown origin) cytoplasmic domain expressed in baculovirus infected Sf9 insect cells after 10 mins followed by addition of ATP-MgCl2 and measured after 1 hr by time-resolved fluorometric analysis,B,CHEMBL4214496,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8,O=C(NC(CO)Cc1ccccc1)c1cc2cc(Cl)ccc2[nH]1,6.096910013008056
18536347,CHEMBL4196434,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by mobility shift assay,B,CHEMBL4207750,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4,CCS(=O)(=O)Nc1cc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cnc1OC,8.619788758288394
18539746,CHEMBL4197223,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4209801,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3,CN1CCN(c2ccc(Nc3cc4c(N5CCCC5)nc(Nc5ccccc5)nc4cn3)nc2)CC1,8.638272163982407
18539777,CHEMBL4197225,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4212884,=,nM,62.2,CHEMBL203,Homo sapiens,IC50,nM,62.2,CN(C)C1CCN(c2ccc(Nc3cc4c(N5CCCC5)nc(Nc5ccccc5)nc4cn3)nc2)CC1,7.206209615309181
18572903,CHEMBL4221420,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,CHEMBL4227210,=,nM,4.2,CHEMBL203,Homo sapiens,IC50,nM,4.2,C=CC(=O)Nc1cc(Nc2ncc3ncn(-c4ccc(C(C)C)cc4)c3n2)c(OC)cc1N(C)CCN(C)C,8.3767507096021
18572914,CHEMBL4221421,Inhibition of recombinant human GST-tagged EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,CHEMBL4225863,=,nM,5.8,CHEMBL203,Homo sapiens,IC50,nM,5.8,C=CC(=O)Nc1cc(Nc2ncc3ncn(-c4ccc(F)cc4)c3n2)c(OC)cc1N(C)CCN(C)C,8.236572006437063
18573663,CHEMBL4221532,Inhibition of EGFR (unknown origin) using peptide substrate after 60 mins by HTRF assay,B,CHEMBL4228120,=,nM,42.3,CHEMBL203,Homo sapiens,IC50,nM,42.3,O=C(N/N=C/c1cc(F)c(F)cc1Cl)N1CCc2ncnc(Nc3ccc(F)c(Cl)c3)c2C1,7.373659632624958
18573675,CHEMBL4221534,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using peptide substrate after 60 mins by HTRF assay,B,CHEMBL4226907,=,nM,939.7,CHEMBL203,Homo sapiens,IC50,nM,939.7,O=C(N/N=C/c1ccc(F)cc1Cl)N1CCc2ncnc(Nc3cccc(Br)c3)c2C1,6.027010773144651
18577489,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4226965,=,nM,143.0,CHEMBL203,Homo sapiens,IC50,uM,0.143,C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c1,6.844663962534939
18585798,CHEMBL4223404,Inhibition of EGFR (unknown origin),B,CHEMBL4225828,=,nM,596.0,CHEMBL203,Homo sapiens,IC50,nM,596.0,CNC(=O)c1ccc(Sc2cccc(NC(=S)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)nc1,6.2247537402597635
18652255,CHEMBL4229651,Inhibition of EGFR (unknown origin),B,CHEMBL4246256,=,nM,52110.0,CHEMBL203,Homo sapiens,IC50,uM,52.11,Oc1cccc(Nc2nnnc3sc4c(c23)CCC4)c1,4.283078926833239
18656479,CHEMBL4231196,Inhibition of recombinant human EGFR using peptide as substrate by fluorimetric analysis,B,CHEMBL4238771,=,nM,45500.0,CHEMBL203,Homo sapiens,IC50,uM,45.5,Clc1ccc(SCc2n[nH]c(-c3ccc(Cl)cc3)n2)cc1,4.341988603342887
18656760,CHEMBL4231282,Inhibition of His-6 tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in Baculovirus infected Sf9 cells by dissociation-enhanced lanthanide fluorescence immunoassay/time-resolved fluorometric analysis,B,CHEMBL4244030,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4,NCCCCCCC(=S)N/N=C1\CC2(CCCCC2)Oc2c1ccc1ccccc21,5.853871964321762
18676729,CHEMBL4235834,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,B,CHEMBL4245415,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1,Cc1coc2ncnc(N(C)c3ccc(N(C)C)cc3)c12,8.508638306165727
18689612,CHEMBL4252893,"Inhibition of EGFR (unknown origin) using poly(Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay",B,CHEMBL4289577,=,nM,632.8,CHEMBL203,Homo sapiens,IC50,nM,632.8,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cc2cccnc2n(-c2ccc(F)cc2)c1=O,6.19873352951038
18690150,CHEMBL4252972,Inhibition of C-terminal His-tagged and N-terminal GST tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using KHKKLAEGSAYEEV substrate peptide and gamma-[32P]ATP,B,CHEMBL4286031,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,nM,60.0,Fc1cc(F)cc(NC(=S)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)c1,7.221848749616356
18695613,CHEMBL4253971,Inhibition of recombinant human C-terminal His/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using biotin-labeled poly[Glu:Tyr] (4:1) as substrate after 30 mins by Kinase-Glo plus luminescence assay,B,CHEMBL4293326,=,nM,951.0,CHEMBL203,Homo sapiens,IC50,uM,0.951,Cc1oc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1C(=O)O,6.021819483062586
18701235,CHEMBL4254926,Inhibition of EGFR (unknown origin),B,CHEMBL4279863,=,nM,45000.0,CHEMBL203,Homo sapiens,IC50,uM,45.0,O=C(N/N=C/c1cccn1CCCN1CCCC1)Nc1ccc(Oc2ccnc3[nH]ccc23)cc1,4.346787486224656
18722854,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4277911,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8,C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(CC)CCN(C)C,9.096910013008056
18722866,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4278815,=,nM,22.4,CHEMBL203,Homo sapiens,IC50,nM,22.4,C=C=CC(=O)Nc1cc(Nc2nccc(-c3cnn4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.649751981665837
18724528,CHEMBL4258941,"Inhibition of EGFR (unknown origin) using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA",B,CHEMBL4293051,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0,C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.698970004336019
18765229,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4276965,=,nM,779.0,CHEMBL203,Homo sapiens,IC50,nM,779.0,COc1ccc(OC)c(Nc2cc(Nc3ccc(S(N)(=O)=O)cc3)ncn2)c1,6.108462542327436
18765346,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4292110,=,nM,1188.0,CHEMBL203,Homo sapiens,IC50,nM,1188.0,CCOC(=O)c1ccc(Nc2cc(Nc3cccc(OC)c3)ncn2)cc1,5.925183559354825
18782529,CHEMBL4270447,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4218431,=,nM,85.2,CHEMBL203,Homo sapiens,IC50,nM,85.2,N#Cc1ccc(O)c(-c2nc(NCc3cnccn3)c3ccccc3n2)c1,7.069560405233299
18782551,CHEMBL4270448,"Inhibition of EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4294743,=,nM,6.8,CHEMBL203,Homo sapiens,IC50,nM,6.8,CCC(=O)N[C@H]1CC[C@H](N2C(=O)N(c3ccccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)CC1,8.167491087293763
18783592,CHEMBL4271007,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",B,CHEMBL4292351,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(CN4CCOCC4)cc3OC)ncc2Cl)c1,7.769551078621726
18783978,CHEMBL4271076,Inhibition of human EGFR L858R mutant expressed in Sf9 cells in presence of 1 mM ATP by HTRF assay,B,CHEMBL4284413,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,uM,0.024,O=C(Nc1nccs1)C(c1ccccc1)N1Cc2ccccc2C1=O,7.619788758288394
18784575,CHEMBL4271179,Inhibition of EGFR T790M/L858R mutant (unknown origin),B,CHEMBL4290869,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0,CC(C)(O)CC(=O)NCCc1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c2c1,7.481486060122113
18784587,CHEMBL4271184,Inhibition of GST-tagged human EGFR catalytic domain expressed in insect cells,B,CHEMBL2110732,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1,8.221848749616356
18784597,CHEMBL4271186,Inhibition of human EGFR T790M/L858R mutant expressed in mouse Ba/F3 cells,B,CHEMBL2138625,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1,8.638272163982407
18784648,CHEMBL4271213,Inhibition of 6x-His-tagged human EGFR cytoplasmic domain (645 to 1186 amino acids) assessed as reduction in autophosphorylation pre-incubated for 10 mins and measured after 1 hr by DELFIA/time-resolved fluorometry,B,CHEMBL4280817,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009,O=C1CSC(N2N=C(c3ccncc3)CC2c2ccc(Br)cc2)=N1,8.045757490560675
18787523,CHEMBL4272061,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay",B,CHEMBL4278886,=,nM,21.4,CHEMBL203,Homo sapiens,IC50,nM,21.4,Nc1ccc(-c2cc3c(Nc4ccc(Oc5cccc(C(F)(F)F)c5)c(Cl)c4)ncnc3s2)cc1,7.669586226650809
18795773,CHEMBL4273762,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL4286998,=,nM,9800.0,CHEMBL203,Homo sapiens,IC50,uM,9.8,c1ccc(-c2nc3sc(-c4ccccc4)cn3n2)cc1,5.008773924307505
18798651,CHEMBL4274200,Inhibition of EGFR in human HepG2 cells,B,CHEMBL4288648,=,nM,751.0,CHEMBL203,Homo sapiens,IC50,uM,0.751,O=C1Nc2ccc(S(=O)(=O)N3CCOCC3)cc2/C1=N/c1ccc(O)cc1,6.124360062995832
18798660,CHEMBL4274201,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus infected insect cells preincubated for 5 mins followed by ATP addition and measured after 30 mins by HTRF assay,B,CHEMBL4282506,=,nM,33.8,CHEMBL203,Homo sapiens,IC50,nM,33.8,N#CCC(=O)N/N=C1\C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc21,7.471083299722345
18851325,CHEMBL4305817,Inhibition of EGFR (unknown origin),B,CHEMBL4448494,=,nM,1970.0,CHEMBL203,Homo sapiens,IC50,nM,1970.0,Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C,5.705533773838407
18854219,CHEMBL4307064,Inhibition of human EGFR by ELISA,B,CHEMBL4578764,=,nM,2160.0,CHEMBL203,Homo sapiens,IC50,uM,2.16,Cc1ccc(C2=NN(c3ccccc3)C(c3ccc(OC4CCCC4)cc3)C2)cc1,5.665546248849069
18856436,CHEMBL4307556,Inhibition of EGFR (unknown origin) using TK substrate incubated for 60 mins by FRET assay,B,CHEMBL4520064,=,nM,384.8,CHEMBL203,Homo sapiens,IC50,nM,384.8,FC(F)(F)c1ccc(COc2ccc(Nc3ncnc4cc5c(cc34)OCCOCCOCCOCCO5)cc2)cc1,6.414764936634224
18887648,CHEMBL4313654,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,B,CHEMBL4561572,=,nM,412.3,CHEMBL203,Homo sapiens,IC50,uM,0.4123,O=[N+]([O-])c1ccc(/C=N/Nc2nnc(-c3ccncc3)o2)cc1,6.384786665198641
18894888,CHEMBL4315485,Inhibition of EGFR (unknown origin),B,CHEMBL75177,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,uM,0.029,Clc1cccc(Nc2ncnc3[nH]c4c(c23)CCCC4)c1,7.5376020021010435
18896895,CHEMBL4315818,Inhibition of wildtype EGFR (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL4552429,=,nM,511.0,CHEMBL203,Homo sapiens,IC50,nM,511.0,C=CC(=O)Nc1cc(Nc2nc3c(c(-c4cn(C)c5ccccc45)n2)CSCC3)c(OC)cc1N(C)CCN(C)C,6.291579099865287
18896904,CHEMBL4315819,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL4476689,=,nM,1128.0,CHEMBL203,Homo sapiens,IC50,nM,1128.0,CC/C=C\C(=O)Nc1cc(Nc2nc3c(c(-c4cn(C)c5ccc(F)cc45)n2)CSCC3)c(OC)cc1N(C)CCN(C)C,5.947690900352677
18902577,CHEMBL4316716,Inhibition of erbB1 (unknown origin) using FRET-capable peptide substrate by FRET assay,B,CHEMBL4439982,=,nM,0.22,CHEMBL203,Homo sapiens,IC50,nM,0.22,C[N+](C)(C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)Cc1ccc([N+](=O)[O-])cc1.[Br-],9.657577319177793
18923643,CHEMBL4324120,Inhibition of GST-fusion tagged EGFR del19/T790M/C797S triple mutant (unknown origin) (696 to 1022 residues) expressed in insect cells assessed as decrease in phosphorylation of ULight-poly-GT using poly-GT as substrate in presence of ATP,B,CHEMBL4444231,=,nM,173.0,CHEMBL203,Homo sapiens,IC50,nM,173.0,CC(C)(O)Cn1/c(=N/C(=O)c2cccc(-c3cccnc3)c2)[nH]c2ccccc21,6.761953896871205
18923666,CHEMBL4324121,Inhibition of GST-fusion tagged EGFR L858R/T790M/C797S triple mutant (unknown origin) (696 to 1022 residues) expressed in insect cells assessed as decrease in phosphorylation of ULight-poly-GT using poly-GT as substrate in presence of ATP,B,CHEMBL4532034,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0,COc1ccncc1-c1cc(C(=O)/N=c2\[nH]c3ccccc3n2CC(C)(C)O)ccn1,7.920818753952375
18945170,CHEMBL4329616,Inhibition of wild type human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,B,CHEMBL4534611,=,nM,6.6,CHEMBL203,Homo sapiens,IC50,nM,6.6,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCNCCNCCNCC1,8.18045606445813
18945187,CHEMBL4329618,Inhibition of human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) T790M mutant expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,B,CHEMBL4522240,=,nM,16.5,CHEMBL203,Homo sapiens,IC50,nM,16.5,COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OCCCN1CCNCCNCCNCC1,7.782516055786093
18948041,CHEMBL4330453,Inhibition of EGFR (unknown origin) using FAM-labelled peptide and ATP incubated for 10 mins by mobility shift assay,B,CHEMBL4587222,=,nM,520.0,CHEMBL203,Homo sapiens,IC50,uM,0.52,CCN1CCN(CCCOc2cc3nccc(Oc4c(F)cc(NC(=O)NN5C(=O)CSC5c5c(F)cccc5F)cc4F)c3cc2OC)CC1,6.2839966563652006
18955311,CHEMBL4332301,Inhibition of EGFR (unknown origin),B,CHEMBL4578466,=,nM,92.0,CHEMBL203,Homo sapiens,IC50,nM,92.0,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(F)c3)c2cc1NC(=O)/C=C/CN(C)C,7.036212172654444
18955869,CHEMBL4332363,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,B,CHEMBL4474073,=,nM,0.76,CHEMBL203,Homo sapiens,IC50,nM,0.76,COCCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,9.119186407719209
18989199,CHEMBL4340725,Inhibition of recombinant human wild-type N-terminal GST-His6-fused EGFR C-terminal domain (H672 to A1210) expressed in Sf9 insect cells using Poly(Glu:Tyr)4:1 as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method,B,CHEMBL4446681,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0,CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12,5.0
18992536,CHEMBL4341613,Inhibition of EGFR L858R mutant (unknown origin) using polyE4Y1 as substrate measured after 60 mins,B,CHEMBL442938,=,nM,56.48,CHEMBL203,Homo sapiens,IC50,nmol,56.48,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(COC(=O)/C=C/c4ccc(O)cc4)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,7.248105311956253
18994323,CHEMBL4341977,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4441392,=,nM,56.0,CHEMBL203,Homo sapiens,IC50,uM,0.056,Cc1cc(=O)n2nc(SCc3ccc(F)cc3)nc2[nH]1,7.251811972993799
18997205,CHEMBL4342766,Inhibition of EGFR T790M mutant (unknown origin) incubated for 60 mins by ADP-Glo kinase assay,B,CHEMBL4436337,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3,C=CC(=O)Nc1cccc(Nc2ncnc3cc(OC)c(OCCN4CCOCC4)cc23)c1,8.366531544420413
18997561,CHEMBL4342870,Inhibition of EGFR (unknown origin) assessed as reduction of phosphorylation of Crk incubated for 10 mins in ice with gamma-ATP followed by incubated for 20 mins in 30 degC by radioactive phosphorylation assay,B,CHEMBL2087361,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0,C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,8.301029995663981
18997565,CHEMBL4342874,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant (catalytic domain 695 to end) expressed in baculovirus-infected Sf9 cells assessed as reduction in phosphorylation of polyglutamic acid/tyrosine incubated for 60 mins by ADP-Glo assay,B,CHEMBL4516586,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3,C=CC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OCCN4CCOCC4)cc23)cc1,8.366531544420413
19016021,CHEMBL4346783,Inhibition of human EGFR C-terminal domain,B,CHEMBL4553708,=,nM,66100.0,CHEMBL203,Homo sapiens,IC50,nM,66100.0,OCCNc1nc(Nc2cccc(F)c2)c2cn[nH]c2n1,4.179798540514359
19026278,CHEMBL4348480,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay,B,CHEMBL4465558,=,nM,765.0,CHEMBL203,Homo sapiens,IC50,nM,765.0,COc1cc(N2CCNC2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,6.116338564846383
19029996,CHEMBL4349142,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,B,CHEMBL4464404,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4ccncc4)c23)c1,8.638272163982407
19036710,CHEMBL4351035,Inhibition of EGFR (unknown origin),B,CHEMBL496174,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0,Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@H]5CCCN5)sc34)cc2Cl)c1,8.154901959985743
19063062,CHEMBL4359338,Inhibition of human EGFR L858R/T790M mutant using poly[Glu:Tyr] (4:1) as substrate measured in presence of [gamma-33P]ATP by radiometric assay,B,CHEMBL4441037,=,nM,111.0,CHEMBL203,Homo sapiens,IC50,nM,111.0,C=CC(=O)Nc1ccc(OC)c(Nc2cc(-c3c(-c4ccc(F)cc4)nc(SC)n3C)ccn2)c1,6.954677021213342
19063064,CHEMBL4359339,Inhibition of human EGFR L858R/T790M/C797S mutant using poly[Glu:Tyr] (4:1) as substrate measured in presence of [gamma-33P]ATP by radiometric assay,B,CHEMBL4098072,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,nM,90.0,C=CC(=O)Nc1ccc(OC)c(Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c1,7.045757490560675
19070426,CHEMBL4361551,"Inhibition of human EGFR L858R mutant (696 to end residues) using poly (Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting analysis",B,CHEMBL4531109,=,nM,4500.0,CHEMBL203,Homo sapiens,IC50,uM,4.5,O=C1Nc2ccccc2N/C1=C\C(=O)c1cccc2ccccc12,5.346787486224656
19072836,CHEMBL4362047,Inhibition of EGFR (unknown origin),B,CHEMBL4439680,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0,COc1ccc(/C=C/C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2O[C@@H]2CCOC2)cc1,8.045757490560675
19072850,CHEMBL4362038,Inhibition of recombinant His-tagged human EGFR (645 to 1186 residues) cytoplasmic domain expressed in baculovirus infected Sf9 cells incubated for 10 mins by time resolved fluorimetry,B,CHEMBL2336355,=,nM,5160.0,CHEMBL203,Homo sapiens,IC50,uM,5.16,COc1ccccc1NC(=O)/C=C/c1ccccc1,5.287350298372789
19110227,CHEMBL4370315,Inhibition of EGFR (unknown origin),B,CHEMBL80302,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0,Cc1cc2cc(Nc3ncnc4cc(-c5ccccc5)sc34)ccc2[nH]1,7.0
19112698,CHEMBL4370781,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL4585048,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2,COc1cc(/C=C/C(=O)c2ccc(NC(=O)c3cc4cc5ccccc5nc4s3)cc2)cc(OC)c1OC,5.920818753952375
19114542,CHEMBL4371479,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4470236,=,nM,3081.0,CHEMBL203,Homo sapiens,IC50,uM,3.081,COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4OC(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,5.5113083016830595
19122073,CHEMBL4373060,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",B,CHEMBL4468464,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCc1cn(Cc2ccccc2F)nn1,7.920818753952375
19132060,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4443413,=,nM,81.7,CHEMBL203,Homo sapiens,IC50,nM,81.7,CCC(=O)N1CC[C@@H](n2c(=O)c(-c3ccccc3Cl)c(C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.087777943467585
19146016,CHEMBL4378482,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4464879,=,nM,101.0,CHEMBL203,Homo sapiens,IC50,uM,0.101,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCO,6.995678626217358
19158934,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4520341,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3P(C)(C)=O)n2)c(OC)cc1N(C)CCN(C)C,7.920818753952375
19163120,CHEMBL4383758,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant (696-end residues) by fluorescence assay,B,CHEMBL4545086,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4cccnc34)n2)c(OC)cc1N(C)CCN(C)C,5.6777807052660805
19168125,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4456234,=,nM,120.7,CHEMBL203,Homo sapiens,IC50,nM,120.7,C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3ccccc3)n2)c(OC)cc1N1CCN(C)CC1,6.91829272990265
19172980,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL4469866,=,nM,8.7,CHEMBL203,Homo sapiens,IC50,nM,8.7,C=CC(=O)N(c1cccc(Cl)c1F)c1ncnc2cc(OC)c(OC(=O)N3CCN(C)C[C@H]3C)cc12,8.060480747381382
19211859,CHEMBL4393296,Inhibition of EGFR (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,B,CHEMBL4446992,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(F)cc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,6.3979400086720375
19211860,CHEMBL4393297,Inhibition of c-MET (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,B,CHEMBL4442035,=,nM,4520.0,CHEMBL203,Homo sapiens,IC50,uM,4.52,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccccc4)cc3)ccnc2cc1OCCCN1CCOCC1,5.3448615651886175
19226237,CHEMBL4396109,Inhibition of human EGFR measured after 3 hrs by ELISA,B,CHEMBL4440012,=,nM,320.0,CHEMBL203,Homo sapiens,IC50,uM,0.32,COc1ccc(/C(CSc2nc3c([nH]2)c(=O)n(C)c(=O)n3C)=N\O)cc1,6.494850021680094
19236717,CHEMBL4398796,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant expressed in baculovirus expression system using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",B,CHEMBL4516635,=,nM,9.3,CHEMBL203,Homo sapiens,IC50,nM,9.3,COc1cc2c(Nc3ccc(NC(=O)C(c4ccccc4)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1,8.031517051446064
19236777,CHEMBL4398840,"Inhibition of EGFR 19D/T790M/C797S mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",B,CHEMBL4443483,=,nM,331.3,CHEMBL203,Homo sapiens,IC50,nM,331.3,COc1cc2c(Nc3ccc(NC(=O)C(c4cc(F)ccc4F)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1,6.47977856411804
19240553,CHEMBL4399533,Inhibition of EGFR-TK in human HeLa cells overexpressing EGFR incubated for 18 to 24 hrs by kinase assay,B,CHEMBL4456370,=,nM,6300.0,CHEMBL203,Homo sapiens,IC50,uM,6.3,OC(c1cccs1)c1cc2ccccc2nc1Cl,5.200659450546418
19240555,CHEMBL4399534,Inhibition of EGFR-TK in human MCF7 cells overexpressing EGFR incubated for 18 to 24 hrs by kinase assay,B,CHEMBL4469453,=,nM,2750.0,CHEMBL203,Homo sapiens,IC50,uM,2.75,Fc1ccc(COC(c2cccs2)c2cc3ccccc3nc2Cl)cc1,5.560667306169737
19244253,CHEMBL4400322,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) cytoplasmic domain expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay,B,CHEMBL4462528,=,nM,617.0,CHEMBL203,Homo sapiens,IC50,nM,617.0,COc1cc(NC(=O)C2CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1,6.209714835966758
19279692,CHEMBL4408847,"Inhibition of recombinant human N-terminal GST-tagged EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay",B,CHEMBL4516916,=,nM,23340.0,CHEMBL203,Homo sapiens,IC50,uM,23.34,Fc1ccc(-c2csc(N3N=C(c4ccc(N5CCOCC5)cc4)CC3c3ccc(Cl)cc3)n2)cc1,4.631899148290649
19287500,CHEMBL4410222,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,B,CHEMBL4557993,=,nM,45.2,CHEMBL203,Homo sapiens,IC50,nM,45.2,CC(C)=CC[C@@H](OC(=O)/C=C\C(=O)c1ccc(C)cc1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,7.3448615651886175
19290295,CHEMBL4410892,Inhibition of EGFR triple T790M/L858R/C797S mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4558528,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2,CN1CCN(c2ccc(Oc3ccc4c(c3)C(=O)N(Cc3ccccc3)c3cc(F)ccc3N4)cc2)CC1,6.698970004336019
19293617,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4472983,=,nM,388.0,CHEMBL203,Homo sapiens,IC50,nM,388.0,CC/C=C\C(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccc(F)cc34)n2)c(OC)cc1N(C)CCN(C)C,6.411168274405793
19310275,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4447036,=,nM,2459.0,CHEMBL203,Homo sapiens,IC50,nM,2459.0,C=CS(=O)(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,5.609241471261283
19310290,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4450843,=,nM,562.0,CHEMBL203,Homo sapiens,IC50,nM,562.0,CN(C)C/C=C/C(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@@H](CO)c4ccccc4)c23)c1,6.250263684430939
19315794,CHEMBL4417016,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL4437863,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11,CC1(C)CC[C@]2(C(=O)OCCO[N+](=O)[O-])CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,6.958607314841775
19319718,CHEMBL4417509,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669-1210 AA) expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,B,CHEMBL4439933,=,nM,315.0,CHEMBL203,Homo sapiens,IC50,nM,315.0,COc1cc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc(OC)c1,6.501689446210399
19408281,CHEMBL4427028,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4290785,=,nM,7.8,CHEMBL203,Homo sapiens,IC50,nM,7.8,C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(N5CCC(N6CCN(C)CC6)CC5)cc4OC)nc32)c1,8.10790539730952
19408324,CHEMBL4427027,"Inhibition of wild type EGFR kinase domain (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4527443,=,nM,272.0,CHEMBL203,Homo sapiens,IC50,nM,272.0,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)c(OC)c3)ncc2C(F)(F)F)c1,6.565431095965801
19445309,CHEMBL4432452,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,B,CHEMBL4549542,=,nM,83.0,CHEMBL203,Homo sapiens,IC50,uM,0.083,CN1CCN(C/C=C/C(=O)N2CCOc3cc4ncnc(Nc5ccc(F)c(Cl)c5)c4cc32)CC1,7.080921907623926
19476567,CHEMBL4479715,Inhibition of recombinant human His-tagged EGFR expressed in mammalian expression system by Z'-LYTE assay,B,CHEMBL4569508,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,nM,1100.0,O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1,5.958607314841775
20601685,CHEMBL4603816,Inhibition of EGFR (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay,B,CHEMBL4646281,=,nM,2360.0,CHEMBL203,Homo sapiens,IC50,nM,2360.0,C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12,5.627087997029894
20613810,CHEMBL4606713,Inhibition of recombinant human N-terminal GST-tagged EGFR (668 to end residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 2 hrs followed by EGF stimulation and measured after 30 mins by TMB peroxidase substrate based assay,B,CHEMBL4647257,=,nM,326.2,CHEMBL203,Homo sapiens,IC50,uM,0.3262,CN(CCOS(=O)(=O)CCc1cn(CCCC(=O)N2CCN(C(=O)c3cc(Cc4n[nH]c(=O)c5ccccc45)ccc3F)CC2)nn1)c1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.486516043295743
20638460,CHEMBL4612446,Inhibition of EGFR (unknown origin),B,CHEMBL4637274,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4,C#Cc1cccc(Nc2cccc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1,8.619788758288394
20656075,CHEMBL4617240,Inhibition of EGFR L858R/T790M (unknown origin),B,CHEMBL4640482,=,nM,30000.0,CHEMBL203,Homo sapiens,IC50,uM,30.0,C=C1CC(CBr)(c2ccc(F)cc2)OC1=O,4.522878745280337
20667648,CHEMBL4619916,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,B,CHEMBL4638857,=,nM,7560.0,CHEMBL203,Homo sapiens,IC50,uM,7.56,Clc1nc2ccccc2c2nnc(/N=C/C=C/c3ccccc3)n12,5.121478204498794
20669683,CHEMBL4620454,Inhibition of human recombinant EGFR in presence of substrate Ulight-CAGAGAIETDKEYYTVKD and Km ATP,B,CHEMBL4635625,=,nM,4110.0,CHEMBL203,Homo sapiens,IC50,nM,4110.0,C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(C)c4)ncc3F)C[C@]12NC(=O)[C@@H]1CC1(F)F,5.386158178123931
20689333,CHEMBL4625049,Inhibition of wild type EGFR (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL4517633,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5,N#Cc1cnc2cc(OC[C@@H](O)CO)c(NC(=O)C3CSSC3)cc2c1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,8.823908740944319
20689367,CHEMBL4625056,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system by competitive binding assay,B,CHEMBL4646030,=,nM,12.3,CHEMBL203,Homo sapiens,IC50,nM,12.3,N#Cc1cnc2cc(OC[C@@H](O)CO)c(NC(=O)CC3CSSC3)cc2c1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,7.910094888560602
20690040,CHEMBL4625256,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL4642177,=,nM,208.0,CHEMBL203,Homo sapiens,IC50,nM,208.0,CCC(=O)Nc1cc(Nc2nccc(-c3c[nH]c4c(CCO)cccc34)n2)c(OC)cc1F,6.681936665037238
20690051,CHEMBL4625257,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL4639459,=,nM,422.3,CHEMBL203,Homo sapiens,IC50,nM,422.3,CCC(=O)Nc1cc(Nc2nccc(-c3cn(CCCO)c4ccccc34)n2)c(OC)cc1F,6.3743789185750925
20708019,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL4643111,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,uM,0.045,CN1CCN(C/C=C/C(=O)N2CCOc3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4cc32)CC1,7.346787486224656
22392387,CHEMBL4667354,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins followed by substrate addition and measured after 1 hr by mobility shift assay,B,CHEMBL4745877,=,nM,2520.0,CHEMBL203,Homo sapiens,IC50,nM,2520.0,COc1ncc(-c2ccc3ncnc(Nc4cnn(CCO)c4)c3c2)cc1NS(C)(=O)=O,5.598599459218456
22408215,CHEMBL4670928,Inhibiton of EGFR (unknown origin) expressed in human A431 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL180022,=,nM,10117.0,CHEMBL203,Homo sapiens,IC50,nM,10117.0,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,4.994948250006004
22409946,CHEMBL4671284,Inhibition of EGFR in human A549 cells measured after 30 hrs by ELISA,B,CHEMBL4746030,=,nM,205.0,CHEMBL203,Homo sapiens,IC50,uM,0.205,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC(=O)CCCCC[N+]4=C(/C=C/C=C/C=C/C=C5/N(CCCC)c6ccccc6C5(C)C)C(C)(C)c5cc(C(F)(F)F)ccc54)cc23)c1.[Br-],6.688246138944246
22415177,CHEMBL4672269,Inhibition of EGFR-TK (unknown origin) relative to control,B,CHEMBL1545480,=,nM,106.0,CHEMBL203,Homo sapiens,IC50,uM,0.106,Cc1cc(NC(=O)CCl)no1,6.97469413473523
22421711,CHEMBL4673685,Inhibition of EGFR (unknown origin) by Kinase-Glo luminescence assay,B,CHEMBL4786003,=,nM,4180.0,CHEMBL203,Homo sapiens,IC50,uM,4.18,COc1cc(/C=N/NC(=O)COc2nc(C)nc3c2c(C)nn3-c2ccccc2)cc(OC)c1OC,5.3788237182249645
22421723,CHEMBL4673696,Inhibition of EGFR (unknown origin),B,CHEMBL4792279,=,nM,186.0,CHEMBL203,Homo sapiens,IC50,nM,186.0,Cc1nn(-c2ccc(F)cc2)c2ncnc(Nc3ccc(F)c(Cl)c3)c12,6.730487055782084
22468733,CHEMBL4684707,Inhibition of EGFR in human RPMI-8226 cells incubated for 2 hrs by ELISA,B,CHEMBL4778826,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0,COc1ccc(/C=C/C(=O)c2nnn(-c3ccc(Cl)cc3)c2C)cc1OC,7.443697499232713
22473597,CHEMBL4685759,"Inhibition of EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 8 mins in presence of ATP by colorimetric analysis",B,CHEMBL4757104,=,nM,1257.0,CHEMBL203,Homo sapiens,IC50,uM,1.2570000000000001,ClCCN(CCCl)c1ccc2ncnc(Nc3cccc(Br)c3)c2c1,5.900664722314042
22475271,CHEMBL4686127,"Inhibition of EGFR L858R/T790M (unknown origin) using Poly (Glu, Tyr) 4:1 as substrate measured after 1 hr by ELISA",B,CHEMBL4753700,=,nM,19.3,CHEMBL203,Homo sapiens,IC50,nM,19.3,C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(CCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCc6ccc(-c7scnc7C)cc6)C(C)(C)C)CC5)cc4OC)nc32)c1,7.714442690992226
22771682,CHEMBL4704542,Inhibition of GST-tagged recombinant HER1 (unknown origin) expressed in baculovirus expression system incubated for 15-45 mins in presence of [gamma32P]-ATP by radiometric assay,B,CHEMBL458997,=,nM,550.0,CHEMBL203,Homo sapiens,IC50,uM,0.55,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl,6.259637310505756
22814201,CHEMBL4714413,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,B,CHEMBL492399,=,nM,2.8,CHEMBL203,Homo sapiens,IC50,nM,2.8,COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1,8.55284196865778
22814384,CHEMBL4714437,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,B,CHEMBL4747078,=,nM,12.08,CHEMBL203,Homo sapiens,IC50,nM,12.08,C=CC(=O)Nc1cc(Nc2ncc(C(F)(F)F)c(-c3cn(C4CC4)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.917933065714887
22822942,CHEMBL4716851,Inhibition of HER1 (unknown origin),B,CHEMBL3651854,=,nM,960.0,CHEMBL203,Homo sapiens,IC50,uM,0.96,Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C)CC1,6.017728766960432
22835791,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4780286,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8,OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1,9.096910013008056
22844282,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4749765,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,nM,28.0,O=C(Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F,7.552841968657781
22853105,CHEMBL4724189,Inhibition of human recombinant EGFR (668 to 1211) expressed in baculovirus infected Sf9 insect cells using poly-Glu-Tyr as substrate incubated for 5 mins in presence of ATP measured after 25 mins by dye based colorimetric analysis,B,CHEMBL483321,=,nM,6400.0,CHEMBL203,Homo sapiens,IC50,nM,6400.0,COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,5.1938200260161125
22856449,CHEMBL4724942,Inhibition of recombinant wild type EGFR (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL4741925,=,nM,307.7,CHEMBL203,Homo sapiens,IC50,nM,307.7,COc1ccc(-c2c3c4cc(OC)c(O)cc4[nH]c(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O,6.511872503752541
22875760,CHEMBL4725783,Inhibition of EGFR (unknown origin),B,CHEMBL98,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9,O=C(CCCCCCC(=O)Nc1ccccc1)NO,6.045757490560675
22892148,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4780058,=,nM,109.71,CHEMBL203,Homo sapiens,IC50,nM,109.71,Cn1c(-c2csc(NN=C3CCCC3)n2)nc2ccccc21,6.9597537849422935
22894015,CHEMBL4730144,Inhibition of wild type EGFR (unknown origin) in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4793105,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,nM,70.0,C=C(Cl)C(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)ncc2Cl)c1,7.154901959985743
22894491,CHEMBL4730214,Inhibition of EGFR T790M/L858R mutant (unknown origin) using FAM-labelled peptide as substrate incubated for 10 mins in presence of ATP by Kinase Glo luminescence assay,B,CHEMBL4776833,=,nM,638.4,CHEMBL203,Homo sapiens,IC50,nM,638.4,C=CC(=O)Nc1cccc(Oc2nc(Nc3cccc(OC)c3)nc3c2CSCC3)c1,6.194907121657327
22903845,CHEMBL4732637,Inhibition of EGFR (unknown origin),B,CHEMBL4798627,=,nM,55000000.0,CHEMBL203,Homo sapiens,IC50,mM,55.0,O=C(Cc1csc2nc3ccccc3n12)Nc1ccccc1O,1.2596373105057561
22903868,CHEMBL4732644,Inhibition of human EGFR TK domain expressed in Escherichia coli BL21 (DE3) pLysS using poly-Glu-Tyr (51 to 68 residues) as substrate incubated for 1 hr by ADP-Glo assay,B,CHEMBL4798434,=,nM,255.6,CHEMBL203,Homo sapiens,IC50,nM,255.6,CNc1nc(C)c(C(=O)/C=C/c2nccs2)s1,6.592439150513638
22921872,CHEMBL4736786,Inhibition of EGFR L858R/T790M (unknown origin) by mobility shift assay,B,CHEMBL4759697,=,nM,8.3,CHEMBL203,Homo sapiens,IC50,nM,8.3,C=CC(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCc1cn(CCC(=O)NO)nn1,8.080921907623926
22921883,CHEMBL4736787,Inhibition of EGFR (unknown origin) by mobility shift assay,B,CHEMBL4759112,=,nM,0.32,CHEMBL203,Homo sapiens,IC50,nM,0.32,CN(C)C/C=C/C(=O)Nc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1O[C@@H]1CCOC1,9.494850021680094
22921893,CHEMBL4736788,Inhibition of EGFR L858R (unknown origin) by mobility shift assay,B,CHEMBL4794670,=,nM,2.9,CHEMBL203,Homo sapiens,IC50,nM,2.9,C=CC(=O)Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1OCc1cn(CCCC(=O)NO)nn1,8.537602002101044
22924302,CHEMBL4737325,Inhibition of EGFR T790M mutant (unknown origin),B,CHEMBL4780210,=,nM,1887.2,CHEMBL203,Homo sapiens,IC50,uM,1.8872,Cc1ccc(C2=N/C(=C\c3ccc(Cl)cc3)C(=O)NN2C(=O)c2nc3c(c(C)nn3-c3ccccc3)c(=O)[nH]2)cc1,5.724182072122461
22950600,CHEMBL4766167,"Inhibition of human recombinant EGFR (696 to end residues) using poly(Glu,Tyr)4:1 as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis",B,CHEMBL4798527,=,nM,651.0,CHEMBL203,Homo sapiens,IC50,uM,0.6509999999999999,Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12,6.186419011431808
22965624,CHEMBL4769431,Inhibition of EGFR (unknown origin) by FRET assay,B,CHEMBL4799700,=,nM,1623.0,CHEMBL203,Homo sapiens,IC50,uM,1.6230000000000002,O=S(=O)(Nc1nccs1)c1ccc(NC(=S)Nc2ccc3c(c2)OCO3)cc1,5.789681480173768
22968038,CHEMBL4770070,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,B,CHEMBL4781497,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,uM,0.25,CN1CCN(c2ccc(Nc3nc(Oc4ccc5ccc(=O)[nH]c5c4)c4sccc4n3)cc2)CC1,6.6020599913279625
22975113,CHEMBL4771545,Inhibition of wild type EGFR in human MCF7 cells assessed as cell growth inhibition measured after 72 hrs by Celltiter-Glo luminescent cell viability assay,B,CHEMBL4779194,=,nM,7309.0,CHEMBL203,Homo sapiens,IC50,uM,7.309,C=CCSSCCC(=O)OCCCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC,5.136142038116027
22986116,CHEMBL4774183,Inhibition of EGFR (unknown origin),B,CHEMBL4791960,=,nM,56780.0,CHEMBL203,Homo sapiens,IC50,uM,56.78,CC(C)(C)c1cc(NC(=O)Cc2ccc(Nc3ncnc4[nH]c(-c5ccc(S(C)(=O)=O)cc5)cc34)cc2)no1,4.245804611810161
23148926,CHEMBL4810017,Inhibition of EGFR (unknown origin),B,CHEMBL4868909,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033,COc1cccc(-c2cc(-c3c(O)c4ccccc4oc3=O)nc(N)c2C#N)c1,7.481486060122113
23152276,CHEMBL4810720,Inhibition of EGFR (unknown origin),B,CHEMBL4845732,=,nM,146.9,CHEMBL203,Homo sapiens,IC50,nM,146.9,CCS(=O)(=O)NNC(=O)CSc1nc2ccccc2c(=O)n1Cc1ccc2c(c1)OCO2,6.832978204209743
23172271,CHEMBL4814657,Inhibition of EGFR in human A-431 cells assessed as antiproliferative activity incubated for 48 hrs by MTS method,B,CHEMBL4463898,=,nM,1640.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.64,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(=O)Cn2cncc2[N+](=O)[O-])CC1,5.785156151952302
23177914,CHEMBL4815790,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4877054,=,nM,18.3,CHEMBL203,Homo sapiens,IC50,nM,18.3,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCC(=O)Nc1ccc(S(N)(=O)=O)cc1,7.73754891026957
23178059,CHEMBL4815841,Inhibition of EGFR (unknown origin),B,CHEMBL4868797,=,nM,176090.0,CHEMBL203,Homo sapiens,IC50,uM,176.09,Cn1cc(-c2cc3ncnc(Nc4ccc(CC(=O)Nc5cc(C(C)(C)C)nn5C)cc4)c3s2)cn1,3.7542653065434144
23193711,CHEMBL4819289,Inhibition of EGFR (unknown origin),B,CHEMBL4863294,=,nM,10.3,CHEMBL203,Homo sapiens,IC50,nM,10.3,O=C(CCCCCCn1cc(-c2ccc3ncnc(Nc4ccc(Br)cc4F)c3c2)nn1)NO,7.987162775294828
23193716,CHEMBL4819292,Inhibition of EGFR (unknown origin) incubated for 40 mins by kinase-glo plus luminescence assay,B,CHEMBL4870955,=,nM,5700.0,CHEMBL203,Homo sapiens,IC50,nM,5700.0,COc1cc(NC(=O)CCCCCCCCCCC(=O)NO)ccc1Nc1nccc(-c2cn(C)c3ccccc23)n1,5.2441251443275085
23203416,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL4858583,=,nM,0.39,CHEMBL203,Homo sapiens,IC50,nM,0.39,CN(/N=N\c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)C(=O)OCCl,9.4089353929735
23220187,CHEMBL4824512,Inhibition of autophosphorylation of EGFR (unknown origin) by Cell free assay,B,CHEMBL4871569,=,nM,72.0,CHEMBL203,Homo sapiens,IC50,uM,0.07200000000000001,Cc1nc2c(Br)cc(Br)cc2c(=O)n1N,7.142667503568732
23232603,CHEMBL4827337,Inhibition of EGFR (unknown origin) by ADP-Glo kinase assay,B,CHEMBL4858176,=,nM,25300.0,CHEMBL203,Homo sapiens,IC50,uM,25.3,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CC[Se]CC1,4.5968794788241825
23236816,CHEMBL4828267,"Inhibition of recombinant human EGFR (696 to end residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis",B,CHEMBL4869634,=,nM,1970.0,CHEMBL203,Homo sapiens,IC50,nM,1970.0,CC(C)Oc1cc(F)ccc1Nc1ncnc2ccc(-c3ccc(C(=O)N4CCNCC4)cc3)nc12,5.705533773838407
23240293,CHEMBL4829094,Inhibition of EGFR (unknown origin),B,CHEMBL4873767,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0,Oc1cc(Nc2ccnc3cc(-c4ccccc4)ccc23)ccc1Cl,7.0
23243130,CHEMBL4829483,Inhibition of wild type EGFR (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4850239,=,nM,111.0,CHEMBL203,Homo sapiens,IC50,nM,111.0,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c([N+](=O)[O-])c3)nc3[nH]ccc23)c1,6.954677021213342
23250035,CHEMBL4830967,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate preincubated with enzyme for 3 hrs followed by substrate and ATP addition by TR-FRET assay,B,CHEMBL4855850,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0,C#CCNC(=O)c1cc(Nc2cc(C3CC3)[nH]n2)nc(N2CCN(Cc3ccc(S(=O)(=O)F)cc3)CC2)n1,8.221848749616356
23250040,CHEMBL4830968,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate preincubated with enzyme and ATP at Km for 3 hrs followed by substrate addition and measured after 1 hr by TR-FRET assay,B,CHEMBL4866162,=,nM,2.8,CHEMBL203,Homo sapiens,IC50,nM,2.8,COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(NCc3ccc(S(=O)(=O)F)cc3)cc2)n1,8.55284196865778
23256347,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4848234,=,nM,116.5,CHEMBL203,Homo sapiens,IC50,nM,116.5,O=C(NO)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1Cl,6.933674074637962
23256926,CHEMBL4832290,Inhibition of EGFR (unknown origin) incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method,B,CHEMBL4860202,=,nM,9920.0,CHEMBL203,Homo sapiens,IC50,nM,9920.0,CS(=O)(=O)c1nccc(-c2c(-c3cccc(OCc4ccccc4)c3)nc3sccn23)n1,5.0034883278458215
23256942,CHEMBL4832301,Inhibition of EGFR- L861Q mutant (unknown origin) incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method,B,CHEMBL4866102,=,nM,4354.0,CHEMBL203,Homo sapiens,IC50,nM,4354.0,c1ccc(COc2cccc(-c3nc4sccn4c3-c3ccncn3)c2)cc1,5.361111575294925
23258730,CHEMBL4832760,Inhibition of EGFR (unknown origin),B,CHEMBL4868123,=,nM,5210.0,CHEMBL203,Homo sapiens,IC50,uM,5.21,COCCOc1cc2ncnc(Sc3nc[nH]n3)c2cc1OCCOC,5.283162276700476
23276947,CHEMBL4836401,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,B,CHEMBL4872030,=,nM,14260.0,CHEMBL203,Homo sapiens,IC50,uM,14.26,COc1ccc(C(Nc2ccccc2)n2c(=O)ccc3cc(O)ccc32)cc1,4.8458804744841535
23277608,CHEMBL4836513,Inhibition of EGFR (unknown origin),B,CHEMBL4647325,=,nM,690.0,CHEMBL203,Homo sapiens,IC50,uM,0.69,Nc1nc(Nc2nnc3c4ccccc4nc(Sc4ccc(Br)cc4)n23)cs1,6.161150909262744
23299080,CHEMBL4841672,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4874550,=,nM,450.0,CHEMBL203,Homo sapiens,IC50,nM,450.0,C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(OC)ccn3)cc2)c(C(N)=O)n1N,6.346787486224656
23310017,CHEMBL4843876,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL3647964,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2,C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,8.920818753952375
23312277,CHEMBL4844330,Inhibition of EGFR d747-749/A750P mutant (unknown origin),B,CHEMBL4871593,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,nM,60.0,C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1ccc2c(n1)C(O)(CC)CC2,7.221848749616356
23312330,CHEMBL4844361,Inhibition of human EGFR using poly(Glu:Tyr)(4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4878790,=,nM,2980.0,CHEMBL203,Homo sapiens,IC50,uM,2.98,O=C(Nc1cncnc1Oc1cccc(C(F)(F)F)c1)c1ccc(F)cc1,5.525783735923745
23314404,CHEMBL4844824,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL4877510,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3,CCn1c(-c2ccccc2)c(-c2ncnc3cc(OC)c(OCCCN4CCOCC4)cc23)c2ccccc21,8.886056647693163
24347779,CHEMBL5031335,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 4 hr followed by EGF stimulation by Western blot analysis,B,CHEMBL5082149,=,nM,17700.0,CHEMBL203,Homo sapiens,IC50,uM,17.7,COc1cc(CC(=O)N2CC(=O)N[C@@H](Cc3ccccc3)C(=O)N(CC(N)=O)C(=O)CCSCc3ccc(cc3)C(=O)N[C@@H](CCCCN)CN(C(=O)CCC3CCCCC3)CC(=O)N[C@@H](Cc3ccccc3)CN(C(=O)CCc3ccccc3)CC(=O)N[C@@H](Cc3ccccc3)C2)cc(OC)c1,4.752026733638194
24348821,CHEMBL5031645,Inhibition of exogenous EGFR (unknown origin),B,CHEMBL5094282,=,nM,10.52,CHEMBL203,Homo sapiens,IC50,nM,10.52,CS(=O)(=O)CCN(Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)C(=O)CCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,7.9779842601822795
24349079,CHEMBL5031761,Inhibition of Wild type EGFR (unknown origin),B,CHEMBL3545311,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,uM,0.021,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,7.6777807052660805
24367047,CHEMBL5036279,"Inhibition of EGFR T790M mutant (unknown origin) using Poly (Glu, Tyr)4:1 as substrate by spectrophotometry",B,CHEMBL3633143,=,nM,5.27,CHEMBL203,Homo sapiens,IC50,nM,5.27,C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.278189384787453
24373111,CHEMBL5036476,Inhibition of EGFR (unknown origin),B,CHEMBL1714813,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0,COc1cc2ncnc(N[C@H](C)c3ccccc3)c2cc1OC,9.0
24377969,CHEMBL5037732,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5085143,=,nM,6.4,CHEMBL203,Homo sapiens,IC50,nM,6.4,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(N3CCc4sccc4C3)n2)c(OC)cc1N(C)CCN(C)C,8.193820026016112
24380977,CHEMBL5038287,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5086894,=,nM,51.2,CHEMBL203,Homo sapiens,IC50,nM,51.2,COc1cc(Nc2ncc(Cl)c(Nc3ccccc3P(C)(C)=O)n2)ccc1N1CCC(N2CCN(C)CC2)CC1,7.29073003902417
24408177,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL5069689,=,nM,18.1,CHEMBL203,Homo sapiens,IC50,nM,18.1,C=CC(=O)Nc1cccc(-n2c(=O)c(-c3ccccc3)nc3cnc(Nc4ccc(OC)cc4)nc32)c1,7.7423214251308154
24409324,CHEMBL5045723,Inhibition of human recombinant EGFR incubated for 1 hrs by HTRF KinEASE TK assay,B,CHEMBL5092606,=,nM,7137.0,CHEMBL203,Homo sapiens,IC50,nM,7137.0,CN(C)C(=O)c1ccc(Nc2ncc(C(F)(F)F)c(N[C@H]3CC[C@@H](N)CC3)n2)cc1,5.146484303243072
24413777,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5094406,=,nM,18.7,CHEMBL203,Homo sapiens,IC50,nM,18.7,C=CC(=O)Nc1cc(Nc2nccc(Nc3cnn(CC)c3)n2)c(OC)cc1N(C)CCN(C)C,7.728158393463501
24661286,CHEMBL5096403,Inhibition of EGFR (unknown origin) incubated for 40 mins by intrinsic ATPase activity luminescence assay,B,CHEMBL5173408,=,nM,88.3,CHEMBL203,Homo sapiens,IC50,nM,88.3,O=C(Cc1csc2nc3ccccc3n12)Nc1cccc2ccccc12,7.054039296422431
24663662,CHEMBL5097717,Inhibition of EGFR T790M mutant (unknown origin),B,CHEMBL5201387,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,uM,0.18,C=CC(=O)Nc1ccc(Nc2nccc(-c3cn(C)c4ccccc34)n2)cc1,6.7447274948966935
24663666,CHEMBL5097720,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL5208349,=,nM,8000.0,CHEMBL203,Homo sapiens,IC50,uM,8.0,CCC/C=C/C(=O)Nc1cc(Nc2ncc(-c3cc4ccccc4n3C)c(C)n2)c(OC)cc1N(C)CCN(C)C,5.096910013008056
24663672,CHEMBL5097724,Inhibition of EGFR L858R/T790M double mutant (unknown origin) in presence of ATP by ADP-Glo assay,B,CHEMBL5196024,=,nM,27.5,CHEMBL203,Homo sapiens,IC50,nM,27.5,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(SCCCN4CCOCC4)cc3)ncc2Cl)c1,7.560667306169737
24663675,CHEMBL5097726,Inhibition of EGFR (unknown origin) by ADP-Glo kinase assay,B,CHEMBL5181237,=,nM,3.76,CHEMBL203,Homo sapiens,IC50,nM,3.76,Brc1cccc(Nc2ncnc3[nH]ccc23)c1,8.424812155072338
24663680,CHEMBL5097728,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5203640,=,nM,88.0,CHEMBL203,Homo sapiens,IC50,nM,88.0,C=CC(=O)N1CCCC(n2nc(-c3ccc4ccccc4c3)c3c(N)ncnc32)C1,7.055517327849832
24663686,CHEMBL5097732,Inhibition of EGFR (unknown origin) incubated for 30 min in presence of ATP by fluorescence based assay,B,CHEMBL5187375,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,uM,0.18,Cc1nn(-c2ccc(F)cc2)c2c(Nc3ccc(F)c(Cl)c3)ncnc12,6.7447274948966935
24663688,CHEMBL5097734,"Inhibition of recombinant EGFR (unknown origin) using Poly-(Glu,Tyr 4:1) peptide as a substrate in presence of ATP by luminescence based assay",B,CHEMBL5198368,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09,CC1=NNC2=NC(=O)NC(c3ccccc3Br)C12,7.045757490560675
24663691,CHEMBL5097735,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL4209019,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1,CN(C)C1CCN(c2ccc(Nc3cc4c(N5CCC(CO)CC5)nc(Nc5ccc(F)cc5)nc4cn3)nc2)CC1,8.958607314841775
24663702,CHEMBL5097745,"Inhibition of recombinant C-terminal His-tagged/N-terminal GST-tagged human EGFR expressed in sf9 insect cells using poly(Glu, Tyr) sodium salt (4:1, Glu:Tyr) as a substrate measured after 40 mins by Kinase-Glo reagent based luminescence analysis",B,CHEMBL5206805,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2,Fc1cccc(COc2ccc(Nc3ncnc4sc5c(c34)CCCC5)cc2Cl)c1,6.698970004336019
24663715,CHEMBL5097758,Inhibition of recombinant EGFR (unknown origin) using TMB as substrate incubated for 3 hrs in presence of ATP by ELISA,B,CHEMBL4780534,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,uM,0.027999999999999997,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(OC)cc3)nc3c2CSCC3)c1,7.552841968657781
24663912,CHEMBL5097849,Inhibition of recombinant EGFR (unknown origin) expressed in baculovirus incubated for 10 mins by europium-labeled antiphosphotyrosine/enhancement solution based assay,B,CHEMBL5195593,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2,Cc1ccc(/C=N/NC(=O)CNc2nc(-c3ccccc3)c(-c3ccccc3)s2)cc1,6.698970004336019
24670251,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5198920,=,nM,7.696,CHEMBL203,Homo sapiens,IC50,nM,7.696000000000001,C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N(C)CCN(C)C)cc3OC)nc3[nH]ccc23)CC1,8.113734940970243
24687381,CHEMBL5104377,Inhibition of EGFR (unknown origin),B,CHEMBL5189340,=,nM,0.45,CHEMBL203,Homo sapiens,IC50,nM,0.45,CN(C)c1ccc(/C=N/NC(=O)Cn2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)cc1,9.346787486224656
24688644,CHEMBL5104912,Inhibition of EGFR (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method,B,CHEMBL4114766,=,nM,368.0,CHEMBL203,Homo sapiens,IC50,nM,368.0,CC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1,6.434152181326482
24713078,CHEMBL5110647,Inhibition of recombinant human EGFR incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,B,CHEMBL5194543,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,uM,0.18,Cc1ccc(-c2c(CN3CCCCC3)nc3scc(C(=O)O)n23)cc1,6.7447274948966935
24723688,CHEMBL5113705,Inhibition of EGFR (unknown origin),B,CHEMBL5178922,=,nM,10.3,CHEMBL203,Homo sapiens,IC50,nM,10.3,O=C(CCCCCCN1CC(c2ccc3ncnc(Nc4ccc(Br)cc4F)c3c2)N=N1)NO,7.987162775294828
24724836,CHEMBL5114135,Inhibition of wild-type EGFR (unknown origin),B,CHEMBL5192318,=,nM,1547.0,CHEMBL203,Homo sapiens,IC50,uM,1.547,NNC(=O)/C=C1/Nc2ccc(Br)cc2NC1=O,5.810509686300632
24726365,CHEMBL5114503,Inhibition of EGFR L858R/T790M mutant (unknown origin),B,CHEMBL5206715,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2,CCc1cc(Nc2ncc(Br)c(Nc3ccc4nccnc4c3P(C)(C)=O)n2)c(OC)cc1N1CCC(N2CCN(CCS(C)(=O)=O)CC2)CC1,9.698970004336019
24731156,CHEMBL5115839,Inhibition of wild type EGFR (unknown origin) incubated for 10 mins by HTRF KinEASE-TK assay,B,CHEMBL5196498,=,nM,3230.0,CHEMBL203,Homo sapiens,IC50,nM,3230.0,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(=O)CCCC(=O)Nc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)cc3OC)ncc2C(F)(F)F)c1,5.490797477668897
24749345,CHEMBL5120449,Inhibition of wild type EGFR expressed in human NCI-H2073 cells,B,CHEMBL5177023,=,nM,545.0,CHEMBL203,Homo sapiens,IC50,nM,545.0,Cc1c(C#Cc2ccc(CN3CCC(CO)CC3)cc2)cc(C(F)F)c2cn(C(C(=O)Nc3nccs3)c3ncn4c3CCC43CC3)nc12,6.2636034977233574
24752269,CHEMBL5121366,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL2029438,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7,C=CC(=O)Nc1cccc(N2C(=O)N(Cc3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.154901959985743
24756990,CHEMBL5122790,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL5174109,=,nM,304.0,CHEMBL203,Homo sapiens,IC50,uM,0.304,CN(C)CCN(C)c1ccc(Nc2ncc3cc(CNc4ccccc4)n(C4CCCC4)c3n2)cc1,6.517126416391246
24769892,CHEMBL5125953,Inhibition of EGFR L858R mutant (unknown origin) using peptide substrate by FRET assay,B,CHEMBL5192185,=,nM,5670.0,CHEMBL203,Homo sapiens,IC50,uM,5.67,C#Cc1cccc(Oc2ncnc3ccc(OCc4ccc(S(=O)(=O)N(C)C#C)cc4)cc23)c1,5.246416941107094
24772920,CHEMBL5127052,Inhibition of wild type EGFR (unknown origin) incubated for 40 mins by Kinase-Glo Plus luminescence kinase assay,B,CHEMBL5191956,=,nM,5700.0,CHEMBL203,Homo sapiens,IC50,uM,5.7,COc1cc(NC(=O)CCCCCCC(=O)NO)ccc1Nc1nccc(-c2cn(C)c3ccccc23)n1,5.2441251443275085
24772921,CHEMBL5127053,Inhibition of N-terminal GST-tagged recombinant human EGFR (669 to 1210 residues) L858R/T790M double mutant expressed in baculovirus infected Sf21 cells incubated for 1 hr in presence of ATP by caliper mobility shift assay,B,CHEMBL5173070,=,nM,43.1,CHEMBL203,Homo sapiens,IC50,nM,43.1,CN1CCN(c2ccc(Nc3ncc(Br)c(Nc4ccc5cn[nH]c5c4)n3)cc2)CC1,7.3655227298392685
24772928,CHEMBL5127060,Inhibition of human EGFR expressed in baculovirus expression system using CAGAGAIETDKEYYTVKD as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 1 hr by TR-FRET assay,B,CHEMBL5182231,=,nM,35.5,CHEMBL203,Homo sapiens,IC50,nM,35.5,O=C(Cc1ccccc1)Nc1cccc(-c2nc3n(c2-c2ccnc(Nc4ccc(N5CCOCC5)cc4)n2)CCS3)c1,7.449771646944906
24772931,CHEMBL5127063,Inhibition of GST-tagged EGFR (unknown origin) assessed as phosphorylation level using biotinylated peptide as substrate in presence of ATP by HTScan EGFR kinase assay,B,CHEMBL5186583,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,uM,0.039,CCc1nnc2c(Nc3ccc(C(=O)/C=C/c4cc(OC)c(OC)c(OC)c4)cc3)nc3ccccc3n12,7.4089353929735005
24772944,CHEMBL5127076,Inhibition of EGFR T790M mutant (unknown origin) incubated for 1 hr by Z-lyte kinase assay,B,CHEMBL5202119,=,nM,97.0,CHEMBL203,Homo sapiens,IC50,uM,0.09699999999999999,CCc1ccc(Cn2cc(-c3cc(-c4ccc(Br)cc4)nc(N)n3)c3ccccc32)cc1,7.013228265733755
24772950,CHEMBL5127078,Inhibition of EGFR (unknown origin),B,CHEMBL5193247,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0,C=CC(=O)Nc1cc2c(cc1OCCNC(=O)CN(C)C)NCN=C2Nc1ccc(Br)cc1F,8.698970004336019
24772957,CHEMBL5127082,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins in presence of ATP by caliper mobility shift assay,B,CHEMBL5207327,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02,COc1cc2c(cc1OC)C(Oc1cccc(NC(=S)Nc3ccc(Cl)c(C(F)(F)F)c3)c1)=NCN2,7.698970004336019
24772972,CHEMBL5127091,Inhibition of EGFR (unknown origin) by ADP-Glo kinase assay,B,CHEMBL5169900,=,nM,11120.0,CHEMBL203,Homo sapiens,IC50,uM,11.12,COc1ccc(CCOc2ccc(C(=O)/C=C/c3ccc(O)c(O)c3)cc2OC)cc1OC,4.953895212753961
24776464,CHEMBL5128251,Inhibition of EGFR (unknown origin) using poly (glu-tyr) as substrate incubated for 1 hr in presence of ATP measured by ADP-Glo kinase assay,B,CHEMBL5201532,=,nM,7.85,CHEMBL203,Homo sapiens,IC50,nM,7.85,COc1cc(/C=C/S(=O)(=O)c2ccccc2)cc(OC)c1OC,8.105130343254748
24779298,CHEMBL5129114,Inhibition of EGFR (unknown origin) assessed as kinase activity by measuring ATP remaining for 40 mins in presence of ATP by Kinase-Glo Plus luminescence kinase assay,B,CHEMBL5185952,=,nM,55000.0,CHEMBL203,Homo sapiens,IC50,uM,55.0,O=C(Cc1csc2nc3ccccc3n12)Nc1cccc(O)c1,4.259637310505756
24795676,CHEMBL5133513,Inhibition of EGFR tyrosine kinase (unknown origin) preincubated for 5 mins followed by substrate addition and further incubated for 10 mins in presence of ATP by fluorescence based microplate reader analysis,B,CHEMBL185686,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9,O=c1c2cccc(O)c2oc2cccc(O)c12,6.045757490560675
24795712,CHEMBL5133518,Inhibition of EGFR tyrosine kinase (unknown origin),B,CHEMBL5192793,=,nM,0.15,CHEMBL203,Homo sapiens,IC50,nM,0.15,COc1ccc(-c2cc(=O)cc(-c3ccc(OC)cc3)o2)cc1,9.823908740944319
24796314,CHEMBL5133605,Inhibition of EGFR (unknown origin),B,CHEMBL5192184,=,nM,342.0,CHEMBL203,Homo sapiens,IC50,uM,0.342,COc1cc(-c2nc3ccccc3s2)ccc1OCC(=O)NNC(=O)CN1CCC[C@H]1C(=O)O,6.465973893943865
24814234,CHEMBL5138009,Inhibition of EGFR derived from human A-431 cells using copolymer of Glu/Ala/Tyr as substrate by scintillation counting method,B,CHEMBL60472,=,nM,3600.0,CHEMBL203,Homo sapiens,IC50,uM,3.6,COc1ccc2c(C(=O)Nc3ccccc3)c(SSc3c(C(=O)Nc4ccccc4)c4ccc(OC)cc4n3C)n(C)c2c1,5.443697499232713
24814242,CHEMBL5138014,Inhibition of EGFR in human A-431 cell membrane vesicles using phospholipase C-gamma-1 as substrate incubated for 10 mins by scintillation counter method,B,CHEMBL153206,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2,COc1ccc2[nH]c3ncnc(Nc4cccc(Br)c4)c3c2c1,8.920818753952375
24814248,CHEMBL5138015,Displacement of 32P-labeled ATP from EGFR derived from human A-431 cell membrane vesicles using copolymer of Glu/Ala/Tyr as substrate incubated for 10 mins by scintillation counting method,B,CHEMBL309276,=,nM,1620.0,CHEMBL203,Homo sapiens,IC50,uM,1.62,O=C(O)CCC1C(S)=Nc2ccccc21,5.790484985457369
24814250,CHEMBL5138016,Inhibition of EGFR derived from human A-431 cell membrane vesicles using copolymer of Glu/Ala/Tyr as substrate by scintillation counting method,B,CHEMBL156797,=,nM,850.0,CHEMBL203,Homo sapiens,IC50,uM,0.85,O=C(CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)Nc2ccccc2)[nH]c2ccccc12)Nc1ccccc1,6.070581074285707
24815694,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL4294264,=,nM,1935.0,CHEMBL203,Homo sapiens,IC50,uM,1.935,COc1cc2ncnc(Nc3ccc(-c4cc(-c5ccc(Br)cc5)c(C#N)c(=N)[nH]4)cc3)c2cc1OC,5.71331903064507
24815714,CHEMBL5138512,Inhibition of EGFR (unknown origin) using biotin as substrate incubated for 2 hrs by HTRF assay,B,CHEMBL4077930,=,nM,83900.0,CHEMBL203,Homo sapiens,IC50,uM,83.9,COc1cc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c4ccccc34)c2cc1OC,4.0762380391713
24815724,CHEMBL5138520,Inhibition of wildtype EGFR (unknown origin) incubated for 40 mins by luminescence based assay,B,CHEMBL4746995,=,nM,3200.0,CHEMBL203,Homo sapiens,IC50,uM,3.2,Cn1cc(-c2ccnc(Nc3ccc(C(=O)NCCCCCCC(=O)NO)cc3)n2)c2ccccc21,5.494850021680094
24815734,CHEMBL5138527,Inhibition of EGFR (unknown origin) by microplate reader,B,CHEMBL5190121,=,nM,86.7,CHEMBL203,Homo sapiens,IC50,nM,86.7,CCOCCSc1nc(-c2ccccc2Cl)nn1CCOCC,7.06198090252379
24823375,CHEMBL5140664,Inhibition of wild type EGFR (unknown origin) by mobility shift assay,B,CHEMBL5188618,=,nM,224.0,CHEMBL203,Homo sapiens,IC50,nM,224.0,COc1cc(N(C)CCN(C)C)c(NC(=O)c2cnccn2)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,6.649751981665837
24823384,CHEMBL5140665,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,B,CHEMBL5174232,=,nM,391.0,CHEMBL203,Homo sapiens,IC50,nM,391.0,COc1cc(N(C)CCN(C)C)c(NC(=O)c2ccncc2)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,6.407823242604133
24823400,CHEMBL5140666,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by mobility shift assay,B,CHEMBL5209075,=,nM,420.0,CHEMBL203,Homo sapiens,IC50,nM,420.0,COc1cc(N(C)CCN(C)C)c(NC(=O)c2ccnc(Cl)c2)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,6.376750709602099
24824725,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5209276,=,nM,290.0,CHEMBL203,Homo sapiens,IC50,nM,290.0,CNC(=O)c1cnc(Nc2ccnc(N3CCC(O)CC3)n2)cc1NC(C)C,6.537602002101044
24824779,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5185287,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0,CNc1ncc(C(C)C)c2cc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)ncc12,5.0
24824969,CHEMBL5141246,Inhibition of N-terminal GST tagged recombinant human EGFR L858R mutant (668 to end residues) expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5095169,=,nM,7.4,CHEMBL203,Homo sapiens,IC50,nM,7.4,CO[C@@H]1CCN(c2nccc(Nc3cc4c(C(C)C)ccc(N5C[C@H](CS(C)(=O)=O)[C@H]5C)c4cn3)n2)C[C@@H]1F,8.130768280269024
24833300,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4090601,=,nM,88.0,CHEMBL203,Homo sapiens,IC50,nM,88.0,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc4ccccc4c3)c3c(N)ncnc32)C1,7.055517327849832
24833337,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL2179119,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,nM,1000.0,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1,6.0
24833374,CHEMBL5143773,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in mouse BaF3 cells,B,CHEMBL5206600,=,nM,662.0,CHEMBL203,Homo sapiens,IC50,nM,662.0,CCC(=O)N1CCC[C@@H](N2CC(c3cccc(F)c3Cl)=C(C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,6.1791420105603
24833378,CHEMBL5143776,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL4228518,=,nM,189.0,CHEMBL203,Homo sapiens,IC50,nM,189.0,CN(C)CCOc1ccc(Nc2ncc3nc(Sc4ccc(F)cc4)n(C4CCOCC4)c3n2)cc1,6.723538195826756
24833389,CHEMBL5143781,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) in human NCI-H1975 cell,B,CHEMBL5179288,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2,N#Cc1ccc(O)c(-c2nc(NCc3ncccn3)c3ccccc3n2)c1,5.920818753952375
24833555,CHEMBL5143814,Inhibition of N-terminal GST fused EGFR (668 to 1091 residues) (unknown origin) using poly (Glu-Tyr) E4Y1 peptide as substrate incubated for 2 hrs by ADP-Glo reagent method,B,CHEMBL3989868,=,nM,449.0,CHEMBL203,Homo sapiens,IC50,nM,449.0,Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1,6.347753658996677
24846751,CHEMBL5146949,Inhibition of wild type EGFR (unknown origin) incubated for 1 hr in the presence of ATP by FRET based Z'-LYTE assay,B,CHEMBL5194482,=,nM,261.2,CHEMBL203,Homo sapiens,IC50,nM,261.2,C=CC(=O)Nc1cccc(Cn2c(=O)ccc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1,6.583026827396964
24848031,CHEMBL5147184,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells using kinase substrate 22 incubated for 30 mins in presence of ATP,B,CHEMBL5186362,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3,C=CC(=O)N1C[C@@H]2C[C@H]1CN2C(=O)Oc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC,9.522878745280337
24849483,CHEMBL5147517,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5095068,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,nM,35.0,COc1cc(N2CCC3(CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,7.455931955649724
24863001,CHEMBL5150886,Inhibition of EGFR (unknown origin) by colorimetric assay,B,CHEMBL5173862,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0,N#CC1=C(c2ccccc2)Nc2c(c(-c3cccs3)nn2-c2ccccc2)C12C(=O)Nc1ccc(Cl)cc12,6.920818753952375
24863089,CHEMBL5150940,Inhibition EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5203118,=,nM,28.8,CHEMBL203,Homo sapiens,IC50,nM,28.8,C=CC(=O)Nc1cccc(N2C(=O)OCc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,7.540607512240769
24867150,CHEMBL5151935,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL5201128,=,nM,6500.0,CHEMBL203,Homo sapiens,IC50,nM,6500.0,COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)NC5CC5)CC4)c(Cl)c3)c2cc1C(N)=O,5.187086643357144
24871120,CHEMBL5153034,Inhibition of wild type EGFR (unknown origin) preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5206697,=,nM,1795.3,CHEMBL203,Homo sapiens,IC50,nM,1795.3,COc1cc2ncnc(Nc3cc(Cl)c(F)cc3O)c2cc1O,5.7458629691145315
24877607,CHEMBL5155250,Displacement of sapitinib-BODIPY tracer from C-terminal NanoLuc-fused full length wild type EGFR (unknown origin) transfected in HEK293T cells incubated for 2 hrs by NanoBRET assay,B,CHEMBL5188399,=,nM,6700.0,CHEMBL203,Homo sapiens,IC50,nM,6700.0,C=CC(=O)Nc1ccc(OC)c(Nc2cc(-c3[nH]c(SC)nc3-c3cccc(NC(=O)c4c(F)ccc(O)c4CN4C(=O)c5ccccc5C4=O)c3)ccn2)c1,5.173925197299173
24902217,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5186969,=,nM,251.3,CHEMBL203,Homo sapiens,IC50,nM,251.3,Nc1ccc2ncnc(Nc3ccc4c(c3)CCC4)c2c1,6.599807511407424
24902265,CHEMBL5161054,Inhibition of recombinant human EGFR L858R/T790M double mutant using GGMEDIYFEFMGG as substrate in presence of ATP by radiometric assay,B,CHEMBL5169547,=,nM,13.7,CHEMBL203,Homo sapiens,IC50,nM,13.7,C=CC(=O)Nc1ccc2ncnc(Nc3ccc4[nH]ccc4c3)c2c1,7.863279432843593
24919428,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5194174,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(-c2cn(S(C)(=O)=O)c3ccccc23)n1,8.721246399047171
24919498,CHEMBL5165819,Inhibition of wild type EGFR (unknown origin) by ELISA,B,CHEMBL5176897,=,nM,816.0,CHEMBL203,Homo sapiens,IC50,nM,816.0,CCS(=O)(=O)n1cc(-c2nc(Nc3cc(Cl)c(N4CCC(N5CCN(C)CC5)CC4)cc3OC)ncc2Cl)c2ccccc21,6.088309841246139
24957272,CHEMBL5214281,Selectivity interaction (MSD Pharma/Taiwan screen (enzymes and receptors) ) EUB0000296b EGFR,B,CHEMBL204232,=,nM,3260.0,CHEMBL203,Homo sapiens,IC50,uM,3.26,CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12,5.486782399932061
24957791,CHEMBL5214829,Selectivity interaction (Enzymatic activity assay) EUB0000596aBDA EGFR,B,CHEMBL2105712,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,9.301029995663981
24958595,CHEMBL5213079,Selectivity interaction (33P-ATP and filter-binding assay (Reaction Biology)) EUB0000646a EGFR,B,CHEMBL3936761,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6,C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1,8.585026652029182
24958838,CHEMBL5215097,Inhibition of EGFR wildtype (unknown origin) incubated for 40 mins in presence of ATP,B,CHEMBL5218998,=,nM,3200.0,CHEMBL203,Homo sapiens,IC50,uM,3.2,Cn1cc(-c2ccnc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)n2)c2ccccc21,5.494850021680094
24959055,CHEMBL5215199,Inhibition of human wild type GST-tagged EGFR expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 25 mins by HTRF assay,B,CHEMBL5218821,=,nM,1203.0,CHEMBL203,Homo sapiens,IC50,nM,1203.0,CCC(=O)Nc1cccc(-c2c(-c3ccccc3)[nH]c3ncnc(OC)c23)c1,5.919734372660155
24959087,CHEMBL5215210,Inhibition of EGFR L858R/T790M mutant (unknown origin),B,CHEMBL5218780,=,nM,916.0,CHEMBL203,Homo sapiens,IC50,nM,916.0,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4c3CC(c3ccccc3)N4)[nH]2)cc1,6.03810452633215
24959104,CHEMBL5215214,Inhibition of human GST-tagged EGFR L858R/T790M mutant expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 20 mins by HTRF assay,B,CHEMBL5220645,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1,CCC(=O)Nc1cccc(-c2c(-c3ccc(N4CCN(C)CC4)cc3)[nH]c3ncnc(OC(C)C)c23)c1,10.0
24959108,CHEMBL5215215,Inhibition of human GST-tagged EGFR L858R/T790M/C797S mutant expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 10 mins by HTRF assay,B,CHEMBL5218797,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0,CCC(=O)Nc1cccc(-c2c(-c3ccc(N4CCN(C)CC4)cc3)[nH]c3ncn(C4CCCCC4)c(=O)c23)c1,7.657577319177793
24959112,CHEMBL5215216,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5219777,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1,CC(=O)N[C@H]1CC[C@@H](N2C(=O)N(c3ccccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)CC1,8.508638306165727
24959115,CHEMBL5215219,Inhibition of human wild type EGFR using ATP-labelled peptide substrate by HTRF assay,B,CHEMBL5172794,=,nM,430.0,CHEMBL203,Homo sapiens,IC50,nM,430.0,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1,6.366531544420414
24959131,CHEMBL5215227,Inhibition of EGFR (unknown origin),B,CHEMBL268501,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0,Cc1ccc2c(-c3ccccc3)nc(=O)n(C(C)C)c2c1,8.698970004336019
24959150,CHEMBL5215241,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins in presence of ATP by caliper mobility shift assay,B,CHEMBL5218459,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02,COc1cc2ncnc(Oc3cccc(NC(=S)Nc4ccc(Cl)c(C(F)(F)F)c4)c3)c2cc1OC,7.698970004336019
24962904,CHEMBL5216306,Inhibition of EGFR (unknown origin) incubated for 1 hr in presence of ATP by Kinase-Glo Plus luminescence kinase assay,B,CHEMBL5221067,=,nM,0.47,CHEMBL203,Homo sapiens,IC50,nM,0.47,N#Cc1c(NC(=O)CNc2n[nH]c3ncccc23)sc2c1CCCC2,9.327902142064282
24976266,CHEMBL5224779,Inhibition of EGFR d746-750/T790M/C797S triple mutant (unknown origin),B,CHEMBL5287438,=,nM,39.6,CHEMBL203,Homo sapiens,IC50,nM,39.6,C=CC(=O)N1CCCCCCn2cc(c3ccccc32)-c2ccnc(n2)Nc2cccc1c2,7.402304814074488
24985438,CHEMBL5227743,Inhibition of EGFR (unknown origin),B,CHEMBL5282499,=,nM,4900.0,CHEMBL203,Homo sapiens,IC50,uM,4.9,COc1ccc(-c2cc(=O)oc3c(O)c(O)ccc23)cc1O,5.309803919971486
24987506,CHEMBL5228534,Inhibition of human EGFR in presence of ATP by Kinase-Glo Plus luminescence kinase assay kit method,B,CHEMBL5281486,=,nM,4180.0,CHEMBL203,Homo sapiens,IC50,uM,4.18,COc1cc(/C=N/NC(=O)COC2=NC(C)=NC3C2C(C)=NN3c2ccccc2)cc(OC)c1OC,5.3788237182249645
24987532,CHEMBL5228551,Inhibition of EGFR (unknown origin) by EGFR Kinase Assay Kit method,B,CHEMBL5288191,=,nM,5827.0,CHEMBL203,Homo sapiens,IC50,uM,5.827,COc1nc2ccccc2cc1-c1nc2c(cnn2-c2ccc(Br)cc2)c(=O)[nH]1,5.23455498190985
24987554,CHEMBL5228562,Inhibition of EGFR (unknown origin) phosphorylation by ELISA,B,CHEMBL5276251,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09,O=C(/C=C/c1ccc(F)cc1)c1cc(Br)cc2cc(-c3ccccc3)oc12,7.045757490560675
24987563,CHEMBL5228569,Inhibition of EGFR (unknown origin),B,CHEMBL5272853,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,uM,0.045,Cc1cc(NC2=NC(=O)/C(=C/c3c4ccccc4cc4ccccc34)S2)no1,7.346787486224656
24987579,CHEMBL5228581,Inhibition of EGFR (unknown origin) by ELISA,B,CHEMBL5266387,=,nM,38.8,CHEMBL203,Homo sapiens,IC50,uM,0.0388,Cc1ccc2c(=O)n(Cc3ccccc3)c(SCc3cn(-c4ccc(C(=O)O)cc4)nn3)nc2c1,7.411168274405793
24987584,CHEMBL5228585,Inhibition of EGFR (unknown origin) phosphorylation using kit-tyr4 peptide as substrate incubated for 1 hr in presence of ATP by UV-Vis spectrophotometer,B,CHEMBL5286373,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,uM,0.22,COc1ccc(CNc2nc3ccccc3c(NCc3ccc(OC)cc3)c2[N+](=O)[O-])cc1,6.657577319177793
24993531,CHEMBL5230828,Inhibition of EGFR (unknown origin) using TK as substrate incubated for 30 min in presence of ATP by TR-FRET assay,B,CHEMBL5272590,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0,C=CC(=O)Nc1ccc2ncc(NC(=O)Nc3ccccc3)nc2c1,7.6020599913279625
24997676,CHEMBL5232098,Inhibition of wild type human EGFR measured by ELISA analysis,B,CHEMBL5291481,=,nM,102.0,CHEMBL203,Homo sapiens,IC50,uM,0.102,O=c1c2ccc(Cl)cc2nc(-c2ccccc2)n1-c1nnc(-c2ccccc2C2CC2)o1,6.991399828238082
24999311,CHEMBL5232555,Inhibition of EGFR (unknown origin),B,CHEMBL5286675,=,nM,2230.0,CHEMBL203,Homo sapiens,IC50,uM,2.23,CN(C)c1ccc(/C=C/c2cc(C(=O)O)c3cc(Br)ccc3n2)cc1,5.651695136951839
24999351,CHEMBL5232559,Inhibition of human EGFR,B,CHEMBL5274305,=,nM,37.07,CHEMBL203,Homo sapiens,IC50,nM,37.07,COc1ccc2nc(Cl)c(/C=C/C(=O)c3ccc(C)cc3)cc2c1,7.430977413970436
25003722,CHEMBL5234032,Inhibition of human EGFR L858R/T790M mutant (696 to 1022 residues) expressed in insect sf9 cells in presence of ATP by HTRF assay,B,CHEMBL4443062,=,nM,0.26,CHEMBL203,Homo sapiens,IC50,nM,0.26,O=C(Nc1nccs1)C(c1cc(F)ccc1O)N1Cc2ccc(-c3ccc(N4CCNCC4)cc3)cc2C1=O,9.585026652029182
25015449,CHEMBL5238131,Inhibition of EGFR (unknown origin),B,CHEMBL4286374,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0,O=C(Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)c1ccc(C(F)(F)F)cc1O,6.920818753952375
25018495,CHEMBL5238867,Inhibition of EGR-induced wild type EGFR phosphorylation in human A-431 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL4650319,=,nM,34.5,CHEMBL203,Homo sapiens,IC50,nM,34.5,C=CC(=O)Nc1cc(Nc2ncc(C(=O)OC(C)C)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.462180904926726
25023159,CHEMBL5240016,Inhibition of wild type EGFR (unknown origin) autophosphorylation by Kinase-Glo luminescent assay,B,CHEMBL5269391,=,nM,87.27,CHEMBL203,Homo sapiens,IC50,nM,87.27,Fc1ccc(Nc2ncnc3ccc4c(c23)OCCN4)cc1Cl,7.059135024033278
25028977,CHEMBL5241194,Inhibition of human EGFR,B,CHEMBL5277101,=,nM,610.0,CHEMBL203,Homo sapiens,IC50,uM,0.61,CN(CCOC(=O)c1ccc(C(=O)Nc2ncnc3c2c(-c2ccc(Cl)cc2)nn3C(C)(C)C)nc1)Cc1ccc(C(=O)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)cc1,6.214670164989233
25028981,CHEMBL5241198,Inhibition of human EGFR phosphorylation by invitro enzyme assay,B,CHEMBL5290094,=,nM,102.0,CHEMBL203,Homo sapiens,IC50,uM,0.102,COc1cccc(-c2cc(=O)c3ccccc3o2)c1NC(=O)OCCOC(=O)NCCN(C)CCN/N=N/c1ccc2c(Nc3cccc(Cl)c3)ncnc2c1,6.991399828238082
25033659,CHEMBL5242668,Inhibition of EGFR (unknown origin),B,CHEMBL5289623,=,nM,4310.0,CHEMBL203,Homo sapiens,IC50,nM,4310.0,C=CC(=O)N1CCc2ccc(N3C(=O)CCc4cnc5ccc(-c6cnn(C)c6)cc5c43)cc21,5.3655227298392685
25035245,CHEMBL5243099,Inhibition of EGFR (unknown origin) incubated for 1 hr in presence of ATP by ADP-Glo kinase assay,B,CHEMBL5273124,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,uM,2.8,CCOc1ccc2nc(NC(=O)CSc3nnc(Cc4c[nH]c5ccccc45)o3)sc2c1,5.552841968657781
25036499,CHEMBL5243469,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4650281,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1,C=CC(=O)N[C@H]1C=C(C)c2c(-c3cnc4ccccc4c3)c3c(N)ncnc3n2C1,8.958607314841775
25036505,CHEMBL5243471,Inhibition of EGFR (unknown origin),B,CHEMBL5286014,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0,C=CC(=O)N1CCC[C@H](n2nc(C(=O)c3ccc(CC(=O)N(C)C)c(C)c3C)c3c(N)ncnc32)C1,7.187086643357144
25036511,CHEMBL5243475,Inhibition of EGFR T790M/C797S mutant (unknown origin),B,CHEMBL4095447,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9,C=CC(=O)N1CCC[C@@H](n2nc(-c3cccc4ccccc34)c3c(N)ncnc32)C1,8.721246399047171
25036514,CHEMBL5243477,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL5268867,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0,N#C/C(=C/C(=O)N1CCC[C@@H](n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)C1)C1CC1,8.698970004336019
25036561,CHEMBL5243511,Inhibition of human recombinant His-tagged EGFR expressed in baculovirus using poly-Gluo-Tyr as a substrate measured after 24 hrs by western blot analysis,B,CHEMBL475584,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,nM,150.0,COc1cccc(-c2cn(-c3ccc(CCN4CCC(O)CC4)cc3)c3ncnc(N)c23)c1,6.823908740944319
25037442,CHEMBL5243749,Inhibition of EGFR (unknown origin),B,CHEMBL1095259,=,nM,44640.0,CHEMBL203,Homo sapiens,IC50,uM,44.64,N=C1N=C(NCCS(=O)(=O)O)/C(=C/C(O)CNC(=O)c2cc(Br)c(Br)[nH]2)N1,4.350275814070478
25043255,CHEMBL5245316,Inhibition of EGFR (unknown origin),B,CHEMBL5279914,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02,COc1cc(C(=NC#N)c2csc(-c3ccccc3)n2)cc(OC)c1OC,7.698970004336019
25046103,CHEMBL5246174,Inhibition of EGFR (unknown origin) infected in insect sf9 cells incubated for 1 hrs in presence of ATP,B,CHEMBL4216765,=,nM,3600.0,CHEMBL203,Homo sapiens,IC50,uM,3.6,COc1ccc(C(=O)n2nc(-c3cccnc3)nc2N)cc1,5.443697499232713
25059890,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5288957,=,nM,609.0,CHEMBL203,Homo sapiens,IC50,uM,0.609,COc1cc2c(Nc3ccc(-c4ccccc4)cc3)ncnc2cc1OCC1CCN(C)CC1,6.215382707367125
25066902,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL3973435,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2,C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1,8.920818753952375
25067027,CHEMBL5251914,Inhibition of human EGFR preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5276374,=,nM,621.0,CHEMBL203,Homo sapiens,IC50,nM,621.0,C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4cc(OC)c(C)c(OC)c4)nn32)CC1,6.20690839982342
25073465,CHEMBL5253687,Inhibition of EGFR (unknown origin) using flurogenic substrate in presence of ATP,B,CHEMBL5270270,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,nM,44.0,COc1cc2ncnc(NCCOc3ccccc3F)c2cc1OC,7.356547323513813
25073488,CHEMBL5253702,Inhibition of EGFR autophosphorylation in human NCI-H292 cells harboring harboring wild type EGFR preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5280555,=,nM,3900.0,CHEMBL203,Homo sapiens,IC50,uM,3.9,CC(C)n1nc(N)c2cnc(Nc3ccnc(-c4cnn(S(=O)(=O)C5CC5)c4)n3)cc21,5.4089353929735005
25078681,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5282641,=,nM,0.053,CHEMBL203,Homo sapiens,IC50,nM,0.053,C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2O[C@H]2CCOC2)CC1,10.275724130399212
25078762,CHEMBL5255141,Inhibition of wild type EGFR (unknown origin),B,CHEMBL3545154,=,nM,0.137,CHEMBL203,Homo sapiens,IC50,nM,0.137,C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1,9.863279432843592
25084778,CHEMBL5256648,Inhibition of recombinant human EGFR del19/T790M using biotinEEPLYWSFPAKKK-NH2 as substrate incubated for 120 mins by TR-FRET assay,B,CHEMBL5265881,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2,C=CC(=O)N1CCC(n2cc(-c3cnc4ccccc4c3)c3c(N)ncnc32)C1,8.920818753952375
25086625,CHEMBL5256977,Inhibition of EGFR (unknown origin),B,CHEMBL5287042,=,nM,134.0,CHEMBL203,Homo sapiens,IC50,nM,134.0,CCc1c(C(=O)NCCc2ccccc2)[nH]c2ccc(C)cc12,6.872895201635193
25089030,CHEMBL5257509,Inhibition of recombinant 6His-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) autophosphorylation expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP and MgCl2 addition measured after 60 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL5275872,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5,COc1cc(/C=C2\CC(C)C/C(=C\c3cc(OC)c(OC)c(OC)c3Br)C2=NO)c(Br)c(OC)c1OC,6.301029995663981
25091695,CHEMBL5258481,Inhibition of EGFR (unknown origin) by Z'LYTE assay,B,CHEMBL5271284,=,nM,197.0,CHEMBL203,Homo sapiens,IC50,nM,197.0,C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3C)c3c(N)ncnc32)C1,6.705533773838407
25094726,CHEMBL5259685,Inhibition of EGFR L858R/T790M double mutant (unknown origin) pre-incubated for 10 mins followed by substrate addition measured after 60 mins in presence of ATP by mobility shifting assay,B,CHEMBL5284780,=,nM,1.08,CHEMBL203,Homo sapiens,IC50,nM,1.08,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)NC3CC3)n2)c(OC)cc1N(C)CCN(C)C,8.96657624451305
25098067,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL5270693,=,nM,0.008,CHEMBL203,Homo sapiens,IC50,nM,0.008,COc1cc(N2CCC(N(C)C)CC2)ccc1Nc1ncc(C(=O)Oc2ccccc2)c(-c2c[nH]c3ccccc23)n1,11.096910013008056
25098082,CHEMBL5260456,Inhibition of EGFR L858R mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 15 mins by HTRF assay,B,CHEMBL5275642,=,nM,0.17,CHEMBL203,Homo sapiens,IC50,nM,0.17,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(C(=O)OC(C)C)c(-c2cn(C)c3ccccc23)n1,9.769551078621726
25104807,CHEMBL5262914,Inhibition of EGFR (unknown origin),B,CHEMBL185853,=,nM,1440.0,CHEMBL203,Homo sapiens,IC50,uM,1.44,Cc1ccc(Nc2ncnn3cccc23)cc1O,5.841637507904751
25105694,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5284972,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,uM,0.046,CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ccc5c4)n3)cc2)CC1,7.337242168318426
25106404,CHEMBL5263429,"Inhibition of EGFR (unknown origin) using (Glu, Tyr) 4:1 as substrate incubated for [gamma-32P]-ATP incubated for 60 mins by scintillation counter analysis",B,CHEMBL244948,=,nM,7670.0,CHEMBL203,Homo sapiens,IC50,uM,7.67,O=c1ccc2ccc(O)c(O)c2o1,5.115204636051019
25456678,CHEMBL5320277,Inhibition of wild type EGFR (unknown origin) preincubated for 5 mins followed by substrate and ATP addition and further incubated for 30 mins by HTRF assay,B,CHEMBL5398727,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1,CN1C(=O)C(C(=O)NN)N(C)c2ccccc21,7.0
25465447,CHEMBL5323119,Inhibition of EGFR (unknown origin) in presence of ATP,B,CHEMBL5431583,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0,CN(Cc1ccccc1)c1ncnc2[nH]c(-c3ccc(CO)cc3)cc12,7.698970004336019
25482720,CHEMBL5327705,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,B,CHEMBL5430683,=,nM,722.0,CHEMBL203,Homo sapiens,IC50,nM,722.0,Cn1cc(-c2ccnc(Nc3ccc(OCCOCCn4ccnc4[N+](=O)[O-])c(F)c3)n2)c2ccccc21,6.141462802430361
25482738,CHEMBL5327706,Inhibition of wild type EGFR (unknown origin) by mobility shift assay,B,CHEMBL5418313,=,nM,9201.0,CHEMBL203,Homo sapiens,IC50,nM,9201.0,Cc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)ccc1OCCOCCn1ccnc1[N+](=O)[O-],5.036164969297852
25495790,CHEMBL5330554,Inhibition of EGFR L858R/T790M/C797S triple mutant in human NCI-H1975 cells assessed as cell growth inhibition measured after 72 hrs by CellTiter-Glo assay,B,CHEMBL5424516,=,nM,12400.0,CHEMBL203,Homo sapiens,IC50,uM,12.4,COc1cc2ncnc(NCc3ccc(NC(=O)C(c4ccccc4)N4Cc5ccccc5C4=O)cc3)c2cc1OCCCN1CCOCC1,4.906578314837765
25497465,CHEMBL5330922,Inhibition of N-terminal His6-tagged human EGFR L858R/T790M/C797S mutant expressed in Sf9 cells assessed as decrease in substrate phosphorylation using Ulight-JAK1 peptide as substrate incubated for 1.5 hrs in presence of ATP by TR-FRET based LANCE Ultra kinase assay,B,CHEMBL5429263,=,nM,32000.0,CHEMBL203,Homo sapiens,IC50,uM,32.0,C=CC(=O)Nc1cc(-c2ccccc2)ccn1,4.494850021680094
25497470,CHEMBL5330925,Inhibition of N-terminal His6-tagged human EGFR L858R/T790M/C797S mutant expressed in Sf9 cells assessed as decrease in substrate phosphorylation incubated for 45 mins using Srctide as substrate in presence of 5uM of ATP by microplate reader analysis,B,CHEMBL5400930,=,nM,599.0,CHEMBL203,Homo sapiens,IC50,nM,599.0,C=CC(=O)Nc1cc(-c2cn(C)c3ccccc23)ncn1,6.2225731776106885
25498343,CHEMBL5331234,Inhibition of EGFR del19 mutant in human HCC827 cells,B,CHEMBL5196318,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCn2cc(COc3cc4ncnc(Nc5ccc(F)c(Cl)c5)c4cc3NC(=O)/C=C/CN3CCCCC3)nn2)C(C)(C)C)cc1,8.221848749616356
25500484,CHEMBL5332003,Inhibition of EGFR (unknown origin),B,CHEMBL608533,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.522878745280337
25520576,CHEMBL5337218,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL5439991,=,nM,52.29,CHEMBL203,Homo sapiens,IC50,nM,52.29,COc1cc(N2CCC(N3CCN(C)CC3)CC2)c(C)cc1Nc1nccc(-n2cc(CNCCO)c(-c3ccccc3)n2)n1,7.281581358170344
25533344,CHEMBL5341566,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) preincubated for 10 mins followed by ATP and substrate addition and measured after 60 mins by plate reader analysis,B,CHEMBL5427561,=,nM,177.0,CHEMBL203,Homo sapiens,IC50,nM,177.0,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)cc2cnn(CCN(C)C)c12,6.752026733638194
25533399,CHEMBL5341567,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5407309,=,nM,1060.0,CHEMBL203,Homo sapiens,IC50,nM,1060.0,CCS(=O)(=O)n1cc(-c2ccnc(Nc3cc(NC(C)=O)c4c(cnn4CCN(C)C)c3)n2)c2ccccc21,5.97469413473523
25536081,CHEMBL5342465,Inhibition of EGFR (unknown origin) in presence of ATP by Z-LYTE based FRET assay,B,CHEMBL5406924,=,nM,118.0,CHEMBL203,Homo sapiens,IC50,nM,118.0,Cc1cccc(CN(C)c2ncnc3[nH]c(-c4ccc(CO)cc4)cc23)c1,6.928117992693875
25552252,CHEMBL5346377,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells incubated for 4 hrs by HTRF assay,B,CHEMBL5208056,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0,O=C(Nc1nccs1)C(c1ncn2c1C[C@@H](F)C2)n1cc2c(Cl)cc(-c3ccc(N4CCOCC4)cc3)c(Cl)c2n1,8.221848749616356
25556368,CHEMBL5347320,Inhibition of EGFR (unknown origin),B,CHEMBL5400975,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06,CC1=NNC2Oc3ncn(N)c(=N)c3C(c3ccccc3Br)C12,7.221848749616356
25588792,CHEMBL5355226,Inhibition of EGFR (unknown origin) by filter binding method,B,CHEMBL5404368,=,nM,712.0,CHEMBL203,Homo sapiens,IC50,nM,712.0,C=CC(=O)N1CC[C@@H](N2N=C(Nc3ccc(Oc4ccccc4)cc3)c3c[nH]c4ncnc2c34)C1,6.147520006363144
25599162,CHEMBL5358073,Inhibition of EGFR Del19/T790M/C797S mutant (unknown origin) phosphorylation,B,CHEMBL5427952,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nmol/L,30.0,CC[C@H](C)Nc1cc(Nc2ccnc(-c3cnn(S(=O)(=O)C4CC4)c3)n2)ncc1C(=O)N1CC(C(C)(C)O)C1,7.522878745280337
25601089,CHEMBL5358605,Inhibition of EGFR (unknown origin),B,CHEMBL5425121,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0,c1ccc2c(c1)CCN2c1ncnc2cc3c(cc12)NCN3CCN1CCCC1,7.494850021680094
25601107,CHEMBL5358616,Inhibition of EGFR T790M/L858R mutant (unknown origin),B,CHEMBL5400539,=,nM,8.4,CHEMBL203,Homo sapiens,IC50,nM,8.4,O=C(N/N=C/c1cnc(N2CCCC2)nc1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@@H]1CCOC1,8.075720713938118
25614335,CHEMBL5361793,Inhibition of human EGFR using MEK1 as substrate incubated for 40 mins by gamma33P-ATP based scintillation counter analysis,B,CHEMBL5405436,=,nM,5900.0,CHEMBL203,Homo sapiens,IC50,uM,5.9,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\CNc3ccc(F)cc32)c1C,5.229147988357856
25665172,CHEMBL5374826,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using polyE4Y1 as substrate incubated for 5 mins with compound followed by substrate addition measured after 60 mins in presence of ATP by ADP-Glo reagent based assay,B,CHEMBL5420857,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0,CN(C)CCn1ccc2cc(Nc3nccc(-n4ccnc4-c4ccc(F)cc4)n3)ccc21,7.769551078621726
25665233,CHEMBL5374830,Inhibition of EGFR L858R mutant (unknown origin) using polyE4Y1 as substrate incubated for 5 mins with compound followed by substrate addition measured after 60 mins in presence of ATP by ADP-Glo reagent based assay,B,CHEMBL5414782,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1,CC(=O)Nc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccc4c(ccn4CCN(C)C)c3)n2)s1,8.67778070526608
25682155,CHEMBL5380163,Inhibition of EGFR (unknown origin) by KINOMEscan method,B,CHEMBL2093753,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,nmol/L,79.0,O=C(Cc1cccs1)Nc1cccc(-c2ccc3nnc(-c4cccnc4)n3n2)c1,7.102372908709558
25692040,CHEMBL5382485,Inhibition of EGFR T790M mutant (unknown origin) using Tyr 04 peptide as substrate incubated for 1 hrs in the presence of ATP by FRET-based Z'-Lyte assay,B,CHEMBL5400371,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,uM,0.21,C#CCCC(=O)N1CCN(c2ccc(Nc3ncc(Cl)c(Oc4cccc(NC(=O)CCCCc5cc5=O)c4)n3)c(OC)c2)CC1,6.6777807052660805
25697631,CHEMBL5384093,Inhibition of EGFR (unknown origin),B,CHEMBL5412768,=,nM,580.0,CHEMBL203,Homo sapiens,IC50,nM,580.0,COc1cc2ncnc(N[C@H](C)c3cccc4ccccc34)c2cc1OC,6.236572006437063
25700929,CHEMBL5384910,Inhibition of human partial length EGFR (R669 to V1011 residues) L858R/T790M mutant expressed in mammalian expression system by KINOMEscan analysis,B,CHEMBL5408234,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N(C)C)cc3)nc3ccc(Cl)cc23)c1,5.7447274948966935
25705893,CHEMBL5386729,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using poly (Glu,Tyr) as substrate incubated for 40 mins in presence of ATP by Kinase-Glo luminescent analysis",B,CHEMBL5408255,=,nM,152.0,CHEMBL203,Homo sapiens,IC50,nM,152.0,CCOC(=O)c1c(-n2ccnc2)nc2ccc(Br)cc2c1N1CCN(c2ccccc2NS(=O)(=O)c2ccc(F)cc2)CC1,6.818156412055227
25706001,CHEMBL5386735,Inhibition of EGFR (unknown origin),B,CHEMBL5206476,=,nM,5300000.0,CHEMBL203,Homo sapiens,IC50,mM,5.3,O=C1c2ccccc2CN1C(c1nc(=O)c2ccccc2[nH]1)c1cc(F)ccc1O,2.275724130399211
25706594,CHEMBL5386905,Inhibition of recombinant EGFR (unknown origin) by kinase glo detection reagent based assay,B,CHEMBL5398753,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,nM,98.0,O=C(CSc1nc2ccccc2c(=O)n1CCc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(Cl)nn2)cc1,7.008773924307505
25755813,CHEMBL5446118,Affinity Biochemical interaction: (DELFIA/Time-Resolved Fluorometry Enzyme Assay (inhibition autophosphorylation of the cytoplasmic domain of EGFR)) EUB0000654a EGFR,B,CHEMBL178654,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,nM,34.0,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,7.468521082957745
25776074,CHEMBL5468487,Selectivity interaction (Invitrogen SelectScreen (enzymatic activity assay)) EUB0000045b EGFR,B,CHEMBL4091991,=,nM,4280.0,CHEMBL203,Homo sapiens,IC50,nM,4280.0,C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NS(C)(=O)=O)cc5)cc4c32)ccc1C,5.368556230986828
